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Abstract 
The ‘endless forms most beautiful’ that populate our planet rely on the process of 
cell division to ensure equal segregation of the cellular content including the DNA 
to the two daughter cells. The accurate segregation of chromosomes in eukaryotes 
relies on connection between replicated sister chromatids, a phenomenon known 
as sister chromatid cohesion. Sister chromatid cohesion is mediated by a 
conserved ring-like protein complex known as cohesin. Defects in this process can 
promote aneuploidy and contribute to meiotic segregation errors with adverse 
consequences for developing embryos. Despite numerous advances into 
understanding cell division at the molecular level, we still lack a comprehensive list 
of the participating proteins and complexes. The aim of this thesis was to use 
available functional genomic and proteomic data to identify novel regulators of 
mitosis in human cells. Using an RNAi approach, we identified a set of factors 
involved in pre-mRNA splicing whose depletion prevents successful cell division. 
Loss of these splicing factors leads to a failure in chromosome alignment and to a 
protracted mitotic arrest that is dependent on the spindle assembly checkpoint. 
This mitotic phenotype was accompanied by a dramatic loss of sister chromatid 
cohesion that we could show happens as soon as DNA replication. While depletion 
of pre-mRNA splicing mediators had no effect on cohesin loading onto chromatin, it 
prevented the stable association of cohesin with chromatin. Immunoblotting 
revealed that the depletion of splicing factors caused a 5-fold reduction in the 
protein levels of Sororin, a protein required for stable association of cohesin with 
chromatin in post-replicative cells. Further analysis suggests erroneous splicing of 
Sororin pre-mRNA upon depletion of splicing factors. Importantly, the sister 
chromatid cohesion loss caused by depletion of splicing factors could be 
suppressed by a Sororin transgene that lacks introns. Our results suggest that that 
pre-mRNA splicing of Sororin is a rate-limiting step in the maintenance of sister 
chromatid cohesion in human cells. Our work reveals that a primary cellular 
pathology of compromised pre-mRNA splicing is a mitotic arrest accompanied by 
split sister chromatids. Our work linking splicing and sister chromatid cohesion has 
implications for the pathology of Chronic Lymphocytic Leukemia (CLL). One of the 
splicing factors that we implicate in sister chromatid cohesion is SF3B1, whose 
gene is one of the most frequently mutated genetic drivers found in CLL patients. 
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Chapter 1. Introduction 
All living organisms, irrespective of their status in evolution, consist of the same 
elementary unit; the cell. In 1858, espousing Theodore Schwann and Mathias 
Schleiden’s views on life, Rudolph Virchow is famous to have declared, ‘Omnis 
cellula e cellula’ or that all cells arise from pre-existing cells (Tan and Brown, 2006). 
Over 150 years later, we are still unsure about many of the molecular mechanisms 
that allow a cell to dutifully duplicate itself. Organisms, no matter the number of 
cells they possess, arise from a single cell that undergoes repeated cycles of cell 
division during which the genetic material is accurately partitioned into the two 
daughter cells. Defects in cell division therefore have adverse consequences not 
just for the cell but also for the organism as a whole. Deciphering the intriguing 
mechanisms that underpin cell division is important not only for decrypting one of 
the many mysteries of the cell but also for developing therapeutic tools to combat 
cancer. 
1.1 The cell cycle 
The cell reproduces by firstly duplicating its contents and then by redrawing its 
boundaries. In the process, it passes though a carefully regulated cycle of events 
called the cell cycle. This process of duplication of cellular content followed by 
division must be carried out with an extraordinary amount of precision, which is why 
a number of checks and balances exist along a cell’s journey to divide itself.  
1.1.1 Cell cycle phases and checkpoints 
The cell cycle in eukaryotes consists of two morphologically distinct phases: 
Interphase and M phase (Figure 1). Interphase in turn is made up of three sub 
phases; the first gap phase (G1-phase), synthesis phase (S-phase), and second 
gap phase (G2-phase). The length of the different phases while tightly controlled, 
can be varied by a number of internal and external stimuli. Interphase, seemingly a 
period of stupor for the cells is actually a period of intense activity wherein the cell 
readies itself for division by duplicating its genetic material (DNA replication) and 
various cellular organelles. In G1-phase, cells restart among others, the 
transcription, translation and transport machinery that had been shut off during the 
preceding mitosis. Having laid the ground work to duplicate itself in the subsequent 
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phases, cells pass through a restriction point that provides a binary decision 
system based on an assessment of whether the cells are ready to pass through to 
the next stage or if they need to pause in the cell cycle. In case conditions are 
unfavourable for the cell to progress through, it either pauses in G1-phase or it 
enters a prolonged quiescent phase termed G0-phase. Under favourable conditions, 
cells initiate S-phase during which the genomic DNA is replicated (Masai et al., 
2010). This process is initiated at specific locations within chromosomes termed the 
origins of replication. At these sites, the DNA double helix is opened up to 
accommodate a number of accessory proteins and enzymes that lead to DNA 
synthesis in a bidirectional and semi conservative manner (Masai et al., 2010). As 
soon as the DNA is replicated, the ‘sister’ DNA molecules are held in place 
together through a tight linkage termed cohesion (Nasmyth and Haering, 2009). 
This cohesion is vital for the cell division process and will be discussed in more 
detail later. 
After having duplicated the DNA and the various cellular organelles in S-phase and 
the subsequent G2-phase, cells enter mitotic phase or M phase. M phase of the cell 
cycle is visually more dynamic with the cell undergoing rapid changes in 
morphology over a relatively short period of time (Flemming, 1882). Through a 
series of choreographed steps, the cell first condenses the DNA to form the 
chromosomes following which the cell segregates them to opposite ends. The 
physical force required for the above essential process is provided by one of the 
cytoskeletal components of the cell; the microtubules. These polymers of the 
tubulin protein, help by attaching to the kinetochores that link the sister chromatids 
of the chromosomes and begin to pull them to opposite poles. A counteracting 
force is exerted by the cohesion machinery, which is the linkage between the sister 
chromatids. This tug of war results in tension that is sensed by the cells. When and 
only when tension is detected across all the chromosomes, a number of signalling 
cascades fire up within the cell, one of which serves to sever the cohesion between 
the sister chromatids that leads to the segregation of the DNA towards the opposite 
poles (Musacchio and Salmon, 2007) (Figure 4).  
The other organelles in the cell such as the centrosome, the ER, the Golgi etc 
would now have segregated through distinct mechanisms (Lowe and Barr, 2007). 
Subsequently, the cell undergoes a series of morphological changes in between 
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the separated chromosomal masses that results in the division of the cell. This 
process is referred to as cytokinesis and completes cell division. The story ends 
differently depending on the cell type but in essence, a barrier is brought in 
between the two nascent cells and the cell is said to have divided into its two 
daughter cells (Barr and Gruneberg, 2007, Green et al., 2012). 
Progression through the cell cycle is controlled by a series of checkpoints (Figure 
1). The first of these checkpoints that the cell encounters is the G1/S checkpoint or 
Start. The presence of favourable conditions activates G1/S and S phase cyclins 
(See section 1.1.2) resulting amongst other events in the phosphorylation of 
proteins that are required for initiating DNA replication. 
  
Figure 1 The eukaryotic cell cycle  
The eukaryotic cell cycle is divided into distinct phases that include interphase (made 
up of G1, S and G2-phases, shown in increasing intensities of Red) and M phase or 
mitotic phase. Within the cell cycle, cells face a number of regulatory hurdles or 
checkpoints that ensure a successful passage of the cell through the cell cycle. These 
checkpoints include the G1-S checkpoint that monitors cell growth and growth signals, 
the intra-S phase checkpoint that monitors DNA replication, the G2-M checkpoint that 
monitors completion of DNA replication and repair processes and the Spindle 
assembly checkpoint (SAC) in mitosis that monitors the error free attachment of 
kinetochores to microtubules. (Adapted from: The cell cycle: Principles of control by 
David Morgan). 
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A different checkpoint exists within S phase that ensures that the DNA replication is 
error free. This checkpoint can also sense damage to the DNA and can regulate 
the replication fork progression in response to damage (Gottifredi and Prives, 2005, 
Jones and Petermann, 2012). In addition to this, DNA damage sensing checkpoints 
exist between the G1/S and the G2/M transitions to assess if there have been any 
damage inflicted upon the DNA and if so, the checkpoint pauses the cell cycle to 
allow the cells time to repair the damage. This checkpoint is crucial to avoid 
transmission of damaged DNA to daughter cells during mitosis leading to genomic 
instability (Harrison and Haber, 2006) Additionally, the transition from G2 phase 
into mitosis is also carefully monitored. Cyclin B-Cdk1 (M phase cyclins), 
phosphorylate key proteins thereby regulating the irreversible entry into mitosis. 
The cell encounters yet another checkpoint during the metaphase to anaphase 
transition in mitosis. This checkpoint, also known as the spindle assembly 
checkpoint (SAC), ensures that cells are allowed to segregate their chromosomes 
and exit mitosis if and only if they have achieved bi-orientation or the stable 
engagement of both the kinetochores of every one of their chromosomes with 
either of the two spindle poles. Unattached kinetochores can send out a signal that 
can delay the segregation of chromosomes until bi-orientation is achieved across 
the board. Upon satisfying the SAC, the anaphase promoting complex or 
cyclosome (APC/C), which initiates the destruction of cyclins and the cleavage of 
the cohesin ring that holds the sister chromatids together, triggers chromosome 
segregation and anaphase onset. The SAC is important because it helps trigger a 
synchronized splitting of sister chromatids globally within the cell in an irreversible 
manner. Concurrently, the destruction of the cyclins along with the activity of 
phosphatases leads to the inactivation of CDKs and the dephosphorylation of CDK 
substrates. This in turn causes leads to the completion of mitosis (mitotic exit) and 
sets the stage for cytokinesis. 
1.1.2 Regulation of the cell cycle 
Considering that fact that the fate of the organism as a whole depends of repeated 
rounds of cell division happening accurately and at a precise time, a number of 
regulatory mechanisms have evolved to control progression through different 
stages of the cell cycle. Failure to follow this pattern of regulated cell growth and 
division could have disastrous consequences for the stability of the genome and 
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the overall viability or fitness of the organism. A number of regulatory pathways in 
the cell cycle function through checkpoints which are one way transitioning sentries 
along the cell cycle that act as decision points for the cell to proceed to the next 
phase provided it has passed through the preceding phase successfully (Hartwell 
and Weinert, 1989). 
Cellular factors that help the cells in traversing between the different stages of the 
cell cycle had been postulated a long time ago. Using cell hybrid experiments, it 
was demonstrated that fusing a cell in S-phase with another in G1-phase induced 
DNA replication in the fusion. It was also shown that fusing a G1 cell with one that 
was in G2-phase (about to enter mitosis), prevented mitotic entry (Rao and Johnson, 
1970). These experiments suggested the existence of physical entities or factors 
that when transferred from one cell to another could influence cell cycle 
progression in the latter. In 1971, Yasuo Masui and Clement Markert identified 
Maturation Promoting Factor (MPF Aka Mitosis Promoting Factor) that in frog 
oocytes induced meiosis even in the presence of protein synthesis inhibitors (Masui 
and Markert, 1971). It was further demonstrated that MPF oscillated through the 
cell cycle suggesting that it might be linked to a cell cycle clock within the cell 
(Masui, 1982). Following this, MPF was shown not only to initiate mitosis in other 
eukaryotes and but also to have an enzymatic activity and that this enzymatic 
activity was sufficient to induce mitosis (Gerhart et al., 1984). In 1983, Tim Hunt, 
while studying protein synthesis in post fertilized frog oocytes, discovered that 
although several proteins accumulated after fertilization of the oocyte, one of them 
disappeared abruptly at the time of cell division. Upon correlating with the cell cycle 
phase, it was shown that the disappearance of the protein occurred at mitosis. The 
protein was named Cyclin after its cyclical pattern of appearance and 
disappearance in the oocytes (It was named Cyclin ostensibly after the favourite 
hobby of the head of the study at that time; cycling) (Evans et al., 1983). The 
existence of cyclins in multiple species was then demonstrated amid the 
observation that addition of cyclins to mitotic extracts led to its disappearance in a 
short span of time implying its degradation through proteolysis. This discovery 
coupled with the finding that the activation of MPF required synthesis of new 
proteins raised the interesting possibility that cyclins were probably linked to MPF. 
After a number of discoveries over the years including the Cyclin Dependent 
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Kinase 1 (cdk1 or cdc2) in fission yeast (Nurse, 1990) and its regulation in higher 
eukaryotes (Morgan, 1995, Bloom and Cross, 2007), it has now been established 
that indeed cyclins form a complex with cyclin dependent kinase to form MPF, to 
define specific stages in the cell cycle. It was also discovered that even though 
CDK protein levels remained constant through the cell cycle, its activation required 
association with its partner, Cyclin, whose levels fluctuated through the cell cycle. 
In a testament to the indispensable requirement and evolutionary conservation of 
CDKs, replacing the S. cerevisiae CDC2 kinase, a key regulator of mitosis, with its 
human counterpart remarkably supported cell viability and growth (Lee and Nurse, 
1987). As their name indicates, CDKs are a family of catalytic serine threonine 
kinase proteins that require association with cyclins, the regulatory subunit of the 
complex to be functional. The binding of cyclins induces a conformational change 
in the kinase that allows it to bind to ATP and a substrate to catalyse the transfer of 
the γ phosphate to the target serine or threonine residue on the substrate.  
In budding and fission yeast, there is only one critical cell cycle CDK protein and 
binding to a diverse range of cyclins generates specificity for each cell cycle phase. 
Different cyclin proteins dominate at different phases of the cell cycle and are 
thought to be crucial for specifying target specificity for CDK based phosphorylation 
(Ubersax et al., 2003, Loog and Morgan, 2005, Jeffrey et al., 1995, Kitagawa et al., 
1996).  
In higher eukaryotes, cells contain a range of cyclin-CDK complexes that regulate 
distinct stages of the cell cycle.  
 
Figure 2 Major transition events of the cell cycle and the cyclins that mediate 
them  
A schematic diagram depicting the major classes of cyclins in the vertebrate cell cycle 
and their abundance. Also shown is the activity level of the anaphase promoting 
complex or cyclosome (APC/C) that targets proteins for proteolytic degradation 
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inducing irreversible cell cycle transitions. (Adapted from: The cell cycle: Principles of 
control by David Morgan) 
 
Firstly, the G1-phase cyclins (cyclin D1, D2 and D3 in vertebrates), in association 
with CDKs (CDK4 and CDK6 in vertebrates) coordinates extracellular factors and 
cell growth with entry into the cell cycle. The levels of these cyclins rise in response 
to cell growth and other extracellular growth signals. G1/S Cyclins (cyclin E1 and E2 
in vertebrates) on the other hand, accumulate in G1-phase and drop precipitously 
during entry into S-phase. The START or the restriction point is a checkpoint and is 
a point of no return in the transition from the G1-S-phase. The restriction point in 
mammalian cells is regulated by the Rb pathway, so named because mutations in 
the primary effector of the pathway, pRb (retinoblastoma protein) led to the 
retinoblastoma (Weinberg, 1995). The primary function of the G1/S cyclins seem to 
be to overcome the restriction point and initiate the programme for entry into S-
phase. These cyclins form complexes with CDK proteins (CDK2 in vertebrates). 
Cyclin D-CDK4/6 and Cyclin E-CDK2 together phosphorylate and inactivate the 
pRB pathway thereby activating E2F to allow transcription of its target genes and 
promote G1/S transition. Chief among these targets include DNA replication factors, 
proteins required in the nucleotide synthesis pathways among others (Tanaka and 
Araki, 2010, Talluri and Dick, 2012).  
S-phase cyclins (cyclin A1 and A2 in vertebrates) also accumulate along with G1/S 
cyclins and complex with CDK1 and CDK2 in vertebrates. Even though these 
cyclins are produced in G1-phase, they remain inactive because of inhibitory 
binding to Sic1 protein in yeast (Schneider et al., 1996) and to proteins of the 
CIP/KIP family namely p21 and p27 in mammals (Nakayama and Nakayama, 
1998). Activation of G1/S cyclins leads to the phosphorylation of these inhibitors 
that eventually leads to their ubiquitylation and degradation by the SCF (Skp, Cullin 
& F box containing complex) pathway (Verma et al., 1997, Koivomagi et al., 2011). 
This results in the activation of the S-phase cyclins that in turn switch on the DNA 
replication machinery. The levels of these cyclins remain high in S-phase through 
to mitosis.  
M-phase cyclins (cyclin B in vertebrates) form complexes with CDK1 in all 
eukaryotes. Their levels rise in G2 phase, but the activity of these complexes are 
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suppressed by both inhibitory phosphorylations on CDK1 and also through binding 
to CDK inhibitors (CKIs) (Harper et al., 1993). The M-phase cyclins peak at 
metaphase and preside over the dramatic scheme of events during mitosis. Once 
bi-orientation of all chromosomes is complete, the mitotic cyclins are targeted for 
proteolytic degradation by the APC/C. 
1.1.3 Mitosis in mammalian cells 
The mitotic phase of the cell cycle albeit smaller in duration, is visually much more 
dramatic than the interphase. In the late 1880s, Wilhelm Waldeyer introduced the 
term chromosome to 19th century cytologists (Zacharias, 2001).  About 10 years 
earlier, Walther Flemming, the father of cytogenetics, was studying cell division in 
cells derived from the fins and gills of salamanders. He observed the process of 
cell division and made detailed sketches of the process. He named the nuclear 
material that was being distributed between the two daughter cells, chromatin 
(Greek for coloured substance) and he called the process of division, Mitosis (Mito 
being Greek for threads) (Flemming, 1882, Mitchison and Salmon, 2001). Mitosis, 
the process of cellular division, has been studied extensively over the past 100 
years or so and can be divided into distinct stages that differ dramatically in cellular 
morphology.  
 
Figure 3 Mitotic phases in a mammalian cell  
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Images of HeLa cells depicting the various stages of mitosis in animal cells with tubulin 
stained in green, the actin cytoskeleton in red and the DNA (DAPI) in blue. Cells enter 
mitosis with a replicated pairs of sister DNA molecules and cellular contents. As cells 
enter prophase and prometaphase, the nuclear envelope breaks down and the mitotic 
spindle starts attaching to the chromosome through their kinetochores. Attachment of 
the kinetochores of all the chromosomes in the cell leads to their plate-like 
arrangement in the equator of the cell in metaphase.  Upon satisfying the SAC, cells 
transit from metaphase to anaphase wherein the sister chromatids separate by being 
pulled towards opposite poles. Subsequently, a plasma membrane driven cleavage 
furrow forms and ingresses in the middle of the cell to cleave the cell into two daughter 
cells. 
 
The different stages of mitosis in mammalian cells are outlined in Figure 3 and will 
be discussed in detail below. Upon entry into mitosis, cells pass through prophase. 
In this phase, the nucleus, which contains the replicated DNA, undergoes an 
extensive process of condensation (Hirano and Mitchison, 1994). Concurrently, the 
centrosomes, the microtubule organizing centres of the cells, begin to disengage 
and migrate towards the opposite ends of the cell to form the spindle poles and 
setup the mitotic spindle (Rusan et al., 2001, Tanenbaum and Medema, 2010). At 
the end of prophase and towards the beginning of prometaphase, the nuclear 
envelope breaks down and the kinetochores of the chromosomes begin to attach 
themselves to the microtubules that are emanating from the spindle poles 
(Cheeseman and Desai, 2008). Both the copies of the replicated chromosomes, 
called sister chromatids, are held together by the cohesin ring complex (Nasmyth 
and Haering, 2009) (See section 1.2) 
The attachment of the pair of kinetochores on each chromosome to microtubules 
from the opposites poles attempts to pull the sister chromatids apart and this force 
is resisted by a phenomenon called sister chromatid cohesion (Nasmyth and 
Haering, 2009, Peters and Nishiyama, 2012). This opposition of the forces exerted 
by the microtubules is critical for successful segregation of chromosome to the two 
daughter cells. During metaphase, the force exerted by the microtubules aligns the 
chromosome at the equator of the cell and leads to tension at the kinetochores. 
Lack of tension at the kinetochores and unattached kinetochores contribute to the 
engagement of the SAC (Figure 4). The SAC subsequently inhibits the activity of 
the APC/C to prevent mitotic progression. Once all chromosomes have achieved 
bi-orientation, the SAC components dissociate away from the kinetochores and the 
SAC is turned off. The cell is now ready to perform nuclear division. This is set in 
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motion by the activity of the APC/C. The APC/C being an E3 ubiquitin ligase, 
mediates the ubiquitylation and the proteasome mediated destruction of a number 
of critical substrates in the cell including cyclin and securin leading to anaphase 
onset and exit from mitosis (Pines, 2011).  
 
Figure 4 Sister chromatid cohesion and chromosome segregation in vertebrates 
A successful segregation of sister chromatids to opposite poles requires concerted 
action of a number of players. The cohesin ring holds the sister chromatid together 
from DNA replication until they are ready to separate in anaphase. Cohesin is present 
both at the centromere and along the arms of the chromosomes and its removal of 
happens in two waves. In the first step, during prophase, the bulk of cohesin is 
removed from the arms while centromeric cohesion is retained until anaphase. The 
kinetochores of each sister chromatid has to be attached to microtubules from opposite 
spindle poles for them to be segregated. The presence of unattached kinetochores 
triggers the spindle assembly checkpoint (SAC) that prevents the onset of anaphase by 
inhibiting APC/C. Upon acheivement of ‘bi-orientation’, the SAC is turned off and the 
APC/C is activated. APC/C causes the degradation of securin, which liberates 
separase. The activated separase being a protease can cleaves the Scc1 subunit of 
cohesin at the centromeres and triggers the segregation of sister chromatids towards 
opposite poles. (Adapted from (Petronczki et al., 2003)) 
  
 
Securin is an inhibitor of the protease separase (Funabiki et al., 1996, Ciosk et al., 
1998). Upon removal of securin, separase is activated and it catalyses the 
cleavage of the SCC1 subunit of the cohesin ring, allowing the sister chromatids to 
be pulled away towards the spindle poles (Uhlmann et al., 1999, Peters and 
Nishiyama, 2012). In the early stages of anaphase, also known as anaphase A, the 
sister chromatids are pulled towards the spindle poles by the rapid shortening of 
the microtubules attached to the kinetochores. In the second stage of anaphase, 
anaphase B, the mitotic spindle elongates by increasing the pole-to-pole distance 
and this ensures the segregation of the chromosomes away from the equator of the 
Chapter 1 Introduction 
 
25 
cell. Simultaneously, the cell prepares to physically cleave the mother cell into two 
daughter cells. In animal cells, the mitotic spindle, including the spindle midzone 
and the astral microtubules, specifies the site of cytoplasmic division ensuring tight 
coordination between nuclear and cytoplasmic division. A subset of spindle pole 
derived microtubules different from the kinetochore microtubules, overlap at the 
equator of the cell. Further bundling and crosslinking of these microtubules by a 
number of microtubule binding and bundling proteins leads to the formation of the 
tightly bundled microtubule rich structure called the central spindle or the spindle 
midzone (Glotzer, 2005, Glotzer, 2009). The central spindle acts as the scaffold for 
a number of signalling proteins including kinases, structural proteins, regulators of 
RhoA GTPase and other proteins that are required to orchestrate the process of 
cytokinesis. In the final stage of mitosis, called telophase, the nuclear envelope 
begins to reform around the segregated DNA masses. The cell physically divides 
by initially forming membrane invaginations called cleavage furrows brought about 
by a contractile ring made of actin and myosin (Green et al., 2012, 
Balasubramanian et al., 2012). The ingression of the cleavage furrow proceeds 
until a dense remnant of the central spindle called the midbody remains at the 
narrow cytoplasmic bridge between the two daughter cells. The final severing of the 
connection between the two daughter cells happens a little while after telophase 
and involves the recruitment of microtubule severing proteins, membrane vesicles 
and membrane sculpting proteins around the midbody in a process called 
abscission (Guizetti and Gerlich, 2010).  
1.1.4 Multiple supervisory mechanisms regulate mitosis 
The successful execution of mitosis involves the accurate segregation and 
transmission of the genetic material to the daughter cells and the precise division of 
the cytoplasm into the two daughter cells. Strict regulatory mechanisms are in 
place to ensure that these processes occur at the right place and at the right time. 
The bulk of the regulatory mechanisms rely on modifications of the proteins 
involved in executing the processes. These modifications include a number of 
posttranslational processes such as phosphorylation by mitotic kinases such as 
Cdk1, Aurora Kinases and Polo-like kinase1, dephosphorylation of the substrates 
of these kinases by a variety of phosphatases and also other mechanisms like 
ubiquitin mediated proteolysis of specific targets. The phosphorylation and 
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dephosphorylation of specific targets provides the cell with a method to rapidly 
activate and deactivate a specific process or pathway during mitosis. Ubiquitin-
mediated proteolysis of substrates on the other hand gives directionality to the cells 
by providing an irreversible pathway towards mitotic exit. These regulatory 
mechanisms and their role in mediating specific aspects of mitosis will be 
discussed below. 
1.1.4.1 Phosphorylation and dephosphorylation based regulation of mitosis 
Multiple kinases and phosphatases carry out the posttranslational modification or 
adding or removing a phosphate group to specific residues on the substrate. Given 
the key role of cell proliferation in cancer, mitotic kinases are a promising cancer 
target and inhibitors against these kinases are in various stages of development 
(Perez de Castro et al., 2008). Chief among these kinases involved in regulating 
mitosis in mammalian cells are Cyclin dependent kinase 1, Aurora kinases family 
and Polo-like kinase 1 (PLK1) and they will be discussed further 
CDK1  
CDK1, controls entry into mitosis by targeted phosphorylation of a number of 
substrates. Phosphorylation by Cdk1-cyclin B complex is known to be required for 
a number of cellular changes during mitosis including but not limited to cell 
rounding, nuclear envelope breakdown, chromatin condensation, formation of 
bipolar spindle, dispersal of organelles etc. The levels of Cyclin B1, the principle 
mitotic Cyclin in vertebrates, rises through G2-phase and M-phase (Gavet and 
Pines, 2010) and associates with Cdk1 thenceforth. These complexes have an 
intricate localization pattern. Upon the formation of these complexes, they remain in 
the cytoplasm and show a marginal localization to the centrosomes in early 
prophase and remain there until late prophase, when they are abruptly translocated 
to the nucleus where it is involved in nuclear envelope breakdown. After the 
disintegration of the nuclear envelope however, Cyclin B-Cdk1 localizes to the 
cytoplasm. In spite of the fact that these complexes are present in G2-phase, they 
are kept inactive by the inhibitory phosphorylation on T14 and Y15 residues of 
Cdk1 by two kinases of the Wee1 related kinase family, wee1 and myt1(Piwnica-
Worms et al., 1991, McGowan and Russell, 1993, Mueller et al., 1995). myt1 is the 
key inhibitory kinase as it can phosphorylate both T14 and Y15 whereas wee1 can 
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only phosphorylate Y15. In addition to the inhibitory phosphorylation of Cdk1, Myt1 
binds to Cyclin B and prevents its translocation into the nucleus thereby preventing 
its activity in two different ways (Liu et al., 1999, Wells et al., 1999). At the 
beginning of mitosis, the phosphatase Cdc25 is activated by Cyclin B-Cdk1 
whereby it removes the inhibitory phosphorylations (T14 and Y15) resulting in a 
feedback loop of Cyclin B-Cdk1 activation that in turn leads to a hyper 
phosphorylation of wee1 and myt1 inactivating these kinases (Watanabe et al., 
1995, Nakajima et al., 2003). The combined action of these phosphorylation and 
dephosphorylation snowballs into a rapid increase in active CyclinB-Cdk1 
complexes during prophase. In mammalian cells, three variants of CDC25 namely 
CDC25A, CDC25B and CDC25C exist and they are all implicated in the activation 
of Cyclin B-CDK1. CDC25B is the first to be activated. Its levels increase at late S 
phase and remains high until prometaphase. CDC25B is thought to be involved in 
the initial activation of Cyclin B-CDK1 when the latter is still at the centrosomes and 
excluded form the nucleus (Lammer et al., 1998, De Souza et al., 2000). CDC25A 
and CDC25C are relatively inactive in G2-phase and gain activity in prophase. 
CDC25A levels increase in prophase due to drop in the rate of its degradation. 
While CDC25C levels remain constant throughout the cell cycle, the proportion of 
active CDC25C increases dramatically in prophase. Activation of CDC25A and 
CDC25C lead to a further activation of Cyclin B-CDK1 to the levels that are 
sufficient to drive the cell into mitosis (Izumi et al., 1992, Hoffmann et al., 1993, 
Strausfeld et al., 1994, Mailand et al., 2002). True to its status as a master 
regulator of mitosis, Cyclin B-Cdk1 phosphorylates a variety of effectors that each 
has roles in hundreds of pathways during mitosis (Holt et al., 2009, Dephoure et al., 
2008). These include mitotic cell rounding (Matthews et al., 2012), nuclear 
envelope breakdown and reformation (Guttinger et al., 2009), mitotic spindle 
assembly (Nigg et al., 1996, Wheatley et al., 1997), segregation of organelles in the 
secretory pathway  (Lowe et al., 1998, Preisinger and Barr, 2005) among others. 
Recent observations indicate that for mitotic entry of cells and for the continued 
maintenance of the phosphorylated state of Cyclin B-CDK1 substrates, in addition 
to the activation of Cyclin B-CDK1, it is necessary to inhibit the activity of PP2A, the 
phosphatase that dephosphorylates CDK1 substrates. These reports demonstrated 
that during mitosis, PP2A activity is inhibited by ARPP19 and alpha-endosulfine, 
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proteins that are activated by a kinase called greatwall (Gharbi-Ayachi et al., 2010, 
Mochida et al., 2010) 
Once the cell initiates chromosome segregation and the Cyclin B-CDK1 complex 
has achieved its objectives of phosphorylating and modulating the activity of its 
substrates, Cdk1 is inactivated by the proteolytic degradation of Cyclin B that is 
induced by the APC/C. The APC/C bound to its activator Cdc20, recognizes a D 
box domain (See section1.1.4.2) in cyclin B and targets it for ubiquitylation and 
subsequent degradation (Pines, 2011). However, in order to exit mitosis, it is not 
just sufficient that cells inactivate Cyclin B-CDK1, the many substrates of Cyclin B-
CDK1 also have to be dephosphorylated for the rapid reversal of processes that 
aided in mitotic entry (Wurzenberger and Gerlich, 2011, Guttinger et al., 2009, 
Moser and Swedlow, 2011). Cytokinesis is one such process that requires the 
inactivation of Cdk1 and the dephosphorylation of its substrates (Niiya et al., 2005, 
Potapova et al., 2006). 
 The identity of the protein phosphatase that dephosphorylates the substrates of 
CDK1 in animal cells has not been fully elucidated. In budding yeast, it has been 
shown that the activity of a phosphatase called Cdc14 is essential for mitotic exit 
(Stegmeier and Amon, 2004). However, Cdc14 phosphatase activity was shown 
not to be essential for mitotic exit in C.elegans (Saito et al., 2004) and knockouts of 
Cdc14A and B in chicken and human cells had no effect on mitosis although a 
modest increase in sensitivity to DNA damage was demonstrated (Mocciaro et al., 
2010). Evidence indicates that two phosphatases belonging to the phosphoprotein 
phosphatase (PPP) family of proteins could be the enzymes that dephosphorylate 
Cdk1 substrates. Evidence for PP1 to be a Cdk1 specific phosphatase comes from 
studies in multiple model organisms. In Drosophila cells, it was shown that 
mutations in one of the four PP1 genes lead to abnormalities in anaphase and 
errors in chromosome segregation (Axton et al., 1990). In frog egg extracts it was 
demonstrated that either immunodepletion or inhibition of PP1 resulted in reduced 
dephosphorylation of known Cdk1 substrates like Cdc27 (Wu et al., 2009). 
Additionally, it was shown in mice that increasing PP1 activity reduced Cdk1 
phosphorylation of its substrates (Manchado et al., 2010). On the other hand, there 
is also evidence to suggest that the phosphatase responsible for dephosphorylating 
Cdk1 substrates in human cells is PP2A. In-vitro experiments revealed that 
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synthetic peptides that carried phosphorylated version of Cdk1 consensus sites 
were the preferred targets for PP2A mediated dephosphorylation (Agostinis et al., 
1992). In addition, an siRNA screen based on time-lapse imaging in Hela cells 
revealed that depletion of PP2A and its regulatory subunit B55α led to delays in 
nuclear envelope reformation, chromosome decondensation, spindle disassembly 
and golgi reassembly, thus an overall delay in mitotic exit (Schmitz et al., 2010). In 
summary, PP1 and PP2A enzymes are likely to collaborate for the removal of 
CDK1 substrate phosphorylation during mitotic exit. 
Polo like Kinase 1 (PLK1) 
Apart from CDK1, PLK1 is a kinase that also plays critical roles in executing the 
process of mitosis. PLK1 is well conserved across eukaryotes and at least a single 
homolog of PLK1 is present in all eukaryotes. During early mitosis, PLK1 localizes 
to the centrosomes and the localization pattern switches to the kinetochores during 
the later stages of mitosis. In anaphase, PLK1 is seen to localize at the central 
spindle (Barr et al., 2004). The N terminus of PLK1 contains a kinase domain and 
the C terminus contains a polo box domain that is composed of a pair of polo box 
sequences called PB1 and PB2. The polo box domain is responsible for binding of 
PLK1 to specific substrates or structures and to localize to specific locations within 
the cell. The polo box domain has a higher affinity for proteins that are 
phosphorylated on a serine or threonine residue in the Polo box-binding region. 
Even though CDK1 is thought to usually provide the priming phosphorylation for 
these proteins (Elia et al., 2003), in late anaphase, a time when Cdk1 has been 
turned off, PLK1 has been shown to self-prime its targets (Neef et al., 2007, 
Burkard et al., 2009).  Like CDK1, PLK1 mediated phosphorylation is important for 
a number of cellular processes during mitosis and loss of its function either through 
mutations or through the use of small molecule inhibitors leads to aberrant 
monopolar spindles and a potent mitotic arrest (Sunkel and Glover, 1988, Lenart et 
al., 2007). PLK1 is involved in mitotic entry (Qian et al., 1998), assembly of mitotic 
spindle (Sumara et al., 2004), maturation of the centrosomes (Lane and Nigg, 1996, 
Santamaria et al., 2007, Oshimori et al., 2006) dispersal of secretory organelles 
(Sutterlin et al., 2001, Barr, 2002), resolution of sister chromatid cohesion at 
chromosome arms in prophase (Sumara et al., 2002), control of cytokinesis 
(Bastos and Barr, 2010, Petronczki et al., 2007, Burkard et al., 2007, Brennan et al., 
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2007) among other processes in the cell (Barr et al., 2004, Petronczki et al., 2008). 
The essential role of PLK1 in early mitotic events precluded the discovery of its 
critical function in cytokinesis until chemical genetic tools to inactivate PLK1 acutely 
and specifically at anaphase became available (Petronczki et al., 2007, Burkard et 
al., 2007, Brennan et al., 2007, Santamaria et al., 2007). Upon completion of 
mitosis, the KEN box domain in PLK1 is recognized by Cdh1, an activator of 
APC/CCdh1 and PLK1 is targeted for ubiquitylation and proteolytic degradation in 
late mitosis and early G1-phase (Lindon and Pines, 2004) 
Aurora kinase 
Another important group of kinases that regulate mitosis is the aurora family of 
kinases (Carmena et al., 2009, Carmena and Earnshaw, 2003, Ruchaud et al., 
2007). In metazoans, three different members of this family exist namely Aurora A, 
Aurora B and Aurora C. Aurora C is found exclusively in mammalian germ cells and 
its functions are presently unknown. All members of the Aurora kinase family have 
a catalytic kinase domain and varying lengths of other non-catalytic domains. The 
levels of Aurora A and B increases in mitosis and it appears that activation loop 
phosphorylation of these kinases is required for their activity. Aurora A localizes to 
the centrosome in and to the mitotic spindle and it has been shown to be required 
for centrosome maturation and for the proper assembly of the mitotic spindle (Barr 
and Gergely, 2007, Glover et al., 1995, Marumoto et al., 2005). Aurora A is also 
known to be important for the activation of PLK1 by phosphorylation of its 
regulatory T loop (Macurek et al., 2008). This is reversed by the activity of the 
phosphotase PP6 (Zeng et al., 2010). 
Aurora B on the other hand forms a complex with INCENP, Survivin and Borealin 
proteins, called the Chromosome Passenger Complex (CPC). Aurora B acts as the 
catalytic subunit of the CPC (Ruchaud et al., 2007). As cells enter mitosis, the CPC 
associates with chromatin and phosphorylates histone H3 at Ser10, a key mitotic 
marker. Additionally, the CPC through Aurora B, promotes the condensation of 
DNA, a process essential for mitosis by helping to recruit condensin, a protein 
complex that is known to be required for DNA condensation (Collette et al., 2011, 
Lipp et al., 2007). Additionally, the CPC is required for correcting erroneous 
microtubule-kinetochore interactions such as merotelic or syntelic attachments and 
is also required for proper functioning of the SAC (Cheeseman et al., 2002, Hauf et 
Chapter 1 Introduction 
 
31 
al., 2003, Tanaka et al., 2002, Carmena et al., 2012). Although it was suggested 
that the localization of Aurora B to the centromeres of chromosomes in early 
mitosis was essential towards its function of preventing erroneous microtubule-
kinetochore attachments (Cheeseman and Desai, 2008), recent evidence suggests 
that its centromeric localization may be dispensable (Campbell and Desai, 2013). 
During the later stages of mitosis, as the cell transits from metaphase to anaphase, 
the CPC shifts in its localization from centromeres to the spindle midzone 
(Ruchaud et al., 2007) where it forms a phosphorylation gradient (Fuller et al., 
2008). This translocation is crucial for a number of reasons. Firstly, Aurora B acts a 
regulator of the cytokinesis (Adams et al., 2000, Hauf et al., 2003, Kaitna et al., 
2000, Schumacher et al., 1998). Second, it ensures that the mitotic checkpoint 
components do not re-associate with kinetochores at anaphase onset (Vazquez-
Novelle and Petronczki, 2010). Recent reports have also proposed a novel role for 
Aurora B in the ‘Nocut’ checkpoint whereby the process of abscission is delayed 
until the chromatin is cleared away (Norden et al., 2006, Mendoza et al., 2009). 
Aurora B was shown to phosphorylate and activate CHMP4C, a key inhibitor of the 
process of abscission (Steigemann et al., 2009, Carlton et al., 2012). 
1.1.4.2 Regulation of mitotic exit by APC mediated proteolysis 
As mentioned above, ubiquitin mediated proteolysis of substrates gives 
directionality to the cell cycle during mitosis by providing an irreversible pathway 
towards mitotic exit based on degradation of key targets (Potapova et al., 2006). 
This process is mediated by the anaphase promoting complex/cyclosome (APC/C) 
(Pines, 2011). The APC/C is an E3 ubiquitin ligase that targets proteins for 
degradation through ubiquitylation and subsequent proteolysis through the 26S 
proteasome. There are two distinct activators whose function confers specificity to 
the activity of the APC/C. These are Cdc20 and Cdh1. Cdc20 is active during the 
metaphase to anaphase transition whereas Cdh1 is not active until late mitosis and 
G1-phase. The binding of APC/C to its activator Cdc20 requires phosphorylation of 
APC/C by Cdk1 and PLK1 (Shteinberg et al., 1999, Kramer et al., 2000, Golan et 
al., 2002, Kraft et al., 2003, Eytan et al., 2006). The APC/CCdc20  targets proteins for 
degradation during the critical metaphase to anaphase transition to initiate mitotic 
exit. The activity of the APC/CCdc20 is inhibited by the SAC (Musacchio and Salmon, 
2007). Substrates of the APC/CCdc20 possess amino acid motifs that are recognized 
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by Cdc20 and these are called destruction box motif (D box). The most important 
substrates of APC/CCdc20 in mitosis are the cyclins and securin. The destruction of 
Cyclin A precedes the destruction of Cyclin B which happens only after the 
satisfaction of the SAC (Clute and Pines, 1999). APC/CCdh1 on the other hand, does 
not require prior activation through phosphorylation in order to bind its effector 
Cdh1. However, Cdh1 is kept inactive by inhibitory phosphorylation by Cdk1 
(Kotani et al., 1999, Kramer et al., 2000, Reber et al., 2006). The removal of Cdk1 
activity at the metaphase to anaphase transition by APC/CCdc20 activates Cdh1 by 
dephosphorylation of the inhibitory phosphorylation (Hagting et al., 2002, Kraft et 
al., 2005). Cdh1 therefore is active from late mitosis until early G1 phase and it 
binds to the APC/C to form the APC/CCdh1 that is now free to bind its effectors 
through their KEN box domains and target them for destruction (Pfleger and 
Kirschner, 2000). The rise of the G1/S cyclins that are not subject to regulation by 
the APC/C causes the eventual phosphorylation of Cdh1 and the inactivation of the 
APC/C in yeast (Zachariae et al., 1998, Jaspersen et al., 1999) and in mammalian 
cells (Lukas et al., 1999). The once in cell cycle directionality provided by the 
specific degradation of substrates at the right time by the APC/C is instrumental for 
cells to undergo a successful mitotic exit. 
 
1.2 Sister chromatid cohesion 
One of the key requirements for the accurate and timely segregation of the 
duplicated chromosomes during mitosis is sister chromatid cohesion (Guacci et al., 
1994). The pulling forces of the kinetochore microtubules at the centromeres of the 
chromosomes is counteracted by the linkage between the sister chromatids not just 
at the centromeres but also along the entire length of the chromosome. These 
counteracting forces lead to a stretching of the chromatids towards opposite poles 
and their alignment at the equator of the cell also known as ‘bi-orientation’ (Tanaka 
et al., 2000). Loss of cohesion between the sister chromatids at the metaphase to 
anaphase transition allows the kinetochore microtubules to pull the sister 
chromatids to opposite poles and complete mitosis successfully. Crucial to this 
process is the fact that the cohesion between the sister chromatids must remain 
effective until all the chromosomes have achieved bi-orientation. Defects in sister 
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chromatid cohesion can promote aneuploidy in cancer (Solomon et al., 2011) and 
are likely to contribute to meiotic segregation errors with deleterious consequences 
for embryos and fertility (Hunt and Hassold, 2010).  
In addition to its indispensible role in cell division, Sister chromatid cohesion (SCC) 
plays a vital role in DNA double strand break repair. Double strand breaks can be 
repaired by an error prone non-homologous end joining mechanism or through an 
error free homologous recombination based mechanism (Chapman et al., 2012). 
Crucial for the homologous recombination repair process is the presence of the 
undamaged sister chromatid that can be used a template for homologous 
recombination and this is ensured by sister chromatid cohesion (Bannister et al., 
2004, Xu et al., 2005, Ellermeier and Smith, 2005, Klein et al., 1999, Sonoda et al., 
2001, Potts et al., 2006, Strom et al., 2004, Strom et al., 2007, Watrin and Peters, 
2006).  
Furthermore, mutations or deletions of genes involved in sister chromatid cohesion 
can lead to a number of congenital developmental disorders such as Cornelia de 
lange syndrome and Roberts syndrome (Mannini et al., 2010b, Mannini et al., 
2010a). 
1.2.1 Sister chromatid cohesion is mediated by a protein complex called 
cohesin 
One of the first hypotheses regarding the interesting phenomena of sister 
chromatids being linked together until anaphase was that the physical 
concatenation between the sister chromatids was not resolved by topoisomerase 
enzymes until the chromosomes were bi-oriented. Also, it was suggested that bi-
orientation followed by the complete deconcatenation of the sister chromatids 
triggered anaphase onset. Douglas Koshland and Leland Hartwell tested this idea 
in their seminal work in 1987. They introduced a circular plasmid DNA into S. 
cerevisiae cells and observed that under conditions that could preserve catenated 
DNA molecules but not protein-DNA interactions, cells that had passed through S 
phase could not hold the sister DNA molecules together arguing against DNA 
catenations being the primary factor holding the sister chromatids together. The 
authors postulated the existence of ‘one or more interesting proteins that function 
to hold sister chromatids together’ (Koshland and Hartwell, 1987) 
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A few years later, scientists working with genetic screens in budding yeast, 
identified MCD1 (SCC1/RAD21 in vertebrates) to be not only associated with 
chromosomes but also to be important for sister chromatid cohesion and 
chromosome segregation (Guacci et al., 1997). Importantly, MCD1 (SCC1) also 
dissociated from chromosomes at the time of anaphase onset when the connection 
between sister chromatids is lost (Michaelis et al., 1997). Following this, a number 
of other discoveries were made into identifying the genes that mediate sister 
chromatid cohesion. Based on these studies, an evolutionarily conserved protein 
complex composed of a number of subunits as detailed below was postulated and 
the complex was christened cohesin. It consists of  
1. A core cohesin complex that is composed of a tripartite ring made up of two 
Structural Maintenance of chromosomes (SMC) proteins called SMC1 and 
SMC3, a non-SMC subunit MCD1 (SCC1 or Rad21 in humans) along with 
SCC3 (SA1/2 in humans) (Anderson et al., 2002, Haering et al., 2002). In 
addition to these 4 core cohesin subunits that are indispensible for cohesion in 
cells, there are a number of other accessory factors that play vital roles in sister 
chromatid cohesion. These include: 
2. The accessory factor Pds5 (PDS5A and PDS5B in vertebrates),  
3. A cohesin loading complex (Also known as Kollerin or Adherin) composed of 
SCC2 protein (NIPBL in mammals) and SCC4 (MAU4 in mammals) that is 
essential for loading cohesin but is dispensable for cohesin’s continued 
association with chromatin,  
4. An acetyl transferase Eco1 (ESCO1 and ESCO2 in mammals) that is also 
required for cohesion establishment for not for its maintenance on chromatin. 
5. And finally, Sororin and WAPL that are accessory proteins that play 
counteracting roles in controlling the dissociation of cohesin from chromatin and 
the maintenance of cohesion after its establishment from S-phase through to 
mitosis. 
1.2.2 Cohesin structure  
At the core of sister chromatid cohesion lies the tripartite ring structure made up of 
a heterodimer of SMC proteins, SMC1 and SMC3 along with the non SMC protein 
SCC1/Rad21. The tripartite structure of cohesin was revealed by biochemical 
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experiments (Haering et al., 2002) (Figure 5) have also been confirmed by electron 
micrograph images (Anderson et al., 2002)  
 
Figure 5 Structure of the cohesin ring complex 
The cohesin complex is made up of a tripartite ring structure formed by an SMC1-
SMC3 heterodimer along with an SCC1 subunit binding the two SMC subunits. In 
addition to the ring, the core cohesin complex contains a fourth component called SA2 
(Aka Stag2). The cohesin ring is thought to function by physically embracing the two 
sister DNA strands and hold them together until it is time for them to separate in 
mitosis. (Adapted from (Nasmyth and Haering, 2009)) 
 
The integrity of this core ring structure has been shown to be essential for cohesin 
function in cells (Gruber et al., 2003). The SMC subunits of the cohesin ring each 
form an approximately 50 nm long rod shaped protein harbouring intramolecular 
antiparallel coiled-coil regions that fold back on themselves. The proteins have a 
globular hinge domain at one end and a nucleotide binding ‘head’ domain at the 
other end (Haering et al., 2002). Since the protein is wound around itself in an 
antiparallel fashion, the ATP nucleotide binding domain or the ATPase domain is 
made up of both termini of the protein and the hinge domain is made up of the 
amino acids in the middle of the protein. The two nucleotide binding domains 
(NBDs) of SMC1 and SMC3 proteins are connected by the third component of the 
cohesin ring, SCC1, with the N terminus of SCC1 binding to SMC3 and the C 
terminus binding to SMC1.  
Considering that the main component of the protein complex that mediates sister 
chromatid cohesion in cells is a tripartite ring, it was postulated that the mechanism 
of sister chromatid cohesion involves a topological link with chromatin being 
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embraced by the cohesin ring. Kim Nasmyth and colleagues tested this hypothesis 
using a circular yeast mini chromosome that contained a centromere. Upon 
isolating the mini-chromosomes from cells, the authors observed that they were 
associated with cohesin. They further discovered that both proteolytic cleavage of 
the cohesin ring using either TEV cleavable forms of SCC1 or SMC1 and 
linearization of the mini-chromosome using a site-specific nuclease released 
cohesin from chromatin. This strongly suggested that the link between cohesin and 
chromatin was purely topological (Ivanov and Nasmyth, 2005). Additionally, the 
authors could also demonstrate the same finding by isolating cohesed mini-
chromosomes and showing that cleavage of either the DNA or cohesin caused the 
loss of cohesion between sister mini-chromosomes (Ivanov and Nasmyth, 2007). 
The nucleotide binding domains (NBD) of SMC1 and SMC3, similar to the NBD of 
ABC transporter superfamily proteins (Smith et al., 2002), have a bi-lobed 
arrangement with a helical domain that is attached to a set of β sheets that contain 
nucleotide binding Walker A and Walker B residues. One molecule of Mg2+ ATP is 
bound to the Walker A and Walker B motifs in the NBD of one SMC subunit and 
simultaneously to the ABC signature motif in the other subunit.  
 
 
Figure 6 Sister chromatid cohesion along the cell cycle  
Schematic diagram depicting the different states of interaction between cohesin and 
chromatin. Cohesin loading happens in telophase or the G1 phase of the subsequent 
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of the cell cycle. Cohesin is dynamically associated with chromatin due to the anti-
establishment effect mediated by WAPL. Stable establishment of cohesion happens 
only after DNA replication and acetylation of the SMC3 subunit of cohesin. This 
coupled with the activity of Sororin, which helps to offset the anti-establishment effect 
of WAPL in S- and G2-phases of the cell cycle. In mitosis, removal of cohesin from 
chromatin happens in two steps: the first step involves the return of the anti-
establishment effect of WAPL due to the inactivation of Sororin and results in removal 
of over 90% of cohesin from chromosome arms. Centromeric cohesion is removed only 
at anaphase onset and involves the proteolytic cleavage of the SCC1 subunit of 
cohesin. (Adapted from (Peters et al., 2008)) 
 
This arrangement wherein the NBDs of the two SMC subunits co-operate to bind a 
single ATP molecule is supported by the fact that the SMC heterodimers cooperate 
to hydrolyse the bound ATP (Arumugam et al., 2006). Though ATP hydrolysis has 
been shown to be critical for cohesin loading onto chromatin (Arumugam et al., 
2003), the molecular effects of ATP binding or hydrolysis on cohesin function have 
not been fully elucidated. It is possible that the binding of ATP cooperatively by the 
two SMC subunits forces them to come together whereas the hydrolysis of the 
bound ATP causes the NBDs of the two SMC subunits to dissociate. 
The third component of the cohesin ring is SCC1 or Rad21.  It is part of the kleisin 
family of proteins (Schleiffer et al., 2003) and acts as a bridge between the two 
SMC proteins with the N terminus of SCC1 binding close to the NBD of SMC3 and 
the C terminus of SCC1 binding to the NBD of SMC1. The crystal structure of the 
junction between SMC1 and SCC1’s C terminus has been solved and it was shown 
that the C terminus of SCC1 forms a winged helical domain that binds to the NBD 
of SMC through hydrophobic interactions (Haering et al., 2004). It was further 
demonstrated that this interaction between SMC1 NBD and SCC1 C terminus is 
instrumental in ATP binding and hydrolysis (Arumugam et al., 2006). The 
interaction between SCC1’s N terminus and the NBD of SMC3 though less well 
studied and less important for the ATPase activity of SMC3 is nevertheless crucial 
for cohesin function. (Arumugam et al., 2006, Gruber et al., 2006). In addition to the 
interaction with SMC3 and SMC1 at its N and C termini respectively, SCC1 also 
contains the two target cleavage sites for the protease separase, which is crucial 
for the removal of cohesion during the metaphase to anaphase transition (Uhlmann 
et al., 1999) (Hauf et al., 2001) 
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The fourth subunit of the core cohesin complex is the SCC3 protein (SCC3 in yeast 
and Stromal Antigen or SA1/2 or STAG1/2 in higher eukaryotes). It is known to 
bind directly to SCC1 at a region downstream of the separase cleavage site of 
SCC1 and is essential for sister chromatid cohesion (Haering et al., 2002, 
Nishiyama et al., 2010). In vertebrate cells, cohesin exists as a complex of the 
trimeric ring with either SA1 or SA2 protein (Losada et al., 2000, Sumara et al., 
2000). Interestingly, depletion of SA1 and SA2 separately affect telomeric and 
centromeric cohesion respectively suggesting that different types of cohesin 
complexes can regulate different functions within the cell (Canudas and Smith, 
2009, Peters, 2012).   
In addition to the above mentioned core cohesin subunits, there are a number of 
other proteins that play specific roles in the different stages though which cohesin 
exerts its effect in cells and will be discussed in accordance with their specific roles 
in the cohesin cycle. 
1.2.3 Models for cohesin mediated sister chromatid cohesion 
Over the years, a number of models have been proposed to explain the ability of 
cohesin to enforce sister chromatid cohesion in cells. Consistent with the 
observation that the link between cohesin and chromatin is topological rather than 
physical (Gruber et al., 2003, Ivanov and Nasmyth, 2005, Ivanov and Nasmyth, 
2007, Haering et al., 2008), the predominant models that seek to explain sister 
chromatid cohesion favour the enveloping of the chromatin by the cohesin complex. 
These ‘ring’ models have at least 3 variants as illustrated in Figure 7. The strong 
ring model (Figure 7A) postulates that the sister DNA molecules are trapped within 
a monomeric cohesin ring. The weak ring models on the other hand (Figure 7B and 
C), predict the existence of inter-cohesin complexes in addition to the topological 
link between chromatin and cohesin.   
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Figure 7 Models for cohesin mediated sister chromatid cohesion  
Schematic diagrams depicting (A) strong ring model where both sister chromatids are 
enclosed by one cohesin ring and (B) handcuff model 1 where a pair of cohesin rings 
each enclosing one of the two sister chromatids, held together by a common SA2 
subunit and (C) handcuff model 2 wherein two cohesin rings are intertwined with each 
harbouring a sister chromatid. (Adapted from (Nasmyth and Haering, 2009)) 
 
Even though experiments have been performed to investigate this hypothesis, little 
evidence seems to support the existence of inter cohesin complex interactions. 
Tagging the same cohesin subunit differently and probing its ability to co-precipitate 
yielded little support for the hypothesis (Haering et al., 2002). Förster Resonant 
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Energy Transfer sensor (FRET sensor) based experiments also revealed no 
significant evidence for inter cohesin complex formation (Mc Intyre et al., 2007).  In 
conclusion, even though the strong ring model cannot at the moment explain how 
cohesin associates with specific areas along the genome if the link with chromatin 
is purely topological, there is no evidence to suggest that multimeric forms of 
cohesin as postulated by the handcuff models exists.  
1.2.4 Cohesin loading onto chromatin involves the Adherin complex, the 
opening of the SMC1-SMC3 hinge and cohesin’s ATPase activity 
The primary step for sister chromatid cohesion to occur is the association between 
cohesin and chromatin. Cohesin loading onto chromatin is known to happen much 
earlier than when sister chromatid cohesion becomes apparent. In vertebrate cells, 
it happens in the telophase of the preceding mitosis. More than 90% of the cohesin 
complexes that associate with chromatin during interphase dissociate from 
chromatin during prophase thereby generating a large pool of soluble cohesin that 
could associate with chromatin in the next interphase (Waizenegger et al., 2000, 
Gerlich et al., 2006, Peters et al., 2008). Experiments in HeLa cells using Inverse 
Fluorescence Recovery After Photobleaching (iFRAP) have revealed that in 
addition to the soluble pool of cohesin, a population of chromatin-associated 
cohesin exists that dissociates from chromatin in less than 25 minutes in pre-
replicative cells. After replication though, about one third of the chromatin bound 
cohesin associates much more stably with chromatin and persists through S-phase 
through to mitosis. (Gerlich et al., 2006). 
One of the main predictions of the ring model with respect to cohesin-chromatin 
association is that since chromatin is trapped topologically inside the cohesin ring, 
at some point either the ring is assembled de-novo around chromatin, or double 
starnds breaks induced in specific regions in the DNA allow the cohesin ring to 
pass through or that the cohesin ring is opened at any of the three junctions within 
the ring structure to accommodate the chromatin. The first possibility could be ruled 
out because cohesin is known to exist as a trimeric ring even when it is not 
associated with chromatin (Gruber et al., 2003). While there is no evidence against 
the second possibility of DNA being excised at specific locations to allow cohesin 
entry, there is mounting evidence to suggest that cohesin association with 
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chromatin involves the transient opening of the cohesin ring. Kim Nasmyth and 
colleagues tested this possibility by artificially closing the different junctions within 
the cohesin ring in order to decipher the ‘entry gate’ for chromatin to enter cohesin. 
They found that fusing either the N or C terminus of SCC1 with SMC3 and SMC1 
NBDs respectively did not prevent the association of cohesin with chromatin. 
Subsequently, they replaced the hinge region of SMC1 and SMC3 with p14 and 
MP1 proteins that formed a pseudosymmetric heterodimer. While these hybrid 
proteins could associate with SCC1, form the ring structure and also hydrolyse ATP, 
they could not associate with chromatin indicating that the opening of the SMC1-
SMC3 hinge regions is necessary for cohesin loading onto chromatin (Gruber et al., 
2006). Additionally, the scientists also introduced sequences that encoded for 
human FRB and FKBP12 proteins into the hinge regions of SMC1 and SMC3 
respectively. FKBP12 and FRB proteins are known to bind each other tightly if and 
only if FKBP12 binds to rapamycin (Choi et al., 1996). These hybrid protein 
complexes were then shown to associate with chromatin only in the absence and 
not in the presence of rapamycin, again indicating that the entry gate for chromatin 
to get into the cohesin ring is the SMC1-SMC3 hinge region (Gruber et al., 2006).  
The process of cohesin loading onto chromatin is also known to require the 
ATPase activity of cohesin as mutations in SMC1 or SMC3 that affect ATP binding 
or hydrolysis abolished cohesin association with chromatin (Arumugam et al., 2003, 
Weitzer et al., 2003).  In addition to the ATPase activity of cohesin, a conserved 
cohesin loading complex also known as adherin or kollerin plays an essential role 
in cohesin loading onto chromatin (Ciosk et al., 2000, Seitan et al., 2006, Watrin et 
al., 2006). Adherin is a protein complex composed of two subunits, the larger of 
which is called SCC2 (NIPBL in mammals) and the smaller subunit being SCC4 
(MAU2 in mammals). Mutations in either SCC2 (Michaelis et al., 1997) or SCC4 
(Ciosk et al., 2000) affect sister chromatid cohesion. Though an association of the 
adherin complex with the pre-replicative (pre-RC) complexes was shown to recruit 
adherin to chromatin (Takahashi et al., 2004, Gillespie and Hirano, 2004), the exact 
mechanism through which adherin loads cohesin onto chromatin is unknown. The 
loading of cohesin does not just require adherin, but also the ATPase activity of 
cohesin and the transient opening of the SMC hinge region of the cohesin ring. 
This leads to speculation that adherin could be an enzymatic regulator of cohesin’s 
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ATPase activity or of hinge disengagement and that this activity might lead to the 
opening of cohesin’s entry gate (Peters and Nishiyama, 2012). 
1.2.5 Establishment of sister chromatid cohesion happens during DNA 
replication 
Even though the association between cohesin and chromatin happens prior to DNA 
replication, functional sister chromatid cohesion is established only during S phase 
(Uhlmann and Nasmyth, 1998). It has been speculated that cohesion establishment 
goes hand in hand with the replication fork progression. The physical proximity of 
sister chromatids following passage of the replication fork may promote the 
establishment of cohesion. Consistent with this idea, a number of components of 
the replication fork are required for sister chromatid cohesion including the PCNA 
clamp loader CTF8 (Terret et al., 2009), the replication fork stabilizing TIM1-Tipin 
complex (Errico et al., 2009). Considering that cohesin is loaded onto chromatin 
much before replication, it is interesting to ponder about the fate of cohesin at 
replication. The possibilities are either that cohesin dissociates from the chromatin 
and then re-associates after the replication fork has passed or that the fork passes 
through the cohesin ring. Experiments that were done to assess the role of sister 
chromatid cohesion in cells that have sustained DNA damage have revealed that 
cohesion can be established in the absence of bulk replication suggesting that fork 
passage through the cohesin ring can not be the sole mechanism through which 
cohesion is established (Strom and Sjogren, 2005, Strom et al., 2007, Strom and 
Sjogren, 2007). iFRAP experiments that were done as described in the section 
above (Gerlich et al., 2006) revealed that even though cohesin is bound to 
chromatin before replication, the residence time of a chromatin bound pool of 
cohesin lasted just a few minutes in pre-replicative cells and this residence time 
increased dramatically to up to a few hours in cells that had undergone DNA 
replication. From this and other experiments, it is prudent to conclude that the 
stabilization of cohesin on chromatin happens simultaneously with cohesin’s ability 
to perform the essential function of mediating sister chromatid cohesion. The ability 
of cohesin to strongly associate with and therefore hold together sister chromatids 
for long periods assumes significance especially in the case of oocytes where 
cohesion, once established during pre-meiotic S-phase in females has to be 
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maintained for the entire reproductive period, up to several decades in humans 
(Hunt and Hassold, 2010).  
In addition to these observations, it has been shown that an acetyltransferase 
called Eco1 (ESCO1 and ESCO2 in humans) is essential for establishment of sister 
chromatid cohesion in yeast (Toth et al., 1999, Tanaka et al., 1999, Ivanov et al., 
2002), Drosophila (Williams et al., 2003) and human cells (Hou and Zou, 2005) . 
While Eco1 is indispensible for cohesion establishment during DNA replication, it is 
neither needed for cohesin loading nor for the continued maintenance of cohesion 
(Toth et al., 1999). Thus, an Eco1-dependent event plays a key role in the 
establishment of sister chromatid cohesion. Subsequent work showed that Eco1 
acetylates cohesin’s SMC3 subunits at either K112 & K113 in yeast (Rolef Ben-
Shahar et al., 2008, Unal et al., 2008) or K105 & K106 in humans (Zhang et al., 
2008b). The major deacetylase that reverses SMC3 acetylation in yeast cells is 
Hos1 (Beckouet et al., 2010, Borges et al., 2010, Xiong et al., 2010) and its 
counterpart in human cells is HDAC8 (Deardorff et al., 2012).  
While it has been demonstrated that the acetylation of SMC3 is a critical step for 
turning cohesin cohesion competent, the exact mechanism by which acetylation 
helps with this process is not well understood. One possibility is that since the 
acetylated lysine residues are close to the NBD of SMC3, it could regulate the ATP 
binding and hydrolysis cycles of cohesin so that once cohesin is loaded onto 
replicated DNA, acetylation could prevent fresh binding and hydrolysis of ATP so 
as to prevent cohesin dissociation from chromatin. 
An alternate explanation for how acetylation of SMC3 could contribute to cohesion 
establishment is based on experiments that suggest that the acetylation function of 
ECO1 becomes unnecessary if two cohesin associated proteins Wpl1 (WAPL in 
humans) and PDS5 (PDS5A and PDS5B in humans) are deleted (Tanaka et al., 
2001, Rolef Ben-Shahar et al., 2008, Unal et al., 2008, Zhang et al., 2008a, 
Rowland et al., 2009, Sutani et al., 2009). There are two distinct possibilities that 
could explain the role of SMC3 acetylation on cohesion establishment based on 
these new data. One possibility is that since WAPL causes cohesin removal from 
chromatin, SMC3 acetylation by Eco1 directly blocks WAPL’s cohesin removal 
activity (Rolef Ben-Shahar et al., 2008, Unal et al., 2008). Data from structural 
studies in yeast suggest that Wpl1 might be involved in regulating the ATPase 
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activity of cohesin and that this may be subject to the acetylation status of Smc3 
(Chatterjee et al., 2013). An alternate hypothesis is that there exists an anti-
establishment activity contributed towards by WAPL, PDS5, SMC3 and SCC3 and 
that acetylation of SMC3 by ECO1 serves to overcome this anti-establishment 
effect (Rowland et al., 2009). There is mounting evidence to support the idea that 
acetylation of SMC3 helps establish cohesion by preventing cohesin dissociation 
from chromatin. Recently it has been shown in human cells that acetylation of 
SMC3 is required for the recruitment of Sororin, a factor that is required for sister 
chromatid cohesion throughout interphase (Rankin et al., 2005, Nishiyama et al., 
2010, Lafont et al., 2010, Song et al., 2012) 
1.2.6 Sororin plays a very important role in maintenance of cohesion in 
post-replicative cells 
Sororin (Aka CDCA5) was discovered in a proteomic screen for novel substrates of 
Cdh1 activated anaphase promoting complex or cyclosome (APC/CCdh1) using the 
Xenopus egg extract system (Rankin et al., 2005). It was subsequently shown to 
associate with cohesin in the nuclei of interphase cells. Importantly, depletion of 
sororin caused severe defects in sister chromatid cohesion. Conversely, 
overexpression of the protein lead to ectopic cohesion or ‘over-cohesion’. With 
reference to its crucial role in sister chromatid cohesion, the protein was named 
Sororin after the Latin word ‘soror’ which means sister. Although initial experiments 
suggested that Sororin was conserved only in vertebrates, recent work has 
demonstrated that orthologs of this protein exist in other species for e.g., depletion 
of Dalmatian, a 95 kDa protein in Drosophila resulted in sister chromatid cohesion 
defects (Nishiyama et al., 2010). 
Sororin is a 27 KDa basic protein with an electrophoretic mobility of 35 KDa on 
SDS PAGE (Rankin et al., 2005). The KEN box domain that is present in the centre 
of the protein is responsible for targeting Sororin for cell cycle dependent 
degradation induced by the action of the APC/CCdh1 (Rankin et al., 2005). Soon 
after its discovery, Sororin was demonstrated to associate with cohesin through its 
C terminus (Wu et al., 2011) and to be essential for the stabilization of cohesin on 
chromatin after cohesion establishment in S-phase (Schmitz et al., 2007). As 
mentioned in the previous section, it was further observed that Sororin recruitment 
to chromatin was induced by SMC3 acetylation along with DNA replication 
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(Nishiyama et al., 2010, Lafont et al., 2010). Based on experiments carried out so 
far, it appears that the primary function of Sororin is to oppose the ‘anti-
establishment’ activity mediated by WAPL. Evidence for this comes not only from 
the fact that depletion of Sororin and WAPL has opposite phenotypes in terms of 
sister chromatid cohesion status but also because the essential function of Sororin 
becomes dispensable if WAPL is also removed from cells (Nishiyama et al., 2010). 
In trying to investigate the mechanism by which Sororin could help overcome the 
‘anti-establishment’ activity of WAPL-PDS5, it was observed that Sororin and 
WAPL both contain a Phenylalanine-Glycine-Phenylalanine motif (FGF motif) that 
could be shown to bind to PDS5 (Nishiyama et al., 2010). It is therefore 
conceivable that competition between Sororin and WAPL in order to bind to PDS5 
dictates the status of cohesin association with chromatin. This is supported by the 
observation that mutating the FGF motif on Sororin disrupts its ability to interact 
with PDS5 and causes sister chromatid cohesion defects without affecting Sororin’s 
ability to interact with cohesin in Xenopus egg extracts (Nishiyama et al., 2010). At 
odds with this report, experiments performed in HeLa cells suggest that Sororin 
FGF mutants can still rescue the loss of sister chromatid cohesion caused by 
depletion of endogenous Sororin (Wu et al., 2011). Irrespective of the 
discrepancies between the reports, it can be hypothesised that Sororin competes 
with WAPL for binding to PDS5 and that it helps to modulate WAPL mediated ’anti-
establishment’ activity at the cohesin-chromatin interface. This hypothesis could 
explain how Sororin helps to stabilize cohesin-chromatin interactions while WAPL 
seeks to do the opposite. The exact molecular basis for this regulation has not 
been resolved yet. While Sororin was shown in vitro to displace WAPL from a 
complex with PDS5, there is no evidence to suggest that it can do so in the cell 
(Nishiyama et al., 2010). Another possibility as to how Sororin could influence the 
stability of cohesin-chromatin association rests of the hypothesis that Sororin 
binding to PDS5 through the FGF motif could confer a conformational shift in the 
interaction between the PDS5-WAPL complex and cohesin preventing WAPL from 
dissociating cohesin off chromatin thereby inducing a stable association between 
cohesin and chromatin. 
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1.2.7 Cohesin removal from mitotic chromosome happens in two distinct 
steps in higher eukaryotes 
The presence of sister chromatid cohesion is essential for chromosome bi-
orientation in cells and therefore for successful cell division. The timely retention 
followed by dissociation of cohesin at chromatin is paramount to achieving this 
objective. As explained above, sister chromatid cohesion mediated by the cohesin 
complex is established in S-phase along with DNA replication and holds the 
replicated sister chromatids together until it is time for them to separate in 
anaphase (Guacci et al., 1994). In higher eukaryotic cells but not yeast, the 
dissociation of cohesin from chromatin takes place in two distinct steps (Losada et 
al., 1998, Sumara et al., 2000, Waizenegger et al., 2000). The two waves of 
cohesin removal in cells confers the characteristic X shape to the chromosomes in 
chromosome spread preparations and will be discussed in more detail below. 
1.2.7.1 The prophase pathway of cohesin removal 
The first step of cohesin dissociation from chromatin takes place in prophase and 
prometaphase. During this step, about 90% of the cohesin dissociates form the 
chromatids although cohesin still persists in the centromeres (Waizenegger et al., 
2000, Peters et al., 2008). In addition to the core cohesin ring components, 
accessory factors such as WAPL, PDS5A, Sororin, Adherin (SCC2 & SCC4) also 
dissociate form chromatin (Sumara et al., 2000, Rankin et al., 2005, Gandhi et al., 
2006, Kueng et al., 2006, Watrin et al., 2006, Wendt et al., 2008). The process is 
different in yeast as a majority of cohesin persists on chromosomes until 
metaphase and the adherin complex is chromatin bound throughout the cell cycle 
(Ciosk et al., 2000).  
The removal of cohesin through the prophase pathway does not rely on the 
proteolytic cleavage of the SCC1 subunit and instead relies on the anti-
establishment activity of WAPL (Gandhi et al., 2006, Kueng et al., 2006) along with 
a series of phosphorylation-based processes. Polo like kinase (PLK1) a kinase that 
is active in mitosis, phosphorylates the SCC1 and SA2 subunits of cohesin and 
causes the dissociation of cohesin from chromatin (Losada et al., 2002, Sumara et 
al., 2002, Gimenez-Abian et al., 2004, Lenart et al., 2007). This observation was 
further supported by the fact that replacing the SA2 subunit of cohesin with a non-
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phosphorylatable form leads to reduced dissociation of cohesin from chromatin in 
prophase and prometaphase (Hauf et al., 2005). In order to understand how PLK1 
is targeted to SA2, scientists tried to identify cohesin subunits that could bind to 
PLK1 through its polo box domain. In the course of this investigation, Sororin was 
identified to be a candidate for PLK1 binding. The consensus sequence for a polo 
box binding domain is [S(S/T)P] and Sororin harbours such a site [157TSTP160] that 
once activated by a Cdk1 priming phosphorylation at the threonine residue 
immediately before proline, can bind to PLK1 through its the Polo Box Domain 
(PBD). It was demonstrated that mutation of the threonine to alanine (T159A) in 
sororin not only abolished PLK1 binding but also prevented the removal of cohesin 
through the prophase pathway (Zhang et al., 2011). These observations collectively 
suggest that PLK1 promotes the prophase pathway by phosphorylating the SA2 
subunit of cohesin. 
Even though SA2 phosphorylation by PLK1 is required for the prophase pathway of 
cohesin dissociation from chromatin, there are other factors that are involved in 
regulating the process. First indications for this came from observations that 
depletion of WAPL prevented the prophase dissociation of cohesion from 
chromatin even though SA2 phosphorylation by PLK1 was unaffected and the 
intensity of the phenotype was much more dramatic than one caused by inhibition 
of PLK1 activity (Gandhi et al., 2006, Kueng et al., 2006). Conversely, 
overexpression of WAPL led to a precocious loss of sister chromatid cohesion even 
though SA2 phosphorylation was unaffected. Since it was shown that Sororin 
played an antagonistic role to WAPL in terms of cohesin-chromatin association, it 
was postulated that mitotic phosphorylation of Sororin could destabilize the Sororin-
PDS5A complex or conversely, stabilize WAPL-PDS5A complex that would now be 
able to dissociate cohesin from chromatin (Nishiyama et al., 2010, Zhang et al., 
2011, Dreier et al., 2011). Jan-Michael Peters and colleagues have recently 
performed experiments wherein they identified Aurora Kinase B (AURKB) and 
Cdk1 phosphorylation sites in Sororin that upon phosphorylation affected Sororin’s 
ability to interact with cohesin. This mitotic phosphorylation of Sororin by AURKB 
and Cdk1 was further demonstrated to lead to a stabilization of the WAPL-PDS5 
complex thereby causing the removal of cohesin from chromatin through the 
prophase pathway independent of SA2 phosphorylation by PLK1 (Nishiyama et al., 
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2013). In addition to the phosphorylation of Sororin by AURKB and Cdk1, its 
degradation by APC/CCdh1 mediated proteolysis ensures that there is no premature 
sister chromatid cohesion being formed before the subsequent S-phase. 
In conclusion, the prophase pathway of cohesin removal from chromatin involves: 
1. The PLK1 dependent phosphorylation of SA2 and SCC1 
and independently, 
2. The AURKB and Cdk1 mediated phosphorylation of Sororin that leads to a 
stabilization of WAPL-PDS5 mediated anti-establishment activity 
3. And possibly the mitotic phosphorylation of WAPL and PDS5 
 
In order to achieve chromosome bi-orientation, sister chromatid cohesion has to be 
maintained at least at the centromere, the DNA sequence upon which the 
kinetochores assemble. Until bi-orientation is achieved, the onset of anaphase is 
prevented by the spindle assembly checkpoint (SAC) that blocks the activity of the 
anaphase promoting complex (APC/C). If and only if all chromosomes have 
achieved bi-orientation can anaphase onset be triggered. Two interesting questions 
here are:  (1) How does cohesin at the centromere resist dissociation through the 
prophase pathway?  (2) Why is the majority of cohesin removed from mitotic 
chromosomes through the prophase pathway  
1.2.7.2 The prophase pathway exit gate for DNA in cohesin is the SMC3-
SCC1 interface 
The molecular details behind the removal of a bulk of chromatin bound cohesin 
during prophase are still being uncovered. Unlike the anaphase-specific separase 
mediated cleavage that acts by cleaving the SCC1 subunit, the prophase pathway 
is known not to require separase-mediated cleavage of SCC1 (Sumara et al., 2002) 
(Waizenegger et al., 2000) (Kueng et al., 2006). These observations led to 
hypothesis that the removal of cohesin from chromatin through the prophase 
pathway must involve a transient opening of the cohesin ring. A clue as to the 
location of the exit gate of cohesin comes from work performed recently in budding 
yeast S. cerevisiae (Chan et al., 2012). In order to decipher the exit gate used by 
the prophase pathway, the researchers created fusions of either SMC3’s NBD with 
the N terminus of SCC1 or the NBD of SMC1 with the C terminus of SCC1 neither 
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of which were shown to be lethal in yeast cells (Gruber et al., 2006). Since the 
SMC3 acetylating activity of ECO1 is necessary for overcoming the anti-
establishment effect mediated by WAPL and also since the WAPL mediated anti-
establishment effect is thought to underly the prophase pathway, the researchers 
reasoned the lethality of eco1 mutants could be suppressed by the artificial closure 
of the prophase pathway DNA exit gate. They discovered that fusion of Smc3’s 
head to the N terminus of SCC1 rescued the loss of Eco1 whereas fusion of 
SMC1’s head to the C terminus of SCC1 did not. This strongly suggested that the 
anti-establishment effect mediated by WAPL involves the opening of the SMC3-
SCC1 junction (Chan et al., 2012). In addition to the study in budding yeast, the 
authors also reported similar results in Drosophila cells where they discovered that 
WAPL dependent release of cohesin from drosophila polytene chromosome is 
perturbed by introducing an artifical fusion at the interface between SMC3’ head 
and Scc1 (Eichinger et al., 2013). Furthermore, a recent study reported 
experiments performed in human cells where researchers used the FRB-FKBP12 
system (Choi et al., 1996, Gruber et al., 2006) (Also see page 40), creating 
rapamycin inducible fusions of each of the 3 junctions within the cohesin ring. They 
observed that fusion of the SMC3-SCC1 interface but not the SMC1-SCC1 or 
SMC1-SMC3 junction prevented the dissociation of cohesin from chromatin 
(Buheitel and Stemmann, 2013). Altogether, these experiments strongly suggest 
that the prophase pathway removes cohesin rings from chromatin by opening 
cohesin’s SMC3-SCC1 interface. 
1.2.7.3 Functions of the prophase pathway 
The prophase pathway removes cohesin from the chromosome arms of mitotic 
cells between the prophase and prometaphase stages of mitosis while cohesin at 
the centromere is not subjected to this process. The loss of arm cohesion is 
dependent on the activity of a number of players such as SA2, Sororin, WAPL, 
PLK1, AURKB and Cdk1. The characteristic X-shape of mitotic human 
chromosomes is a result of the differential ability cohesin to dissociate from the 
arms of the chromosomes but not at the centromeres (Waizenegger et al., 2000). It 
was observed that the lack of resolution of arm cohesion upon loss of the prophase 
pathway while delaying mitosis is nevertheless not lethal to cells (Kueng et al., 
2006).  It is possible that separase mediated cleavage at anaphase is sufficient to 
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dissociate cohesin from centromeres and the arms of chromosomes in the absence 
of the prophase pathway. Moreover, cohesin dissociation through the prophase 
pathway is largely absent in yeasts. Therefore, it is interesting to ponder about the 
function that the prophase pathway fulfils in higher eukaryotes. There are a number 
of possible reasons for the prophase pathway to exist. Firstly, its is thought that the 
removal of arm cohesion could help the deconcatenation of the chromosome arms 
by Topo II and could therefore help in timely and accurate disjunction during 
anaphase. Another possibility is that the prophase pathway creates a large pool of 
soluble and more importantly intact cohesin rings whose SCC1 subunit is 
untouched by separase. A substantial fraction of this pool could readily re-
associate with chromatin in the subsequent cell cycle. It has been shown cohesin 
has an important role in gene regulation in G1-phase, much before the 
establishment of sister chromatid cohesion (Wendt et al., 2008). If all cohesin 
associated with chromosomes were to be removed through separase mediated 
cleavage, re-association of cohesin with chromatin would have to await the new 
synthesis of SCC1 subunits to replace the ones that have been cleaved by 
separase. Presumably this process while seemingly feasible in budding yeast, may 
not be favoured in higher eukaryotes. 
1.2.7.4 Protection of centromeric cohesion from the prophase pathway 
The removal of cohesin from chromatin during mitosis proceeds in two waves. The 
first step, called the prophase pathway removes most of the arm cohesin while 
centromeric cohesion is retained until anaphase. What makes the centromeric 
cohesion immune to the prophase pathway? One of the first observations that 
served to solve this conundrum was that the depletion of Sgo1 (SGOL1 in humans) 
gene led to a precocious loss of even centromeric sister chromatid cohesion in 
prometaphase (Salic et al., 2004, Kitajima et al., 2004, Watanabe and Kitajima, 
2005, McGuinness et al., 2005). This premature loss of centromeric cohesion upon 
loss of Sgo1 led to the conclusion that Sgo1 protected centromeric cohesion from 
being targeted by the prophase pathway thereby maintaining sister chromatid 
cohesion until anaphase onset. Subsequently it was demonstrated that Sgo1 could 
interact with and could recruit PP2A, a phosphatase to the centromere. Consistent 
with this observation, PP2A, similar to Sgo1, localizes to the centromere and is 
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required for maintenance of centromeric cohesion (Kitajima et al., 2006, Riedel et 
al., 2006, Tang et al., 2006). The Sgo1-PP2A complex has been shown in vitro to 
be able to dephosphorylate the SA2 subunit of cohesin (Kitajima et al., 2006). It 
was further demonstrated in human cells that that the loss of centromeric sister 
chromatid cohesion caused by depletion of SGOL1 could be rescued by the 
expression of a non-phosphorylatable form of SA2 (McGuinness et al., 2005). 
Recently, Jan-Michael Peters and colleagues showed that the SGOL1-PP2A 
complex can dephosphorylate Sororin that is phosphorylated in mitosis by AURKB 
and Cdk1 thereby protecting centromeric cohesion from WAPL mediated 
dissociation in prophase and prometaphase. The authors could further demonstrate 
that the phosphorylation of SA2 and Sororin in mitosis contributed independently to 
the prophase pathway but that they could both be silenced by SGOL1-PP2A 
mediated dephosphorylation (Nishiyama et al., 2013). Thus, sister chromatid 
cohesion at centromeres is protected from prophase pathway removal by the Sgo1-
PP2A complex which antagonizes mitotic phosphorylation of cohesin and Sororin 
(Liu et al., 2012). 
1.2.7.5 Separase mediated cleavage of SCC1 removes cohesin from 
centromeres during anaphase onset 
The prophase pathway helps to dissociate about 90% of cohesin from chromatin 
during the early stages of mitosis. However, cohesin at the centromeres is retained 
until anaphase onset when cleavage of its SCC1 subunit by the protease separase 
removes it. It has been known that while removal of separase from cells prevents 
resolution of sister chromatid cohesion (Waizenegger et al., 2002), the expression 
of a non-cleavable variant of SCC1 slows down but does not block the resolution of 
centromeric cohesion (Hauf et al., 2001) suggesting that in addition to the known 
sites, there are cryptic cleavage sites in SCC1 that are also cleaved by separase or 
that separase has additional targets. Separase is normally held in a complex with a 
protein called securin that prevents separase from acting on its substrates before 
anaphase onset possibly by blocking access to separase’s active site (Ciosk et al., 
1998, Hornig et al., 2002, Waizenegger et al., 2002). In addition to securin based 
inactivation, separase in vertebrate cells is held inactive by spatial confinement with 
cyclin B induced by Cdk1 phosphorylation on S1121 (Stemmann et al., 2001, Gorr 
et al., 2005). Therefore separase activity is controlled by two distinct checks within 
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cells in order to prevent premature loss of cohesion. Once all the chromosomes 
have achieved bi-orientation, the spindle assembly checkpoint is inactivated and 
the APC/C becomes active through the liberation of its activator protein Cdc20 
(Musacchio and Salmon, 2007). The APC/C subsequently catalyses the 
ubiquitylation and degradation of a number of substrates including cyclin B and 
securin. The removal of securin and cyclin B activates separase, which undergoes 
an autocatalytic cleavage that may not be necessary for its subsequent activity 
(Waizenegger et al., 2000). Subsequently, it acts by cleaving SCC1 thereby leading 
to the destruction of centromeric cohesion (Uhlmann et al., 1999, Uhlmann et al., 
2000, Waizenegger et al., 2000, Hauf et al., 2001, Sun et al., 2009). Even though 
separase normally performs SCC1 cleavage of centromeric cohesin, it is capable of 
removing arm cohesion in case the prophase pathway is suppressed (Kueng et al., 
2006). The separase mediated cleavage of SCC1 (also known as kleisin which is 
Greek for closure) during anaphase onset facilitates the removal of the cohesin ring 
from chromatin and thereby dissolves sister chromatid cohesion. Furthermore, It 
has been demonstrated in yeast and Drosophila that artificial cleavage of SCC1 by 
the introduction of TEV cleavage sites that can be cleaved by the TEV protease is 
sufficient to trigger disjunction of sister chromatids and the pole ward movement of 
chromosomes (Uhlmann et al., 2000, Pauli et al., 2008, Oliveira et al., 2010). 
1.2.8 Roles of cohesin beyond sister chromatid cohesion 
In addition to its canonical role in mediating sister chromatid cohesion, cohesin 
plays important roles in other areas of cell physiology. These include but are not 
limited to DNA damage repair, chromatin organization and transcriptional control. 
These will be discussed in more detail below. 
1.2.8.1 Cohesin and DNA damage repair processes in somatic cells 
Cohesin is known to be involved in regulating DNA damage repair processes both 
in mitotic cells (Cortes-Ledesma and Aguilera, 2006, Sjogren and Nasmyth, 2001) 
and in meiotic cells (van Heemst et al., 1999, Klein et al., 1999, Ellermeier and 
Smith, 2005). In human cells, cohesin, in addition its role in regulating repair of 
DNA damage also plays a role as a DNA damage G2/M checkpoint-signaling 
platform that is independent of cohesion (Kim et al., 2002, Watrin and Peters, 
2009). DNA damage, when it happens, can be repaired by an error prone non-
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homologous end joining mechanism or through an error free homologous 
recombination based mechanism (Chapman et al., 2012). Crucial for the 
homologous recombination repair process is the presence of the undamaged sister 
chromatid that can be used as a template for homologous recombination during S-
phase and G2-phase. It is thought that sister chromatid cohesion ensures close 
physical proximity of the template for homologous recombination. In mitotic cells, it 
is not only the cohesin complexes that have established cohesion in S-phase that 
mediate in the repair process but also the new cohesin complexes that are 
recruited onto the chromatin in response to DNA damage (Strom et al., 2004, 
Strom and Sjogren, 2005, Unal et al., 2008). New functional cohesin complexes 
can be recruited not just at the site of DNA damage but globally on the 
chromosome in response to DNA damage (Unal et al., 2007). However, this was 
only possible if the cohesion that was established during DNA replication was 
maintained (Sjogren and Nasmyth, 2001). It was further demonstrated that the 
formation of DNA damage induced cohesion required not only adherin (Strom et al., 
2004) but also modulation of its SCC1 subunit by phosphorylation at Ser83 by 
Chk1 kinase and acetylation at K84 and K210 by Eco1 in yeast (Heidinger-Pauli et 
al., 2008, Heidinger-Pauli et al., 2009).  
1.2.8.2 Cohesin and DNA damage repair processes in meiotic cells 
In meiotic cell division, two rounds of chromosome segregation has to follow a 
single round of DNA replication to achieve the reductional division necessary for 
distributing each of the 4 chromatids (2 each from the maternal and paternal 
chromosomes) to 4 haploid nuclei (Petronczki et al., 2003). Key to achieving this 
process is the dissolution of cohesin from the chromatids in two distinct steps. 
Firstly, the cohesin from the arms is removed by separase mediated cleavage in 
meiosis I. Centromeric cohesin is preserved until meiosis II where it is used to bi-
orient and segregate chromatids (Klein et al., 1999, Toth et al., 2000, Watanabe 
and Nurse, 1999). In addition to generating cross-overs and join homologous 
chromosomes during meiosis, cohesin in involved in mediating programmed double 
strand break repair (PDBR) wherein the repair process favours using the 
homologous chromatid as template for the repair process rather than the sister 
chromatid (Petronczki et al., 2003). This process, leads to the physical exchange of 
segments of non-sister chromatids and the formation of the chaismata. This 
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process depends on the substitution of the SCC1 subunit of the cohesin ring with a 
meiosis specific version of the kleisin subunit called Rec8, that is required for 
chaismata formation (Klein et al., 1999, Bannister et al., 2004, Xu et al., 2005). 
Apart from the experiments described above that used budding yeast, the role of 
cohesin in meiotic DNA damage repair has been demonstrated in fission yeast 
(Ellermeier and Smith, 2005) and in higher eukaryotes (Llano et al., 2012). 
1.2.8.3 Cohesin in chromatin organization and transcription control 
Among the first indication that cohesin functions beyond sister chromatid cohesion 
came from experiments in Drosophila cells where it was shown that a mutant 
carrying a mutation in Nipped-B gene (SCC2 component of adherin), was deficient 
in activation of homeobox genes (Rollins et al., 2004). This was also observed in 
cells from the human patients suffering from Cornelia de Lange syndrome (CdLS), 
a disease that leads to mental retardation and upper limb malformations (Tonkin et 
al., 2004). Mutations in the human counterpart of SCC2, NIPBL is known to cause 
CdLS (Krantz et al., 2004, Tonkin et al., 2004). Cohesin associated with the 
nucleus of post mitotic cells where no sister chromatid cohesion is possible (Wendt 
et al., 2008). Inactivation of cohesin in Drosophila post-mitotic mushroom body γ-
neurons resulted in axon pruning defects caused partially by loss of expression of 
the ecydysone receptor revealing the role of cohesin as a regulator of the 
expression of the receptor (Pauli et al., 2008, Schuldiner et al., 2008). In addition to 
the above-mentioned experiments, subsequent studies demonstrated the role of 
cohesin in transcription control in zebrafish (Horsfield et al., 2007), fission yeast 
(Gullerova and Proudfoot, 2008) and trypanosomes (Landeira et al., 2009). 
Even though, a role for cohesin in chromatin organization and transcription control 
is evident in a number of species, its precise role in regulating these processes 
remains hazy. Recent reports have begun to shed light into these activities of 
cohesin. Firstly chromatin immunoprecipitation (ChIP) experiments in a number of 
species have demonstrated that cohesin preferentially binds to specific locations 
within the chromatin. In budding and fission yeast, cohesin is predominantly found 
to associate with centromeres and pericentric regions with small amounts also 
associating with Cohesin Attachment Regions (CARs) (Blat and Kleckner, 1999, 
Megee et al., 1999, Tanaka et al., 2001). Surprisingly, cohesin binding sites in 
chromatin were different from adherin binding sites suggesting that cohesin is 
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loaded at adherin loading sites and subsequently translocated to the centromere 
and the CARs (Lengronne et al., 2004, Schmidt et al., 2009, Hu et al., 2011). 
Although how cohesin achieves this translocation is unknown, it is known that 
cohesin translocates to regions of convergent transcription and that induction of 
genes removes cohesin to the end of that particular transcription unit (Lengronne et 
al., 2004). This raises the possibility that the cohesin distribution seen in yeast is a 
consequence of gene transcription activity and not a specific pattern that is related 
to controlling transcription (Peters and Nishiyama, 2012). In spite of this it is still 
thought that cohesin helps specify the boundary to restrict the spreading of 
transcriptional silencing at the silent mating type loci in budding yeast (Donze et al., 
1999) and is also thought to regulate transcription termination in fission yeast 
(Gullerova and Proudfoot, 2008) 
In Drosophila cells, contrary to the situation in yeast, cohesin binding sites on 
chromatin completely overlap with adherin binding sites and they localize along the 
entire length of actively transcribed genes (Misulovin et al., 2008). A yet another 
situation prevails in mammalian cells where although cohesin can be found bound 
to chromatin at NIPBL binding sites (Kagey et al., 2010), there are far more cohesin 
binding sites than NIPBL (Schmidt et al., 2010) suggesting that similar to yeast, 
cohesin loading might occur at a site that is different from the eventual 
accumulation site. In contrast to yeast cells however, the pattern of cohesin binding 
to chromatin in mammalian cells is thought to be specified by DNA sequences that 
are recognized by the CTCF protein (CCCTC binding factor) (Parelho et al., 2008, 
Rubio et al., 2008, Stedman et al., 2008, Wendt et al., 2008). CTCF is a protein 
that binds to DNA using one or more of its 11 zinc finger domains and is thought to 
delineate the border between active and inactive regions of the chromatin (Ohlsson 
et al., 2010). Depletion of CTCF reduces cohesin binding at these specific sites 
without reducing overall cohesin levels along the chromatin suggesting that in 
mammalian cells, CTCF is not required for cohesin loading onto the chromatin but 
is required for its subsequent distribution to specific locales (Wendt et al., 2008, 
Parelho et al., 2008, Stedman et al., 2008).  
As of now, there is no evidence to suggest that recruitment of cohesin to sites 
specified by CTCF is essential for its function in sister chromatid cohesion because 
depletion of CTCF does not cause premature loss of SCC (Wendt et al., 2008). 
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However depletion of cohesin in mammalian cells leads to defects in gene 
expression that resemble defects caused by depletion of CTCF. For instance, 
depletion of cohesin and CTCF leads to similar decrease in levels of H19 and igf2 
proteins (Nativio et al., 2009, Wendt et al., 2008). Based on these experiments, it 
has been hypothesized that cohesin regulates gene expression by arbitrating long 
range intra-chromatid interactions between distant CTCF binding sites through the 
formation of chromatin loops. This postulation relies on the observation that CTCF 
functions through formation of chromatin loops (Splinter et al., 2006, Majumder et 
al., 2008) and on the idea that gene expression driven by the activity of enhancers 
and silencers depends on proximity between these elements that can be afforded 
through chromatin loops produced through topological links between distant 
regions of the chromatin (Nativio et al., 2009, Peters and Nishiyama, 2012). In spite 
of these advances into understanding cohesin’s role in gene expression, the 
importance of cohesin’s interaction with CTCF in regulating gene expression and 
the precise molecular mechanism through which it acts remains to be understood. 
1.2.9 Cohesinopathies and cohesin in cancer 
Defects in cohesin function leads to a number of human pathologies that are 
collectively known as Cohesinopathies (Remeseiro et al., 2013). Many of these are 
monogenic human diseases that have been linked exclusively to loss of cohesin 
subunits. Cornelia de Lange syndrome (CdLS) is one such disorder that leads to 
developmental defect and mental retardation (Dorsett and Krantz, 2009). About 
60% of patients with CdLS have a heterozygous mutation in NIPBL (Adherin) with 
5% harbouring mutations in SMC3 and 1% in SMC1 (Krantz et al., 2004, Tonkin et 
al., 2004, Liu and Krantz, 2009, Musio et al., 2006, Deardorff et al., 2007). 
Furthermore, it was recently shown that ablation of SA1 subunit in mice led to 
CdLS like phenotype (Remeseiro et al., 2012). Irrespective of the cohesin subunit 
implicated, it was observed that most patients did not have defects in sister 
chromatid cohesion suggesting that the function of cohesin in gene expression may 
cause CdLS pathologies. In support of this hypothesis, it was recently reported that 
SMC3 acetylation defects caused by loss of HDAC8, the deacetylase antagonizing 
SMC3 acetylation by ESCO1/2 leads to CdLS (Deardorff et al., 2012). It remains to 
be identified whether the role of cohesin in gene expression or sister chromatid 
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cohesion or a combination of both is responsible for the developmental defects 
observed in CdLS. 
Roberts syndrome and SC phocomelia are genetically recessive disorders that are 
characterized by slow growth, mental retardation and limb malformation similar to 
CdLS (Van den Berg and Francke, 1993, Herrmann and Opitz, 1977, Jackson et al., 
1993). Even though they were initially classified as distinct disorders, later studies 
reported that both the syndromes were characterized at the cellular level by gross 
chromosomal abnormalities and this was confirmed recently by the observation that 
patients from either disorders had mutations in ESCO1 (ECO1 in yeast) (Vega et 
al., 2005, Schule et al., 2005). Patient cells from both Roberts syndrome and SC 
phocomelia share defects in centromeric cohesion that is consistent with the fact 
that ESCO1, a factor required for cohesion establishment, harbours the mutations 
(Tomkins et al., 1979, German, 1979). While it has long been postulated that both 
RS and SC phocomelia are results of protracted mitosis caused by faulty cohesion 
in cells (Tomkins and Sisken, 1984), it has also been suggested that perturbations 
in cohesin binding to heterechromatin regions of the chromatin could influence 
gene expression of hetereochromatic genes (Dorsett, 2007) and that this could be 
a possible reason for the growth and developmental abnormalties that are 
characteristic of RS /SC phocomelia. Whether the disease results out of loss of 
cohesion or if it is a result of a different function mediated by ESCO1/cohesin 
remains to be determined. 
Meiotic aneuploidy is the most common known cause of developmental disorders 
and mental retardation (Hunt and Hassold, 2010). Loss of cohesin function could 
contribute to trisomies caused by irregular chromosome segregation during meiosis. 
Down’s syndrome is one such example where sister chromatid non-disjunction of 
chromosome 21 leads to its irregular inheritance in the progeny (Gilliland and 
Hawley, 2005, Hassold and Hunt, 2001, Hunt and Hassold, 2010). Although non-
disjunction events involving other chromosomes are also reported, with the 
exception of chromosome 13 and 18, they are embryonically lethal. The non 
disjunction of chromatids appear to increase with maternal age and since there is a 
correlation between increased maternal age and precocious sister chromatid 
cohesion loss in oocytes, the non-disjunction events are thought to be due to faulty 
cohesin function (Angell, 1995, Wolstenholme and Angell, 2000, Pellestor et al., 
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2003, Pellestor et al., 2006). Mutation of the meiosis specific SMC1β in mice lead 
to age related oocyte defect that are similar to human diseases lending credence to 
the above mentioned hypothesis (Hodges et al., 2005). Although there is no 
definitive evidence to link loss of cohesin function with down’s syndrome, it is 
plausible that cohesion established during DNA replication has to be maintained for 
months and years in case of human oocytes and this probably explains why 
incidences of non-disjunction increases with maternal age (Peters et al., 2008). 
In addition to these developmental disorders that are caused by faulty cohesin 
function in cells, there is mounting evidence to suggest the cohesin malfunction 
may contribute to aneuploidy and chromosomal instability that is a hallmark of 
human tumours. Firstly, elevated levels of WAPL were found in a number of 
cervical cancers and it was also demonstrated that down regulation of WAPL 
inhibits the growth of tumour derived from cervical cancer tissues (Oikawa et al., 
2004, Oikawa et al., 2008). Since WAPL plays a critical role in the timely removal of 
arm cohesion, perturbations in its levels in cells could cause non-disjunction events 
that lead to aneuploidy. Secondly, elevated levels of one of the two 
acetyltransferases required for cohesion establishment, ESCO2, has also been 
implicated in melanomas (Ryu et al., 2007). Thirdly, mutations that inactivate the 
function of STAG2, a component of the core cohesin ring structure were shown to 
cause sister chromatid cohesion defects that lead to aneuploidy in a near diploid 
human cell line. It was also demonstrated that targeted correction of faulty 
endogenous STAG2 alleles in human glioblastoma cells led to increased fidelity in 
chromosome segregation (Solomon et al., 2011). Finally, mutations in SMC1, 
SMC3, NIPBL and SA2 were implicated in colorectal cancer patent cells based on 
a mutational study. The authors also postulated that loss of sister chromatid 
cohesion through somatic mutations could lead to the chromosomal instability that 
is observed in cancer cells (Barber et al., 2008). 
1.3 Pre-mRNA splicing 
The primary aim of my PhD project was to identify novel regulators of mitosis and 
cytokinesis in animal cells. Recently, a number of studies have reported on the role 
of pre-mRNA splicing factors in regulating mitosis. A brief introduction into the 
mechanism of pre-mRNA splicing, the composition of the spliceosome; the protein 
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complex responsible for pre-mRNA splicing and the current understanding of the 
role of pre-mRNA splicing in mitosis is presented below. This is intended to 
facilitate the interpretation of the results that we have obtained through our studies.  
1.3.1 The spliceosome and pre-mRNA splicing 
One of the critical steps in the expression of eukaryotic genes is the removal of the 
non-coding introns from the precursor mRNAs (pre-mRNAs) to form the mature 
mRNA. A multi-megadalton complex called the spliceosome mediates the process 
of pre-mRNA splicing. The vast majority of human genes contain introns that span 
about 1000 base pairs or more on average and dwarf the average eukaryotic exon 
by a factor of 10 to 1 (Lander et al., 2001). Removal of these non coding introns 
with pinpoint accuracy is the function of the spliceosome, arguably the most 
complex macromolecular complex within the cell (Nilsen, 2003). Even though some 
exons seem to be present in every variant of the mature mRNA produced from the 
pre-mRNA, also referred to as constitutively spliced, some exons are skipped by 
the splicing machinery, or alternatively spliced to grant the cell the ability to 
generate the multiple protein variants from the same pre-mRNA (Nilsen and 
Graveley, 2010). Understanding the intricacies involved in the pre-mRNA splicing 
process is important not only for a better comprehension of gene expression but 
also for developing therapies against diseases known to stem from splicing defects 
(Wang and Cooper, 2007, Ward and Cooper, 2010). In eukaryotes, two unique 
forms of the spliceosome exist. The U2-dependent spliceosome which catalyses 
the splicing of the U2-introns whereas the U12-dependent spliceosome catalyses 
the splicing of the more rare form of U12-introns (Patel and Steitz, 2003).  
1.3.2 Models of pre-mRNA splicing and cis-acting pre-mRNA elements in 
splicing 
Short sequences in the pre-mRNA contribute towards differentiating an intron from 
an exon. These include the 5’ splice site (ss), the 3’ splice site (ss) and the branch 
site (Figure 8). The branch site is usually located about 30-40 base pairs upstream 
of the 3’ss and is immediately followed by a polypyrimidine tract (PPT). In addition 
this, there are a number of Exonic and intronic splicing enhancers (ESEs and ISEs) 
and silencers (ESSs and ISSs). These enhancers and silencers can act on 
constitutive as well as alternative splicing and act by binding to cognate regulatory 
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factors to control the assembly and disassembly of the spliceosome (Smith and 
Valcarcel, 2000, Wang and Burge, 2008). There are also other factors that help to 
differentiate between an intron and an exon. While a group of well conserved 
proteins called the SR proteins helps in splice site recognition by binding to ESEs, 
a different group of factors called heterogeneous nuclear small nuclear ribonuclear 
proteins (hnRNP proteins) bind to ESSs and are involved in intron skipping 
(Graveley, 2000, Caputi and Zahler, 2002, Martinez-Contreras et al., 2007, Long 
and Caceres, 2009) 
The removal of the introns from the pre-mRNA involves two trans-esterification 
reactions (Moore and Sharp, 1993).Firstly, the 2’OH group of the branch site 
adenosine performs a nucleophilic attack on the 5’splice site. This leads to the 
cleavage of the intron at this site and joining of the cleaved 5’ss with the branch site 
adenosine. This reaction forms the characteristic lariat structure, an intermediate in 
the splicing reaction. During the second reaction, the 3’ss is subjected to a 
nucleophilic attack by OH group of the 5’ exon, thereby leading to the ligation of the 
exons together and the release of the intron lariat. While the above scheme of the 
two catalytic reactions acting to remove the introns from the pre-mRNA is widely 
accepted, there are competing models that seek to explain how the spliceosome 
goes about performing its functions and these will be described below briefly. 
1.3.2.1 Classical model of spliceosome assembly and pre-mRNA splicing 
The classical model of spliceosome assembly envisages a step-wise and ordered 
assembly of individual components of the spliceosome along the pre-mRNA 
junction as and when the transcription machinery is generating it (Figure 8). The 
U2-spliceosome is composed of 5 snRNP (small nuclear ribonucleic particle) 
molecules namely U1, U2, U5 and U4/U6 snRNPs and a large number of other 
non-snRNP proteins that associate either transiently or stably with the snRNPs. 
Each snRNP moiety is composed of an snRNA (small nuclear RNA), a common set 
of 7 Sm proteins (B, D1, D2, D3, E, F and G) and number of other proteins specific 
for each snRNP (Will and Luhrmann, 2011). 
 In the first step of spliceosome assembly, the U1 snRNP recognizes the 5’ss by 
virtue of the base pairing between the intron and the snRNA component of the U1 
snRNP following which non-snRNP proteins such as SF1 and U2AF interact with 
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the branch site and the PPT respectively forming the E complex (Berglund et al., 
1997, Berglund et al., 1998). This engagement of the branch site leads to the 
recruitment of the U2 snRNP to the branch site which analogous to the U1 snRNP 
recruitment is dependent on base pairing between the U2 snRNA and the intron 
and forms what is known as the A complex or the prespliceosome. In a subsequent 
step, the U5, U4/U6 tri snRNP which is assembled from the U5 and U4/U6 snRNPs, 
is recruited along with a large number of non snRNP proteins including the 
nineteen containing complex to the prespliceosome leading to the formation of the 
B complex (Makarova et al., 2001). Conformational rearrangements occur within 
the B complex which leads to the dissociation of the U1 and U4 snRNPs forming 
the activated form of the spliceosome also known as the B* complex. The first 
catalytic step of the splicing reaction happens now and results in the excision of the 
intron at the 5’ss. The spliceosome is now converted into the C complex which after 
a few structural rearrangements is ready to the second step of catalysis in which 
the 5’ exon is ligated with the 3’ exon and the intron is removed as a lariat with the 
5’ss bonded to the 2’OH group of the branch site. The spliceosome is then 
disassembled and reassembled onto any other nascent transcript being produced 
(Jurica, 2008, Valadkhan, 2007, Smith et al., 2008, Makarov et al., 2002, Makarova 
et al., 2004, Wahl et al., 2009, Will and Luhrmann, 2011). Meanwhile, a protein 
complex called the exon junction complex marks the mature mRNA at the splice 
site to indicate a successful splicing event. This mark is important for the export 
and subsequent stability of the spliced mature mRNA in the cytoplasm where it will 
then be engaged by the translational machinery (Le Hir et al., 2000, Tange et al., 
2004, Giorgi and Moore, 2007, Le Hir and Seraphin, 2008)  
1.3.2.2 Alternative spliceosome assembly pathways 
In addition to the canonical stepwise spliceosome assembly pathway as described 
above (Figure 8), other methods of spliceosome assembly seem to exist in cells. 
For instance, a spliceosome complex containing all 5 snRNPs but without a pre-
mRNA was isolated from yeast cells and this complex, when added to a pre-mRNA, 
was shown to be able to form an active spliceosome without first undergoing 
disassembly (Stevens et al., 2002). This led to the postulation of the 
holospliceosome model wherein a single recruitment of a fully formed penta-snRNP 
complex onto the nascent transcript is assumed (Rino and Carmo-Fonseca, 2009). 
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This complex is thought to then undergo rapid conformational changes as the 
splicing reaction proceeds.  
Additionally, at least in metazoans, a phenomenon termed exon definition also 
seems to operate. Exon definition is the idea that in cases where the intron size 
exceeds ~200 bases, the spliceosome initially forms across an exon rather than 
along an intron (Robberson et al., 1990, Sterner et al., 1996, Fox-Walsh et al., 
2005). This phenomena, more common in mammals than in other metazoans (Xiao 
et al., 2007), involves binding of the U1 snRNP to the 5’ss downstream of the exon 
but the ensuing respective binding of the SF1 and U2AF to the 3’ss and the PPT 
upstream of the said exon. The subsequent binding of the U2 snRNP to the branch 
site upstream of the exon along with the recruitment of SR proteins by the Exon 
Splicing Enhancers (ESEs) leads to the formation of the spliceosome across the 
exon (Hoffman and Grabowski, 1992, Reed, 2000). The subsequent catalytic steps 
of splicing require a switch from the exon defined complex assembly to an intron 
defined one. The mechanism for this switch is poorly defined. However, an exon 
defined spliceosome complex can be directly converted into an intron defined B 
complex (Schneider et al., 2010). This phenomenon is important for regulation of 
exon inclusion or skipping during alternative splicing events (House and Lynch, 
2006, Bonnal and Valcarcel, 2008, Sharma et al., 2008). 
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Figure 8 Schematic diagram depicting the classical spliceosome assembly and 
splicing pathway 
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1.3.3 The protein composition of the mammalian spliceosome  
The eukaryotic spliceosome is a giant multi megadalton protein that relies not just 
on snRNPs but also on a number of other non-snRNP proteins that associate either 
transiently or stably with the snRNPs. These proteins play important roles in splice 
site recognition, facilitating interaction between various subunits of the spliceosome, 
and in linking splicing with other post transcriptional activities such as mature 
mRNA export to the cytoplasm. Proteomic studies employing mass spectrometry 
have managed to uncover the components of the mammalian spliceosome to 
varying extents (Jurica and Moore, 2003). Since most of the transitions of the 
spliceosomal complex between different states are rapid and very transient, initial 
proteomic studies to identify proteins that are part of the spliceosome relied on 
purifying the spliceosome as a mixture of different stages along the splicing 
process (Neubauer et al., 1998, Rappsilber et al., 2002, Zhou et al., 2002). 
Subsequently, purification and mass spectrometry analysis, in vitro, of three 
individual complexes along the splicing pathways including complex A (Hartmuth et 
al., 2002), complex B* (Makarov et al., 2002) and complex C (Jurica et al., 2002) 
were reported. In addition to these studies carried out in vitro using human cell 
extracts, a penta-snRNP complex that was formed without a pre-mRNA attached to 
it was also isolated from yeast cells raising the possibility of a completely 
assembled spliceosome being able to bind to and mediate splicing of a pre-mRNA 
without first undergoing disassembly (Stevens et al., 2002). Another in-vivo 
analysis (Ohi et al., 2002) led to the isolation of spliceosome complexes from both 
budding and fission yeast that corresponded with complex C isolated in-vitro from 
human cells (Jurica et al., 2002). These complexes were found to contain U2, U5 
and U6 snRNAs along with splicing factors involved in the second catalytic step 
suggesting that unlike the in vitro experiments where the pre-splisosomal 
complexes predominate, in vivo, the second step of catalysis is rate limiting (Ohi et 
al., 2002). Ranging from just over 17 proteins identified in the first mass 
spectrometry study (Neubauer et al., 1998) to between 150-300 using later in-vitro 
studies (Rappsilber et al., 2002, Zhou et al., 2002), the spliceosome emerged to be 
one of the largest assembly of nuclear proteins in the cell. Recent analysis of 
spliceosomal complexes from Drosophila, human cells (Herold et al., 2009) and 
budding yeast (Fabrizio et al., 2009) combined with the more refined analysis of the 
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human spliceosome at distinct stages (Behzadnia et al., 2007, Deckert et al., 2006) 
has led to a broad agreement of the spliceosome to contain about 170 proteins.  
In summary, about 45 proteins are packaged in the spliceosome in the form of 
snRNPs whereas non-snRNP proteins make up the rest of the protein complement 
of the spliceosome. While there are about 110 proteins associated with the pre-
catalytic B complex in metazoans including the components of the U1 snRNP, U2 
snRNP, the tri snRNPs and the nineteen containing complex (NTC), there are only 
60 in the same complex in yeast. Similarly, while there are approximately 110 
proteins associated with metazoan C complexes, yeast C complexes have only 50 
associated proteins. It is possible that the proteins found exclusively in metazoans 
might play important roles in alternative splicing which is not of significance to yeast 
cells (Bartels et al., 2002). As mentioned above, the spliceosome undergoes rapid 
conformational changes through the process of splicing and a variable number of 
proteins associate and dissociate from the spliceosome at each stage of the 
splicing process. In spite of this, the fact that the same homologous proteins 
associate and dissociate from the spliceosome at a specific step in both metazoans 
and yeast goes on to suggest the conservation of the spliceosome and its action 
across phyla and also is testament to the effectiveness of various experiments 
performed in different species to isolate the components of the spliceosome 
(Deckert et al., 2006) (Fabrizio et al., 2009, Herold et al., 2009). 
1.3.4 Role of splicing proteins in mitosis and the cell cycle 
In one of the first siRNA based screens to identify novel regulators of the cell cycle, 
Frank Buchholz and colleagues used siRNAs to target over 5000 human genes in 
HeLa cells and identified about 37 genes with novel roles in mitosis (Kittler et al., 
2004) of which 7 were known components of the spliceosome. Subsequently the 
authors expanded their analysis using siRNAs to a genome level and performed 
similar assays as above (Kittler et al., 2007) and estimated that  about 1351 genes 
were involved in regulating different stages of the cell cycle of which about 18 
genes were previously known to be associated with the spliceosome (Zhou et al., 
2002, Hofmann et al., 2010) 
More recently, the European consortium MitoCheck, published the results form 
their genome wide screen for cell cycle regulatory genes using time-lapse 
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imaging(Neumann et al., 2010). Of the ~150 genes thought to be part of the human 
spliceosome, based on the time lapse recoding available in the MitoCheck 
database, we estimate about 30 genes to have mitotic phenotypes when depleted. 
Our estimate is in agreement with a literature discussion regarding the potential 
role of splicing factors in mitosis (Hofmann et al., 2010) in which the authors 
pinpointed 27 spliceosome-associated genes with a mitotic phenotype within the 
MitoCheck dataset(Neumann et al., 2010, Hofmann et al., 2010). These findings 
suggest that a surprising number of splicing factors contribute to the successful 
execution of mitosis in human cells in an as yet undefined manner. 
In addition to these large-scale screens identifying novel roles for spliceosome 
factors in mitosis, a number of studies have reported the role of individual 
spliceosomal genes in mitosis. Firstly, Kathy Gould and colleagues described 
mutants of Cdc5 in fission yeast to be defective in G2-M transition (Ohi et al., 1994). 
The authors then found that fission yeast Cdc5 associated with the U2, U5 and U6 
snRNPs and was essential for pre-mRNA splicing (McDonald et al., 1999). 
Subsequently, the authors established that mutants without cdc5 were defective in 
nuclear division because they failed to form a functional spindle which was a result 
of faulty pre-mRNA splicing of α-tubulin mRNA. They also demonstrated that these 
defects could be rescued by removing the single intron in α-tubulin mRNA although 
the cells still suffered from global loss of splicing (Burns et al., 2002). 
Additionally, it was reported that mutants of budding yeast lacking cdc40 (PRP17 in 
humans), a gene known to be part of the yeast spliceosome, arrested in mitosis. It 
was also subsequently shown that these defects in mitosis stemmed from a loss of 
pre-mRNA splicing of anc1 mRNA, anc1 being an important transcription factor for 
a number of cell cycle regulatory genes (Dahan and Kupiec, 2004). The authors 
could also demonstrate that the mitotic defects sustained by loss of cdc40 could be 
rescued by replacing the genomic anc1 with a cDNA variant that lacked the introns.  
Thirdly, drosophila cells lacking dprp38 and MFAP1, components of the tri snRNP 
were shown to arrest in G2/M transition (Andersen and Tapon, 2008). The authors 
observed that this correlated with a reduction of mature mRNA levels of cdc25, a 
known regulator of mitosis. This finding was similar to finding in HeLa cells where 
knockdown of U2AF1, a known component of the U2snRNP, was shown to cause 
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cells to arrest in mitosis. This was also accompanied by a reduction in mature 
mRNA levels of many genes including CDC25 (Pacheco et al., 2006) 
Finally, it was shown that a protein belonging to the SR family of splicing regulators, 
SRm160 (Serine/Arginine repeat related nuclear matrix protein of 160 KDa) was 
associated with factors involved in sister chromatid cohesion such as SMC1, SMC3, 
SCC1 and SA2 (McCracken et al., 2005). Supplementing the above-mentioned 
work, while we were performing our experiments, a report was published that 
investigated the role of an RNA binding protein RBMX in sister chromatid cohesion 
in HeLa cells. RBMX belongs to the hnRNP family of proteins, a group of proteins 
that are important regulators of pre-mRNA splicing. The authors discovered that 
depletion of RBMX led to a potent mitotic arrest and that this arrest was caused by 
premature loss of sister chromatid cohesion. Based on co-depletion experiments 
with Sororin and WAPL, the authors concluded that RBMX is involved, in addition 
to Sororin, in removing the anti-establishment effect mediated by WAPL (see 
section 1.2.6)(Matsunaga et al., 2012).  
In addition to the effects of splicing factors on mitosis, a number of genes involved 
in processes downstream of pre-mRNA splicing have also been implicated in 
regulating cell division. Illustratively, a report on the depletion of UAP56 and 
URH49, members of the TREX family of proteins in HeLa cells was published. The 
TREX family of proteins are involved in coupling transcription and pre-mRNA 
splicing to mRNA export (Masuda et al., 2005, Reed and Cheng, 2005, Strasser et 
al., 2002). In the study, the authors depleted UAP56 and URH49 and observed its 
effects on gene expression at a genome level (Yamazaki et al., 2010). Additionally, 
the authors noticed mitotic defects in cells depleted of these genes. They further 
demonstrated that the mitotic progression defects in the case of UAP56 was 
caused by a premature loss of sister chromatid cohesion. The authors further 
showed that depletion of additional components of the TREX family led to similar 
defects in sister chromatid cohesion.   
In summary, loss of a variety of splicing factors has been shown to affect cell 
division in a number of different ways. It is possible that the defects in cell division 
observed upon loss of spliceosome components could arise through indirect ways 
(i.e. loss of mature mRNA levels of known cell division regulator through loss of 
splicing factor) or through direct effects (direct role of splicing factors in mitosis) or 
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a combination of both. While there have also been reports highlighting the role of 
splicing-associated factors in specific processes within mitosis, the mechanism and 
the precise targets of the splicing factors remain to be discovered. 
1.3.5 Splicing defects in disease and cancer 
Splicing factors have been reported to have either a causative role in disease, or 
act as modulator of disease severity or susceptibility in humans. Splicing 
associated diseases can arise as a result of either cis-acting factors (mutations 
within the gene that is the target of the splicing machinery) that affect the 
expression of a specific gene or due to trans-acting factors (mutations in subunits 
of the spliceosome machinery) that affect the expression a large number of genes 
(Wang and Cooper, 2007). Cis-acting factors include mutations that either affects 
splice site specification or the activity of exon and intron splicing enhancers (ESEs 
& ISEs) or exon and intron splicing suppressors (ESSs and ISSs) to affect the 
expression the protein concerned. It has been postulated that up to 60% of all 
mutations that cause disease do so by affecting splicing of the gene concerned 
(Lopez-Bigas et al., 2005). Of all the mutations in the human gene mutation 
database (HGMD), 78% are single nucleotide substitutions in exons (Stenson et al., 
2003). While at first glance most of these mutations could be predicted to alter the 
protein code and thereby function, it is also possible that splicing defects caused by 
alteration in ESE or ESS sequences could result in the reported pathogenicity. For 
instance, based on a mutational study in exon 9 and 12 of CFTR, the gene 
implicated in cystic fibrosis, it was reported that a quarter of even synonymous 
substitutions resulted in an altered splicing pattern (Pagani et al., 2005). In addition 
to these factors, the role of alternative splicing in generating a number of splice 
variants of the same protein further complicates the issue as a large fraction of 
splice variants thus generated remain to be identified. For instance, in a recent 
study it was revealed that out of a set of 50 well characterized genes, two third 
were found to express novel isoforms that in 40% of the cases were found to be the 
predominant variant in normal cells (Roy et al., 2005). 
In addition to cis-acting mutations, trans-acting mutations that target the 
spliceosome leading to a disruption of the splicing machinery are also known to 
result in human pathologies. Since the spliceosome is a gigantic protein complex 
containing over 150 proteins, it is easily susceptible to defects. Spinal muscular 
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dystrophy (SMA) is caused by mutations in genes involved in snRNP assembly. 
SMA is an autosomal recessive disorder that is caused by loss of Survivor of Motor 
Neuron-1 (SMN) gene specifically in motor neurons (Winkler et al., 2005). Retinitis 
pigmentosa is caused by mutations that disrupt snRNP function (Briese et al., 2005, 
Mordes et al., 2006, Tanackovic et al., 2011). Retinitis pigmentosa is a retinal 
degeneration disorder that specifically affects photoreceptor cells. Three genes that 
are dominant for the disease namely PRPF31, PRPF8 and HPRP3 are involved in 
the assembly of the tri snRNP, a complex required for proper functioning of the 
spliceosome (See section 1.3.2.1) (McKie et al., 2001, Vithana et al., 2001, 
Makarova et al., 2002, Chakarova et al., 2002).  
The role of splicing abnormalities in tumorigenesis is also well established (Bonnal 
et al., 2012, Skotheim and Nees, 2007, Srebrow and Kornblihtt, 2006, Venables, 
2006). Cis-acting mutations in known tumour suppressor such as LKB1 (Hastings 
et al., 2005), KLF6 (Narla et al., 2005), BRCA1 (Pettigrew et al., 2005) and 
oncogenes such as KIT (Chen et al., 2005) have been known to lead to 
tumorigenesis. Additionally there is growing evidence to suggest that changes in 
trans-acting splicing elements could cause cancer. Firstly there are reports that 
demonstrate that phosphorylation of SR proteins is increased in cancers (Ghigna et 
al., 2005, Karni et al., 2007) and a report also highlighted that in a sequenceing 
based screen, out of 189 genes identified to be mutated in breast and colon 
cancers, one of them was an SR protein SRP55 (Aka SFRS6) (Sjoblom et al., 
2006). More recently, a number of studies report that sequencing of DNA from 
abnormal blood cells of patients suffering from leukemia and pre-leukemeic 
syndromes revealed that a high proportion of these cases were linked to mutation 
in genes that were part of the spliceosome (Papaemmanuil et al., 2011, Visconte et 
al., 2012, Wang et al., 2011). These diseases include chronic lymphocytic leukemia 
(CLL), chronic myelomonocytic leukemia (CMML), myelodysplastic syndrome 
(MDS) and acute myeloid leukemia (AML). The spliceosomal genes associated 
with these disorders have all been shown to be part of the early prespliseosomal 
U2 snRNP complex. One of these, SF3B1, is among the most frequently mutated 
genes in CLL patients (Wang et al., 2011, Rossi et al., 2012, Quesada et al., 2012, 
Landau and Wu, 2013). Similarly, while 43% of CMML patients had single amino 
acid mutations in SRSF2 (Meggendorfer et al., 2012), 10% of MDS patients had 
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mutations in U2AF1 (U2AF35) (Graubert et al., 2012). Furthermore, other splicing 
factors such as ZRSR2 (URP), SF1, PRPF40B, U2AF2 (U2AF65) and SF3A1 were 
also mutated in myeloid neoplasms (Papaemmanuil et al., 2011, Visconte et al., 
2012, Wang et al., 2011, Yoshida et al., 2011). Despite the overwhelming 
association of mutations of these spliceosomal components with myeloid 
neoplasms and leukemias, the mechanisms by which these mutations contribute to 
pathogenesis at the cellular level and the specific targets of these splicing factors 
that are perturbed remain unclear. 
 
1.4 Functional genomics in cell cycle research 
With the emergence of the RNAi technology in mammalian cells, it is now possible 
to not only study the function of a gene in a particular biological process, but also to 
perform a search for all the genes in the genome that are involved in a specific 
biological phenomenon. By performing a high throughput genome-wide siRNA 
screen, it is now possible to construct maps of protein coding genes that are 
involved in biological processes. The cell cycle is one such area of research where 
functional genomics can help throw light on the role of novel genes in known 
biological processes. A number of genome wide screens have been reported in 
Drosophila cells and C.elegans (Sonnichsen et al., 2005, Eggert et al., 2004, 
Kamath et al., 2003). Three genome-wide screens have been performed in 
mammalian cells aiming to identify genes involved in the cell cycle (Neumann et al., 
2010, Kittler et al., 2007, Mukherji et al., 2006). Alternatively, a proteomics 
approach has also been used to investigate the protein complement of structures 
important for the cell division process (Skop et al., 2004).  
Rebecca Heald and colleagues performed a proteomic study on the mammalian 
midbody, the microtubule remnant that is thought to play an important role in the 
final separation of the two cells (Skop et al., 2004). The authors isolated midbodies 
from mammalian cells and identified the proteins using multidimensional protein 
identification technology (MudPIT). About 160 novel proteins were found to be 
associated with the midbody. Following this, the authors assessed protein function 
in Caenorhabditis elegans using siRNA-based depletion of 172 homologs of the 
proteins identified in the mammalian midbody proteomic study. While 38 of these 
Chapter 1 Introduction 
 
71 
genes were known to have a role in cell cycle progression, depletion of 
approximately 58% of the rest of the genes displayed defects in cytokinesis. It is 
also interesting to note that 14% of the genes identified to have a role in cytokinesis 
are also implicated in diseases including leukemia, Huntington’s disease among 
others. 
The first genome-wide screen for cell cycle regulators targeted 95 % of the protein-
coding genes in the human genome (Mukherji et al., 2006) and used DNA staining, 
automated microscopy, and image analysis to produce a list of cell cycle regulatory 
genes. The authors used siRNA pools against 24000 predicted human genes and 
also 10000 siRNAs against 5000 druggable human genes. Approximately 2 million 
images were acquired and automated image segmentation analysis was performed. 
It was demonstrated that cell cycle progression was affected by depletion of 1,152 
genes that could be classified into eight different phenotypic classes based on 
specific phase of arrest, nuclear shape and area etc. Out of the 1,152 genes 
identified, the authors tested the reproducibility by transfecting siRNAs against 57 
targets and assessing the phenotypic penetrance. Following this, they performed a 
deconvolution analysis wherein the siRNAs that made up the pool were transfected 
individually and the ability of the siRNAs to reproduce the phenotype produced by 
the pool was tested. Out of 24 randomly chosen genes tested, 19 of them 
displayed the phenotype in at least 2 out of the 4 siRNAs that made up the pool 
thereby suggesting that at least among the genes tested, the majority of the hits 
were not a result of siRNA off-target effects. 
In a second study, Frank Buchholz and colleagues used in vitro transcribed 
endonuclease prepped siRNAs (esiRNAs) for gene silencing followed by DNA 
content analysis to identify genes that controlled cell cycle progression in human 
cells (Kittler et al., 2007). As a pilot experiment the authors performed a study with 
a subset of 5,305 human genes and had identified 37 genes that upon depletion 
led to defects in cell division or cell cycle progression (Kittler et al., 2004). 
Subsequently, the authors targeted about 17,828 genes in the human genome 
esiRNAs in HeLa cells for a genome wide analysis. The cells were stained with 
propidium iodide to visualize the DNA after 72 h of esiRNA treatment. DNA content 
analysis was subsequently used to identify genes that regulated cell cycle 
progression. The authors also performed validatory assays using a stringent nine 
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parameter fingerprint to assign genes to specific functions. Based on their study, 
the authors estimated around 1351 genes to be involved in cell cycle regulation. 
Finally, MitoCheck, a European consortium, has accomplished the challenging task 
of performing a genome-wide screen for cell cycle regulatory genes using high 
content time-lapse microscopy (Neumann et al., 2010). Prior to performing the 
genome-wide screen, the authors performed extensive optimization experiments. 
The authors also optimized the process of reverse transfecting cells on arrays in an 
approach that would be conducive for high-content live cell imaging (Erfle et al., 
2007).The authors performed a proof-of-principle screen for 49 genes involved in 
chromosome segregation in HeLa cells expressing histone H2B (histone subunit) 
fused to GFP (green fluorescent protein) (Neumann et al., 2006). The siRNAs 
targeting the candidate genes were spotted as arrays on microscopic slides, 
thereby facilitating high throughput live imaging. 42 of the genes targeted (85%), 
showed visible defects in chromosome segregation whereas no defects were 
observed in non-targeting control siRNA treated cells. Using this approach, the 
authors were able to obtain a time-resolved phenotypic profile for each of the 
genes targeted. Extending this screen to a genome-wide scale, in 2010 the authors 
published the results of their screen where they targeted 21,000 protein-coding 
human genes (Neumann et al., 2010). Based on the automated analysis similar to 
their screen before, they identified a list of 1249 genes that were potentially 
involved in mitosis. Following this, the authors performed validation using multiple 
siRNAs against individual genes to narrow down the list of mitotic genes to about 
572. In addition to the validation experiments, complementation assays were 
carried out on a fraction of the hits. Even though 21 genes were targeted for the 
analysis, only 12 were successfully complemented by mouse transgenes 
suggesting that many of the hits generated by the siRNAs were probably false 
positives . The data generated by this screen is publicly available at the MitoCheck 
website (www.mitocheck.org). 
The above screens provide a rich source of information regarding the genes 
involved in the cell cycle. However, genome-wide screens often use generic 
readouts and do not focus on a particular process, and therefore lack the detailed 
level of analysis necessary. For this reason, the above-mentioned screens suffer 
from a lack of specificity and it is difficult to assign particular functions to many 
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novel genes. Intriguingly, the percentage overlap between at least two different 
screens referred to above was only about 10% (Kittler et al., 2007, Mukherji et al., 
2006). Yet all the siRNA screens mentioned above produced a list of over 1000 
candidate cell cycle regulatory genes. 
1.5 Goal of this research 
The high throughput cell cycle screens as detailed above are useful data resources 
for further studies that focus on individual processes within the cell cycle. Although 
large-scale screens are useful in assigning a putative role in a process for a 
specific protein, these screens as such are not capable of solving important 
biological questions. Reviews that accompanied the report from the MitoCheck 
consortium (Swedlow et al., 2010) and others (Conrad and Gerlich, 2010) stress 
the necessity for more focussed and targeted approaches to better understand 
individual processes that make up the cell cycle. Thus, cell division research has to 
move from screens covering a multitude of processes to screens scrutinizing a 
specific process using new and targeted assays. The aim of this study is to use the 
data from existing genome wide genomic and proteomic screens to identify novel 
regulators of mitosis and upon identification of such genes, to characterize them 
functionally and understand their role in executing mitosis. 
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Chapter 2. Materials & Methods 
2.1 Cells and growth conditions 
HeLa Kyoto cells, HEK 293FT and HCT116 used in this study were grown in 
Dulbecco’s Modified Eagle Medium, DMEM (Invitrogen 41965) supplemented with 
10% FCS (Sigma) and 1% Pen Strep (Invitrogen). In order to establish stable cell 
lines, media supplemented with either 0.35 µg/mL puromycin (Sigma) or 500 µg/mL 
G418 (Invitrogen) was used. Cells were grown in an incubator that was maintained 
at 37oC along with 5% CO2. 
2.2 siRNA screen and siRNA transfection  
2.2.1 siRNA screen 
To perform the siRNA screen, Dharmacon siGENOME smartpool siRNAs were 
obtained for the 718 genes selected for the screen in 0.1 nmole quantities in 96 
well plate format. Each well in a 96 well plate contained a pool of 4 siRNAs against 
a gene and were distributed across ten 96 well plates along with positive controls 
(known mitotic regulators such as ECT2, MgcRacGAP, AurKB etc.) and non-
targeting negative controls (scrambled siRNA, RISC free siRNA etc.). HeLa Kyoto 
cells were seeded at a concentration of about 2,500 cells per well in clear bottomed 
96 well plates (Falcon, Beckton Dickinson). Prior to cell seeding, siRNA pools at a 
final concentration of 37.5 nM, and the transfection reagent, Lipofectamine 
RNAiMax (Invitrogen 13778-150) at a final concentration of 1:600 (0.167µl/well), 
were deposited and mixed in the wells. Cells were grown for 52 hrs at 37OC and 
5% CO2 in DMEM and then processed for fixation with ethanol at -20oC overnight. 
Following the fixation, the cells were stained with Cellomics Whole cell stain 
(Thermo Scientific 8403402) at a final concentration of 1:75 and the DNA was 
visualized by DAPI (4',6-Diamidino-2-Phenylindole,Dihydrochloride, Invitrogen) at a 
final concentration of 1 µ/mL. The screen was performed in triplicate and was 
performed in collaboration with Dr. Michael Howell’s High Throughput Screening 
lab (HTS) at the Lincoln’s Inn Fields branch (LIF) of the London Research Institute 
(LRI) where automated image acquisition was performed using an ArrayScan ATI 
microscope (Thermo Scientific) equipped with a 10X objective. 20 images per well 
were captured and subsequently processed using imageJ software. The processed 
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images were visually scored for the percentage of cells containing abnormally 
shaped nuclei (including multilobed or fragmented nucleus) or multiple nuclei. The 
three biological plates were scored independently and the median value (the 
percentage of cells with abnormal nuclei) was calculated and plotted.   
2.2.2 siRNA sequences and transfection protocol 
The siRNA duplexes listed below were used at a final concentration of 37.5 nM. 
The siRNA duplexes highlighted in bold were used a reference for generating 
siRNA resistant transgenes of the respective genes. Control siRNA (Thermo 
Scientific siGENOME Non-Targeting siRNA #1 and #4 D-001210-01 D-001210-04 
and RISC free siRNA D-001220-01). Smartpool siRNAs against ECT2 (M-006450-
00), MgcRacGAP (M-008650-00), AurKB (M-003326-08), ESCO1 (M-023413-01), 
ESCO2 (M-025788-01) were used. siGENOME individual siRNAs were used 
against ARL5A (D-012408-01, D-012408-02, D-012408-03, D-012408-04), MFAP1 
(D-020071-01, D-020071-02, D-020071-03, D-020071-17), SART1 (D-017283-01, 
D-017283-02, D-017283-03, D-017283-04), NHP2L1 (D-019900-01, D-019900-02, 
D-019900-03, D-019900-04), CDC5L (D-011237-01, D-011237-02, D-011237-03, 
D-011237-04), Sororin (D-015256-06), Sgol1 (D-015475-17) and Scc1 (D-006832-
03). siRNA against Scc4 (ACACAUUGCUGGGCCUGUAUU) was obtained from 
Sigma Aldrich. The candidate genes for the primary screen are listed in Table 1 
below.  The full list of siRNAs used in the primary siRNA screen and the 
spliceosome chromosome spread screen is available in the appendix. 
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1	   AAK1  	   41	   ASB12 	   81	   CLASP1	  	  
2	   ABLIM1  	   42	   ATXN2 	   82	   CLCNKB	  	  
3	   ABTB1  	   43	   B3GALTL 	   83	   COG7	  	  
4	   ACOT4  	   44	   BAHCC1 	   84	   COTL1	  	  
5	   ADAM19  	   45	   BARD1 	   85	   COX7A2L	  	  
6	   ADAM33  	   46	   BAZ2B 	   86	   CRABP1	  	  
7	   AIFM3  	   47	   BCAS2 	   87	   CRISP2	  	  
8	   AKAP5  	   48	   BFAR 	   88	   CSN3	  	  
9	   AKR1C4  	   49	   BLES03 	   89	   CTLA4	  	  
10	   ALDH9A1  	   50	   BMP2 	   90	   CTNNBL1	  	  
11	   AMPD3  	   51	   BMPR1A 	   91	   CXORF58	  	  
12	   ANKFN1  	   52	   BTBD14A 	   92	   CYC1	  	  
13	   ANKRD5  	   53	   BTN3A2 	   93	   C2ORF17 
14	   ANXA11  	   54	   C10ORF45 	   94	   C2ORF25 
15	   ARL13B  	   55	   C10ORF53	   	   95	   C3F 
16	   AVPR2  	   56	   C11ORF24 	   96	   C3ORF14	  
17	   ABC1 	   57	   C11ORF38 	   97	   C3ORF52 
18	   ACAD9 	   58	   C12ORF39 	   98	   C4B 
19	   ACTL6A 	   59	   C13ORF23 	   99	   C4ORF23 
20	   ACTR3B 	   60	   C14ORF121 	   100	   C6ORF110 
21	   ACTRT2 	   61	   C14ORF177 	   101	   C6ORF167 
22	   ACVR1C 	   62	   C14ORF4 	   102	   C6ORF51 
23	   AGXT2L1 	   63	   C14ORF54 	   103	   C7ORF47 
24	   AKAP12 	   64	   C14ORF94\HAUS4	   	   104	   C8ORF44 
25	   AKT3 	   65	   C18ORF24 	   105	   C9ORF16 
26	   ALOX15B 	   66	   C19ORF35 	   106	   C9ORF167 
27	   AMIGO 	   67	   C19ORF54 	   107	   CA12 
28	   ANK2 	   68	   C19ORF7 	   108	   CABP7 
29	   ANKRD2 	   69	   C1GALT1 	   109	   CACNG4 
30	   ANKRD7 	   70	   C1ORF102\OSCP1	   	   110	   CACYBP 
31	   ANXA5 	   71	   C1ORF109 	   111	   CALR 
32	   ANXA6 	   72	   C1ORF125 	   112	   CAMK1 
33	   ANXA7 	   73	   C1ORF156 	   113	   CAMK2B 
34	   AP1G1 	   74	   C1ORF178 	   114	   CAMKV 
35	   AP2M1 	   75	   C1ORF210 	   115	   CANX	  
36	   ARHGAP17 	   76	   C1ORF50 	   116	   CAPZA1 
37	   ARHGEF11 	   77	   C1ORF71\CNST	   	   117	   CASC5	  
38	   ARL4A 	   78	   C1QTNF2 	   118	   CASP2	  
39	   ARL5A 	   79	   C20ORF77 	   119	   CBX7 
40	   ARPC2 	   80	   C21ORF91 	   120	   CCDC108	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121	   CCDC17	   	   161	   CSNK2B	   	   201	   EGFL7 
122	   CCDC56	   	   162	   CTDSPL	   	   202	   EGLN1 
123	   CCDC70	   	   163	   CTNND1	   	   203	   EGLN2 
124	   CCDC8 	   164	   CTRC 	   204	   EHD1 
125	   CCDC89	   	   165	   CTRL 	   205	   EIF2AK3 
126	   CCDC9 	   166	   CUL1	   	   206	   ELA3B 
127	   CCL28 	   167	   CYP2C19 	   207	   ELAC2 
128	   CCT4	   	   168	   DARC	   	   208	   ELMOD1 
129	   CDC5L	   	   169	   DBN1	   	   209	   ENAH 
130	   CDC6	   	   170	   DBNL 	   210	   ENPP5 
131	   CDK4	   	   171	   DCLRE1C	   	   211	   ERH 
132	   CDK8	   	   172	   DCTN1	   	   212	   EXOC1 
133	   CDKL2	   	   173	   DCTN2	   	   213	   EXOC3 
134	   CDKL5	   	   174	   DDX24 	   214	   F2RL2 
135	   CDT1	   	   175	   DEPDC7 	   215	   FAM101A 
136	   CDYL2	   	   176	   DGAT2	   	   216	   FAM101B 
137	   CENP	  E	   	   177	   DGKI 	   217	   FAM118B 
138	   CENP	  T	   	   178	   DHPS 	   218	   FAM131A 
139	   CEP192 	   179	   DHX8 	   219	   FAM136A 
140	   CHRDL1	   	   180	   DKFZP434P0316	   	   220	   FAM38A 
141	   CHRNA5 	   181	   DKFZP564C186	   	   221	   FAM47B 
142	   CKAP2 	   182	   DKFZP686L1814 	   222	   FAM76B 
143	   CKAP5 	   183	   DMRTC1 	   223	   FAM82B 
144	   CKS2	   	   184	   DNCL1	   	   224	   FANCC 
145	   CLDN16	   	   185	   DNM1L	   	   225	   FANCE 
146	   CLIP1	   	   186	   DOCK2	   	   226	   FANCI 
147	   CLK1	   	   187	   DOCK9	   	   227	   FATE1 
148	   CLPB 	   188	   DOPEY2	   	   228	   FBLN5 
149	   CMBL 	   189	   DPEP3	   	   229	   FBXL21 
150	   CNTFR 	   190	   DRD1	   	   230	   FBXO5	  
151	   CNTNAP1	   	   191	   DSE 	   231	   FCRL6 
152	   COL10A1	   	   192	   DTL	   	   232	   FFAR3 
153	   COPA	   	   193	   DUSP19	   	   233	   FGF12 
154	   COPB1	   	   194	   DUSP8	   	   234	   FGFR2 
155	   CORO1B 	   195	   DYNC1H1	   	   235	   FKBP6 
156	   CORO1C 	   196	   DYRK2	   	   236	   FLJ10276 
157	   CPA5 	   197	   EDA2R	   	   237	   FLJ20397 
158	   CRADD 	   198	   EDC4	   	   238	   FLJ22318 
159	   CRYGN 	   199	   EEA1	   	   239	   FLJ23657 
160	   CSK	   	   200	   EFCAB4B	   	   240	   FLJ25084 
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241	   FLJ33008 	   281	   GZMA 	   321	   KCNK5 
242	   FLJ46041 	   282	   HAVCR2 	   322	   KCNK6 
243	   FLOT1 	   283	   HAX1 	   323	   KCNN4 
244	   FOSL2 	   284	   HCFC1 	   324	   KCNT2 
245	   FZD8 	   285	   HDX 	   325	   KCTD13 
246	   GABRR1 	   286	   HEXA 	   326	   KCTD5 
247	   GALNT5 	   287	   HHIP 	   327	   KEAP1 
248	   GALR3 	   288	   HIP2 	   328	   KIAA0350 
249	   GAS1 	   289	   HISPPD2A 	   329	   KIAA0368 
250	   GDF9 	   290	   HIST1H2AJ 	   330	   KIAA0649 
251	   GDI1 	   291	   HIST3H2A 	   331	   KIAA0895 
252	   GEM 	   292	   HLA-DQA1 	   332	   KIAA1166 
253	   GIMAP5 	   293	   HNMT 	   333	   KIAA1267 
254	   GIPC1 	   294	   HOOK1 	   334	   KIF12 
255	   GJA5 	   295	   HOXD1 	   335	   KIF18B 
256	   GJB1 	   296	   HP1BP3 	   336	   KIF22 
257	   GJB3 	   297	   HSD17B7 	   337	   KIF2A 
258	   GJE1\ GJC3 	   298	   HSPA14 	   338	   KIF2C 
259	   GLRX 	   299	   HSPA5 	   339	   KIF5B 
260	   GLT1D1 	   300	   HSPBAP1 	   340	   KIFC1 
261	   GLT8D1 	   301	   HTF9C	   	   341	   KIFC3 
262	   GNA14 	   302	   HTR5A 	   342	   KLC2 
263	   GNAI2 	   303	   IBSP 	   343	   KLK1 
264	   GNAS 	   304	   IFNK 	   344	   KRT28 
265	   GNB2 	   305	   IFNW1 	   345	   KY 
266	   GNB2L1 	   306	   IK 	   346	   LAD1 
267	   GNG5 	   307	   IKIP	   	   347	   LCE1B	  
268	   GOLPH3L 	   308	   IL4R 	   348	   LCK 
269	   GORASP1 	   309	   INHBA 	   349	   LCN9 
270	   GORASP2 	   310	   IQUB 	   350	   LGALS1	  
271	   GOSR2 	   311	   IRAK4 	   351	   LIMA1 
272	   GPATC1 	   312	   ITGB1 	   352	   LIMD1 
273	   GPR19 	   313	   ITSN2 	   353	   LIMK1 
274	   GPR55 	   314	   JAG2 	   354	   LIMS1 
275	   GPR68 	   315	   JAK1 	   355	   LIN54 
276	   GPRIN1 	   316	   JUP 	   356	   LIN9	  
277	   GPX5 	   317	   KALRN	   	   357	   LMNA 
278	   GRK5 	   318	   KCNAB3 	   358	   LMNB1 
279	   GTPBP1 	   319	   KCNJ6 	   359	   LOC147645 
280	   GUCY1B3	   	   320	   KCNK18 	   360	   LOXL3 
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361	   LRP1 	   401	   MYO6 	   441	   NSUN5C	  
362	   LRP10 	   402	   MYOF 	   442	   NSUN7 
363	   LRP5 	   403	   MYOZ1 	   443	   NTRK3 
364	   LRTM2 	   404	   MYST1 	   444	   NUP214 
365	   LY86 	   405	   MZF1 	   445	   NUTF2 
366	   LYPLAL1 	   406	   NAGS 	   446	   ODZ3 
367	   M6PR 	   407	   NCOA6 	   447	   OGG1 
368	   MAGOH 	   408	   NCOR2 	   448	   OIP5 
369	   MAOA 	   409	   NDUFB10 	   449	   OPRS1 
370	   MAP2K5 	   410	   NDUFS3	   	   450	   OR51E1 
371	   MAP4K2 	   411	   NEDD1	   	   451	   OR51T1 
372	   MAPK15 
(ERK7/8) 
	   412	   NEDD4 	   452	   OR52E4 
373	   MAPKSP1 	   413	   NEDD4L 	   453	   OSM 
374	   MASTL 	   414	   NEGR1 	   454	   P2RY10 
375	   MC3R	   	   415	   NEK10 	   455	   PAEP 
376	   MC5R 	   416	   NEK3 	   456	   PAFAH1B1 
377	   MCP 	   417	   NEU1 	   457	   PALM 
378	   MCPH1 	   418	   NEURL 	   458	   PAPPA 
379	   MEGF11 	   419	   NFKBIE 	   459	   PARP14 
380	   MFAP1	   	   420	   NHP2L1	   	   460	   PCDH8	  
381	   MFI2 	   421	   NIPSNAP1 	   461	   PCLO 
382	   MFSD4 	   422	   NKTR 	   462	   PDE4B 
383	   MGAT4B 	   423	   NMNAT1 	   463	   PDE4C 
384	   MGC11061 	   424	   NOD1 	   464	   PDK1 
385	   MGC13125 	   425	   NOD27 	   465	   PDK1 
386	   MGC15763 	   426	   NOG 	   466	   PDK2 
387	   MGC20398 	   427	   NOX4	   	   467	   PDLIM7 
388	   MGC3036 	   428	   NP_001007190.1 	   468	   PDXP 
389	   MGC4707 	   429	   NP_001008271.1 	   469	   PDZD4 
390	   MGLL 	   430	   NP_001010866.1 	   470	   PEX10 
391	   MICAL3 	   431	   NP_277022.1 	   471	   PEX13 
392	   MKLN1 	   432	   NP_689812.2 	   472	   PHACTR2 
393	   MLL5 	   433	   NP_689919.1 	   473	   PHPT1 
394	   MMP12 	   434	   NP_981947.1 	   474	   PI4KB 
395	   MS4A1 	   435	   NPM1 	   475	   PICALM 
396	   MSN 	   436	   NPM3 	   476	   PINK1 
397	   MTBP 	   437	   NR5A1 	   477	   PIP 
398	   MTP_18 
HUMAN 
	   438	   NRIP3 	   478	   PIP5K2C 
399	   MYD88 	   439	   NSF 	   479	   PJA2 
400	   MYH9 	   440	   NSG2_HUMAN 	   480	   PLCB2 
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481	   PLCE1 	   521	   RAB8A 	   561	   SCN5A 
482	   PLEC1 	   522	   RABGAP1L 	   562	   SCYL1 
483	   PLK3 	   523	   RABGGTB 	   563	   SDK1	  
484	   PLRG1 	   524	   RAC2 	   564	   SDK2 
485	   PLXNA1 	   525	   RAPGEF3	   	   565	   SEC23A 
486	   PML 	   526	   RASL11A 	   566	   SEC23B 
487	   PNUTL2 	   527	   RBBP9 	   567	   SEC31 
488	   POLG 	   528	   RBM10 	   568	   SEMA4B	  
489	   POP5 	   529	   RBM41 	   569	   SEPP1 
490	   POU2F2 	   530	   RCN3 	   570	   SGK196 
491	   PP1A 	   531	   RCN3 	   571	   SH2D4A 
492	   PPAP2C 	   532	   RDH10 	   572	   SH3GLB2 
493	   PPIH 
CYCLOPHILIN 
H 
	   533	   RDH11 	   573	   SIGLEC1 
494	   PPIL5 	   534	   REEP4 	   574	   SIGLEC11 
495	   PPM1L 	   535	   RGMA 	   575	   SIGMAR1 
496	   PPP1CB 	   536	   RGS11 	   576	   SIPA1 
497	   PPP1R12A 	   537	   RHBDL1 	   577	   SLAMF1 
498	   PPP2R2A 	   538	   RHOT2 	   578	   SLC22A12 
499	   PPP2R2B 	   539	   RNASE4 	   579	   SLC25A5 
500	   PPP5C 	   540	   RNASE4 	   580	   SLC30A8 
501	   PPP6C 	   541	   RNF141 	   581	   SLC35D2 
502	   PRG2 	   542	   RNF215 	   582	   SLC37A4 
503	   PRICKLE2 	   543	   RP6-213H19.1 	   583	   SLC5A2 
504	   PRKAB1 	   544	   RPAIN 	   584	   SLC5A3 
505	   PRMT1 	   545	   RPS6KA2 	   585	   SLCO4A1 
506	   PRMT5 	   546	   RSAD1 	   586	   SLK 
507	   PRMT6 	   547	   RSU1 	   587	   SMC2 
508	   PRTN3 	   548	   RXFP2 	   588	   SMTN 
509	   PTAFR 	   549	   RYK 	   589	   SMU1	  
510	   PTGER2 	   550	   RYR2 	   590	   SNFT 
511	   PTGS2 	   551	   S100A10 	   591	   SNRPG 
512	   PTPDC1 	   552	   S100A2 	   592	   SNX4 
513	   RPA1 	   553	   S100A6 	   593	   SON	  
514	   GJD4 	   554	   SAP30BP 	   594	   SPAG4L 
515	   OR4D1 	   555	   SART1 	   595	   SPATC1 
516	   RAB22A 	   556	   SCCPDH 	   596	   SPCS2 
517	   RAB24 	   557	   SCGB1D1 	   597	   SPP1 
518	   RAB37 	   558	   SCGB2A2 	   598	   SPRY4	  
519	   RAB4A 	   559	   SCN11A 	   599	   SRBD1	  
520	   RAB7A 	   560	   SCN1B 	   600	   SRP14 
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601	   ST14 	   641	   TRIM63 	   681	   VTI1A 
602	   ST6GAL2 	   642	   TRMT1 	   682	   WDR5B 
603	   STAU1 	   643	   TRPA1 	   683	   WDR61 
604	   STK33 	   644	   TRPC3 	   684	   WDR81 
605	   STK39 	   645	   TRPV1 	   685	   WDR85 
606	   STRN 	   646	   TRUB2 	   686	   WDR89 
607	   STS 	   647	   TSP50 	   687	   WFDC2	  
608	   SVOPL	   	   648	   TSPYL1 	   688	   WNK1 
609	   SYP 	   649	   TTLL12 	   689	   WNK4 
610	   SYT8 	   650	   TTYH2 	   690	   WNT4 
611	   TAAR1 	   651	   TTYH3 	   691	   WTIP 
612	   TAS1R2	   	   652	   TUBA4A 	   692	   XAGE2	  
613	   TBC1D17 	   653	   TUBB2C 	   693	   XP_498354.1/ 
MAGEB16 
614	   TBL1X 	   654	   TXNDC3 	   694	   XPO1 
615	   TCTN3 	   655	   TXNL4A 	   695	   YEATS4 
616	   TDG 	   656	   UBE2M 	   696	   YPEL5 
617	   TDO2 	   657	   UBL5 	   697	   ZBED4 
618	   testis serine 
protease 1 
precursor 
	   658	   UBQLN2 	   698	   ZBTB40 
619	   TFIP11 	   659	   UBQLNL 	   699	   ZC3H8 
620	   TGFBR1 	   660	   UCK1 	   700	   ZFP3 
621	   THEG 	   661	   UCN 	   701	   ZFP42 
622	   TIMELESS	   	   662	   UCP3 	   702	   ZHX2 
623	   TIPARP 	   663	   UGT3A2 	   703	   ZNF114 
624	   TJP2 	   664	   UNC93A 	   704	   ZNF189 
625	   TLR1 	   665	   UNQ3033 	   705	   ZNF362 
626	   TLR2 	   666	   USE1 	   706	   ZNF479 
627	   TM2D1 	   667	   USP1 	   707	   ZNF511 
628	   TMEM129 	   668	   USP29 	   708	   ZNF549 
629	   TMEM185A 	   669	   USP30 	   709	   ZNF561 
630	   TNFAIP3 	   670	   USP52 	   710	   ZNF575 
631	   TNIP2 	   671	   USPL1 	   711	   ZNF579 
632	   TNKS 	   672	   UTP11L 	   712	   ZNF641 
633	   TNP2 	   673	   UTS2 	   713	   ZNF664 
634	   TNPO1 	   674	   VAMP1 	   714	   ZNF688 
635	   TOMM22 	   675	   VAPA 	   715	   ZNF750 
636	   TOR1A 	   676	   VCL 	   716	   ZNF85 
637	   TOR1AIP1 	   677	   VCX 	   717	   ZSCAN2 
638	   TOR1B 	   678	   VPS35 	   718	   ZSCAN5 
639	   TREML4 	   679	   VRK1 	   	   	  
640	   TRIM21 	   680	   VRK2 	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Positive	  controls	  
1	   ANLN 
2	   AURKB 
3	   CEP55 
4	   CIT 
5	   ECT2 
6	   INCENP 
7	   KIF20A 
8	   KIF23 
9	   KIF23 
10	   PLK1 
11	   PRC1 
12	   RACGAP1 
	    
Negative	  controls	  
1	   siGENOME 
NTC 
2	   RISC free 
NTC 
Table 1 List of candidate genes in functional genomic screen 
 
The siRNA transfections were performed using a reverse transfection protocol with 
Lipofectamine RNAiMax (Invitrogen 13778-150) as per the manufacturer’s 
instructions. Briefly, siRNA at 37.5 nM was diluted with OptiMEM (GIBCO 31985-
047) and mixed with appropriate volume of RNAiMax as per surface area of the 
wells as (indicated in Table 2). After incubating for 15 minutes at room temperature, 
the mixture was added to appropriate number of cells, as per the culture vessel, in 
DMEM medium. Cells were then incubated for 24, 36, 48 or 52 h and processed for 
downstream experiments as applicable. 
Plate OptiMEM RNAiMax 
siRNA 
(stock =20uM) 
Cell 
number 
Final 
volume 
10 cm plate 1 ml 15 ul 11.25 ul 800,000 6 ml 
6 cm plate 1 ml 10 ul 7.5 ul 300,000 4 ml 
12 well 175 ul 2.6 ul 3.75 ul 40,000 2 ml 
24 well 100 ul 1 ul 0.9375 ul 25,000 500 ul 
Table 2 siRNA transfection in Hela Kyoto cells across various cell culture 
surfaces 
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2.3 Plasmids and cell lines 
2.3.1 List of plasmids used in the study 
The plasmids used in the study are listed in Table 3 below. 
 Name DNA id Description Source 
1 pIRES puro 3 AcFL dna0049 AcFL tag (AcGFP-FLAG) at the N terminus 
of an MCS (Multiple Cloning Site) 
(Su et al., 
2011) 
2 pIRES puro 3 AcFL 
MFAP1 siRes 
dna0428 SiRNA resistant MFAP1 transgene with 
AcFL tag at N terminus 
This 
study 
3 pIRES puro 3 AcFL 
SART1 siRes 
dna0429 SiRNA resistant SART1 transgene with 
AcFL tag at N terminus 
This 
study 
4 pIRES puro 3 AcFL 
NHP2L1 siRes 
dna0430 SiRNA resistant NHP2L1 transgene with 
AcFL tag at N terminus 
This 
study 
5 pLVX puro-AcFL dna0431 AcFL tag (AcGFP-FLAG) at the N terminus 
of an MCS. Vector for Lentiviral expression 
system 
This 
study 
6 pLVX puro-AcFL 
Sororin siRes 
dna0433 SiRNA resistant Sororin transgene with 
AcFL tag at N terminus. Vector for lentiviral 
expression system 
This 
study 
7 pSPAX2 dna0435 2nd generation packaging vector for 
lentiviral expression system 
Addgene 
8 pMD2.G dna0436 Envelope vector for lentiviral expression 
system 
Addgene 
9 pEGFP-M27-
RNaseH1 
dna0434 RNase H1 variant that localizes specifically 
to nucleus, tagged at the C terminus with 
EGFP 
(Cerritelli 
et al., 
2003) 
Table 3 List of plasmids used in this study 
 
2.3.2 Preparation of stable cell lines using plasmid transfection 
To create tagged alleles of the genes used in the study (MFAP1, NHP2L1, SART1) 
for expression in human cells, AcGFP (Aequorea coerulescens GFP) was amplified 
from pAcGFP-N1 (Clontech) and inserted into pIRESpuro3 (Clontech). During 
amplification, a Kozak sequence (CGCCACC) and a FLAG epitope (DYKDDDDK) 
were added to AcGFP before the start codon and after the last amino acid, 
respectively. The coding sequences of the above mentioned genes were obtained 
(Source Biosciences) and introduced into this pIRES puro 3-AcFL vector using the 
restriction enzymes AgeI and EcoRI. To create siRNA-resistant variants of the 
genes the following sequences were mutated using Quikchange II site directed 
mutagenesis kit (Stratagene #200523). Highlighted in yellow are the single 
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nucleotide substitutions that were performed. For MFAP1, the sequence 
aagtgaaggtaaagcgtta was mutated to aggttaaagtgaaacgcta, for NHP2L1, the 
sequence ttgaaaggctcttagtcta was mutated to ttgagagactgttggtgta, for SART1, the 
sequence gcaagagcatgaacgcgaa was mutated to gcaaaagtatgaatgccaa. The 
plasmids were transfected into HeLa Kyoto cells using FuGENE 6 transfection 
reagent (Roche 11815091001) for the generation of stable cell lines.  Briefly, HeLa 
Kyoto cells were pre seeded at appropriate density at 37oC and 5% CO2 in DMEM 
(Invitrogen) medium with 10% FCS (Sigma). On the day of the transfection, the cell 
confluence was visually confirmed to be about 50% following which the plasmid 
and Fugene 6 were mixed at the ratio of 1 µg plasmid : 3 µl FuGENE 6 transfection 
reagent and diluted with OptiMEM. After incubating the mixture at room 
temperature for no more than 10 min, the mixture was added to cells along with 
fresh DMEM. The cells were grown for 24 h after which the medium was 
supplemented with 0.35-0.4 µg/ml puromycin (Sigma) to selectively maintain cells 
expressing pIRESpuro3-AcFL tagged alleles of the genes concerned. Clonal cell 
lines were then generated after two weeks of antibiotic selection and were 
characterized by immunofluorescence microscopy and immunoblotting. HeLa 
Kyoto cells were also transfected as above with a plasmid coding for RNase H1-
EGFP (a generous gift from Dr. Robert Crouch (Cerritelli et al., 2003) following 
which the GFP positive cells were enriched by fluorescence activated cell sorting 
(FACS) at the FACS facility at the LRI. 
2.3.3 Preparation of stable cells lines using Lentiviral infection 
To create tagged alleles of Sororin for expression in human cells, the coding 
sequence of Sororin was introduced into pIRES-puro 3-AcFL vector using the 
restriction enzymes AgeI and EcoRI. To create siRNA-resistant variant of sororin 
the sequence cgcaggagccctaggattt was mutated to agaagatcccccagaatct using 
Quikchange II site directed mutagenesis kit (Stratagene #200523). After this, the 
entire AcFL-Sororin sequence was excised from pIRES-puro3 vector using the 
restriction enzymes ClaI and EcoRI and cloned into pLVX-puro (Clontech). HEK 
293FT cells were pre seeded and grown to about 50% confluency before being 
transfected with a combination of three plasmids containing pLVX-puro-Sororin 
(WT or siRNA resistant) and second generation packaging system: psPAX2 
(Addgene, 12260) and pMD2.G (Addgene, 12259) using Lipofectamine 2000 
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(11668-019) according to the manufacturer’s instructions. Viral particles were then 
collected 48 hrs after transfection by harvesting the supernatant and filtering it 
through a 0.45µm PVDF filter unit (Millex HV SLHV033RS). Cycling HeLa Kyoto 
cells were infected with various titres of the viral particles in presence of 8 µg/ml 
polybrene (Sigma 107689). The cells were grown for 48-60 h in the presence of the 
viral particles after which the medium was supplemented with 0.35-0.4 µg/ml 
puromycin (Sigma) to selectively maintain cells expressing pIRES-puro3-AcFL 
tagged alleles of sororin. After passaging the cells for 3 generations, clonal cell 
lines were generated by picking individual colonies of cells using a cloning ring and 
growing the cells so isolated for two weeks with antibiotic selection. The cell lines 
were characterized by immunofluorescence microscopy and immunoblotting.   
2.3.4 Other transgenic cell lines used in the study 
Cells expressing H2B-mCherry were kindly provided by Dr. Kuan Chung-Su (Su et 
al., 2011) and were grown in DMEM media supplemented with 500 µg/ml G418 
(Invitrogen). Cells stably expressing SMC1-EGFP were used for Inverse 
Fluorescence Recovery After Photobleacing (iFRAP) experiments and were a kind 
gift from Dr. Jan-Michael Peters (Schmitz et al., 2007).  
2.3.5 List of cell lines used in this study 
The cell lines used in this study are listed in Table 4 below. 
Table 4 List of cell lines used in the study 
No. Cell line name Description Source/ Reference 
cl017 AcFL tag Tag only cell line (Su et al., 2011) 
cl132 AcFL MFAP1 
siRes 
Cell line expressing siRNA resistant 
MFAP1 tagged with AcFL 
This study 
cl133 AcFL SART1 
siRes 
Cell line expressing siRNA resistant 
SART1 tagged with AcFL 
This study 
cl134 AcFL NHP2L1 
siRes 
Cell line expressing siRNA 
resistantNHP2L1 tagged with AcFL 
This study 
cl135 AcFL tag 
(viral) 
Tag only cell line made by lentiviral 
expression system 
This study 
cl136 AcFL sororin 
siRes 
Cell line expressing siRNA resistant 
Sororin tagged with AcFL made by 
lentiviral expression system 
This study 
cl137 RNaseH1 M27 RNaseH1 M27 (nucleus only) with 
EGFP tag at C terminus 
This study. Plasmid 
from: (Cerritelli et al., 
2003) 
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2.4 Cell synchronization and drug treatments 
To synchronize cells in S phase, 2.5 mM of thymidine (T9250 Sigma) was added to 
cells either at the time of transfection or 24 h later. At the time of release, cells were 
rinsed twice with DMEM and fresh medium was added. To synchronize cells for 
performing chromosome spreads, asynchronously growing HeLa Kyoto cells that 
were grown for 24, 44 or 52 h following siRNA transfection were treated with 330 
nM nocodazole (M1404 Sigma) for 4 h. To score for the ability of the cells to form a 
metaphase plate (See Figure 15) HeLa Kyoto cells were synchronized in 
metaphase by treatment for 3 h with the proteasome inhibitor MG132 at a final 
concentration of 10 µM. 
2.5 Western blotting (WB) 
2.5.1 Preparation of whole cell lysates 
Cells were grown until the indicated time point and then harvested either by 
trypsinization or by mitotic shake off as appropriate. Cells were then spun down at 
3000 rpm for 3 minutes (Eppendorf desktop centrifuge 5434) and subjected to a 
PBS wash (4oC). Following pelleting of the cells and removal of PBS, lysates were 
prepared by direct resuspension of cells in Laemmli buffer (12.5 mL 4x SDS-PAGE 
stacking buffer (0.5 M Tris-Cl pH 6.8, 0.4% SDS w/v), 10 mL glycerol (anhydrous), 
20 mL SDS (10% w/v), 2.5 mL ß-mercaptoethanol, 2.5 mL bromophenol blue (1% 
w/v)). Lysates were boiled at 95oC for 5 minutes and subsequently sonicated at 10 
Amp microns in a sonicator (Soniprep, Sanyo). 
2.5.2 SDS PAGE and Western blotting 
Following the preparation of whole cell lysates, the protein concentration was 
measured by Bradford’s assay using the Bradford’s reagent (BioRad) and 
subsequently 30 ug each of the samples were loaded per well in an SDS-PAGE  
(sodium dodecyl sulphate poly acrylamide gel electrophoresis) gel in a criterion 
cassette (BioRad) and subjected to electrophoresis. Following this, the proteins 
were transferred onto an Immobilon PVDF membrane (Millipore) using a semi dry 
transfer procedure. Subsequently, the membrane was blocked with 5% milk for 30 
min and incubated with the primary antibody as indicated at 4OC overnight and then 
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with the appropriate secondary antibody conjugated with HRP for 1 h at RT. The 
detection of the protein was then carried out using an ECL chemiluminescence 
reaction (GE Healthcare). 
2.5.3 Fluorescent detection of western blotting 
For performing fluorescent detection of western blotting, the procedure similar to 
the one above (Section 2.5.2) was used except that the membrane used, 
Immobilon FL PVDF (Miilipore), exhibits low autofluorescence activity. Moreover 
the secondary antibody used was coupled to a fluorescent tag (Anti rabbit IgG 
conjugate (Dylight R 680) and anti mouse IgG conjugate (Dylight R 800) (Cell 
signalling). Both the secondary antibodies were used a final concentration of 
1:15,000. The proteins on the membrane were subsequently detected using an 
Odyssey Imaging System (LI-COR Biosciences).    
2.6 Real time PCR for measurement of mRNA levels 
The following primers were used for the quantitative real Time PCR (qRT-PCR) 
experiments. ARL5A (Fwd: ttgggctggataatgcaggg, Rev: ttttcttaggtcctcatgcgct), 
CEP55 (Fwd: tggaacaacagatgcaggca, Rev: tgagtgcagcagtgggactt), Sororin Intron1 
(Fwd: acgcagtccggtgaaagat, Rev: agcgagaagattcccaaaca), Sororin Exon 2  (Fwd: 
agggccccatctcctactaa, Rev: gccagatttcagggaggatg), Sororin Exon1-Exon2 (Fwd: 
atgtctgggaggcgaacg, Rev: acctccgcagaggcttagta), GAPDH (Fwd: cctcccgcttcgctcct, 
Rev: ctggcgacgcaaaagaaga). HeLa Kyoto cells were reverse transfected with the 
indicated siRNAs along with thymidine either added at the time of transfection or 
added 6 or 24 h post transfection. Cells were released from thymidine after 24 h 
and allowed to proceed though the cell cycle. 5 h after release, the cells were 
harvested and lysed in RLT plus buffer (Qiagen RNeasy Plus kit) + β-
Mercaptoethanol (Sigma). RNA was extracted from the cells using the RNeasy plus 
MiniKit (Qiagen) according to the manufacturer's instructions. After measuring the 
RNA concentration in a nanodrop spectrophotometer, 1.5 µg of total RNA was 
reverse transcribed with random hexamers using the TaqMan reverse transcription 
kit (Applied Biosystems). Pre-mRNA and mature mRNA levels were assessed by 
quantitative real time PCR (qRT-PCR) performed using the indicated primer pairs 
using iQ-SYBR Green Supermix and CFX96 Real-Time System (BioRad) using the 
following reaction conditions. 
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Reagent Volume (µL) 
cDNA 1 
H2O 3.6 
Primer 1 (10 µM stock) 0.2 
Primer 2 (10 µM stock) 0.2 
Sybr Green SuperMix 5 
Total 10 
Table 5 qRT-PCR reaction constituents 
 
No. Step Time 
(Secs) 
1 95OC 180 
2 95OC 10 
3 58-65OC (as appropriate) 30 
4 Plate read  
5 Go to step No.2 40 times  
6 Melt curve 60-95 OC  
7 Plate read  
8 End  
Table 6 Program for qRT-PCR reaction 
 
 The relative percentage mRNA was calculated using the ΔΔCT method as 
described earlier (Winer et al., 1999) and the GAPDH gene was chosen for 
normalization of the mRNA measurements. 
2.7 Immunofluorescence microscopy (IF) 
Cells grown on coverslips with a diameter of 18 mm and thickness 1 (Assistent) 
were fixed overnight with methanol at -20°C or for 10 min at 37°C in 4% 
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formaldehyde (Thermo Scientific, 16% PFA stock diluted with PBS). After fixation, 
samples were washed thrice in 0.01% Triton X-100 in PBS for 5 minutes each and 
then permeabilized with 0.2% Triton X-100 in PBS for 10 minutes. Following three 
more washes in 0.01% Triton X-100 in PBS, the coverslips were incubated with the 
blocking solution of 3% BSA in PBS containing 0.01%TritonX-100 for 1 h. Samples 
were incubated with the primary antibody in the blocking solution at 4OC overnight 
after which three washes with 0.01% Triton X-100 in PBS was done and the 
coverslips were incubated with appropriate secondary antibody in the blocking 
solution at room temperature for an hour along with 1µg/mL DAPI. Following three 
more washes with 0.01% Triton X-100 in PBS, the coverslips were mounted onto 
microscopic slides with ProLong Gold (Molecular Probes) and left to dry overnight. 
Images of the samples as processed above were acquired on Zeiss Axio Imager 
M1 or M2 microscopes using a Plan Neofluor 40x/1.3 oil objective lens or 63X/1.4 
Apochromat oil objective lens (Zeiss) equipped with an ORCA-ER camera 
(Hamamatsu) and controlled by Volocity 6.1. software (Improvision). Images were 
deconvolved using Volocity’s iterative restoration function. 
2.8 Antibodies and dyes 
The following primary antibodies were used in this study for Western blotting (WB) 
and Immunofluorescence (IF) experiments: mouse monoclonal anti-AcGFP (JL8, 
Clontech, IF & WB 1:2000), rabbit anti-AcGFP (Clontech, IF & WB 1:2000), mouse 
monoclonal anti-α-tubulin (B512, Sigma, IF & WB 1:10000), rabbit monoclonal anti-
β-tubulin HRP Conjugate (9F3, Cell Signaling, WB 1:2000), mouse monoclonal 
anti-Aurora B (AIM-1, 611083 BD Transduction Laboratories, IF: 1:500), mouse 
monoclonal anti-SMC1 (6892, Cell signalling, WB 1:1000), rabbit polyclonal anti-
SMC3 (ab9263, Abcam, WB 1:2000), goat polyclonal anti-SA1 (A300-157A, Bethyl 
labs, WB 1:1000), rabbit monoclonal anti-SA2 (5882, Cell signalling,  WB 1:1000), 
rabbit polyclonal PDS5A (A300-089A, Bethyl labs, WB 1:10000), rabbit polyclonal 
PDS5B (A300-537A, bethyl labs, WB 1:2000), rabbit polyclonal anti-MFAP1 
(SAB2104903, Sigma, WB 1:2000), rabbit polyclonal anti-NHP2L1 (95958, Abcam 
WB 1:5000), rabbit polyclonal anti-SART1 (SC376460, Santa Cruz, WB 1:1000). Dr. 
Jan Michael Peters (IMP, Vienna) kindly provided the following antibodies: rabbit 
polyclonal anti-Sgol1 (#975, WB 1:500), rabbit polyclonal anti-Sororin (#953, WB 
1:2000), rabbit polyclonal anti-Scc4 (#974, WB 1:1000), rabbit polyclonal anti-Scc1 
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(#890, WB 1:1000). Dr. Katsuhiko Shirahige (University of Tokyo) kindly provided a 
monoclonal mouse antibody against acetylated SMC3 (WB 1:1000). Secondary 
antibodies conjugated to either Alexa Fluor 488 or 594 (Molecular Probes) at a final 
concentration of 1:1000 were used for IF detection. DNA was stained with 1 µg/ml 
DAPI (Molecular Probes). HRP-conjugated secondary antibodies at a concentration 
of 1:5,000 were used to detect proteins on immunoblots using chemiluminescence 
(GE Healthcare). For fluorescent detection of western blotting, anti rabbit IgG 
conjugate (Dylight R 680) and anti mouse IgG conjugate (Dylight R 800) (Cell 
signalling) at a final concentration of 1:15,000 were used for detection with 
Odyssey Imaging System (LI-COR Biosciences).   
2.9 Time-Lapse microscopy  
To quantify mitotic duration and cell division status in Figure 17 & Figure 26, HeLa 
Kyoto cells were seeded in 12 well plates (Nunc). An hour prior to imaging the 
media was switched to CO2 independent media without phenol red (Invitrogen). 
Phase contrast images of cells were acquired every 5 min, as indicated at 37oC 
using a Zeiss Axio Observer Z1 microscope controlled by SimplePCI software 
(Hamamatsu) equipped with an Orca 03GO1 camera (Hamamatsu) and a Plan-
Apochromat 10x/0.45 objective. The images so acquired were processed using 
ImageJ software and analysed using the mitotic duration plugin (Lenart et al., 2007). 
For higher resolution imaging as in Figure 38, cells were seeded in Labtek 
chambered borosilicate coverglass chambers (Nunc, Thermo Scientific) and 
imaged with the microscope as above at intervals of 3 or 5 min as indicated but 
with a 40x/1.3 DIC H oil objective. The images so acquired were then processed 
using ImageJ software. 
2.10  Flow cytometry 
To quanity cell cycle progression for thymidine-synchronized cells in (Figure 32), 
flow cytometry analysis was performed as below. HeLa Kyoto cells were 
synchronized in thymdine for 24 h and were released for 3 h after which they were 
trypsinized, fixed in 75% EtOH and stored at –20ºC until analysis. For analysis, 50 
µL of FBS was added to each sample. The cells were then centrifuged, washed in 
PBS and re-suspended in 300 µL of PBS containing 200 µg/ml of RNase (Sigma) 
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and 5 µg/ml of propidium iodide (Sigma). Samples were incubated 15 min. at 37°C 
and analyzed using a FACScalibur (Becton Dickinson), using doublet discrimination 
to gate single cells. Cell cycle profiles were analyzed with FlowJo (Tree Star 
softwares).  
 
2.11 Chromosome spreads, interphase and mitotic 
Fluorescence In-Situ Hybridization (FISH) 
2.11.1 Chromosome spreads 
Chromosome spreads of HeLa Kyoto and HCT116 cells treated with siRNA 
duplexes were performed as follows. Cells were reverse transfected with the 
indicated siRNAs at a final concentration of 37.5 nM following which they were 
grown at 37oC for 24, 48 or 52 h as indicated. To enrich for mitotic cells, the 
medium was supplemented with 330 nM nocodazole for 4 hrs. Following this cells 
were harvested by mitotic shakeoff and centrifugation. Subsequently, cells were 
incubated in a hypotonic solution (DMEM: filtered deionized water at 1:2) for 6 min 
at room temperature (RT). Subsequently, cells were fixed with freshly made 
Carnoy's buffer (1:3 Glacial acetic acid:methanol) for 15 min at RT and spun down. 
This fixation step was repeated thrice. The suspension of cells in Carnoy's buffer 
(final volume: 100-200 µl depending on cell density) was then dropped onto a clean 
slide from a distance of about 2 feet and left to dry overnight at RT. The dried slides 
were washed in PBS solution containing 1µg/ml DAPI and was then mounted using 
Prolong Gold mounting solution. 
2.11.2 Interphase Fluorescence In-Situ Hybridization (FISH) 
Interphase FISH experiments were performed on cells treated as shown before 
(Schmitz et al., 2007). Briefly, cells were reverse transfected with siRNA onto 
coverslips with a diameter of 18 mm and thickness 1 (Assistent). 2.5 mM thymidine 
added either at the time of transfection or 24 h later. Following 24 h of thymidine 
arrest, cells were released from the thymidine arrest by rinsing twice in DMEM and 
allowed to proceed through the cell cycle. 5 h after release, they were fixed with 
Carnoy’s buffer (15 min at RT) and left to dry overnight.  
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BAC clone RP11-113F1 corresponding to the human tff1 gene was kindly provided 
by Dr. Erwan Watrin (University of Rennes). The BAC was used to produce FISH 
probes labeled with PrimeIt II Random primer labeling kit (Stratagene) and Cy3-
dCTP (Amersham Biosciences) as per the manufacturer’s instructions. Briefly, the 
about 100 ng of the BAC was denatured at 95OC for 2 min and then incubated with 
10 µl of random hexamers, denatured again at 95OC for 2 min and mixed with 1 µl 
of Klenow polymerase, 1 µl cy3 labelled dCTP and 10 µl of 5X dCTP buffer and 
incubated in the dark at 37OC overnight. After performing a DNA cleanup using 
Qiaquick gel extraction kit (Qiagen 28704), 20 µg Human cot-1 DNA (Invitrogen; to 
avoid probe binding to repetitive sequences) and 10 µg salmon sperm DNA 
(Invitrogen; to avoid non specific probe binding) were added to the probes. Ethanol 
precipitation was then performed for concentrating the probe following which the 
probes were resuspended in 50 µl MilliQ. Just before use, the probes were diluted 
in hybridization buffer (Cytocell aquarius) to a final ratio of 1:10. The probe was 
added to the fixed coverslips. The coverslip, now with the probes were denatured 
for 3 min at 75oC. Subsequently, they were incubated in a humidified chamber at 
37oC overnight. After the incubation, the coverslips were washed fbriefly in 0.4X 
SSC made from a stock of 20X (3M NaCl + 300 mM Na3C6H5O7) at 72oC for 3 min 
and then in 2X SSC with 0.05% Tween 20 at RT for 30 secs. Following this, DNA 
was counterstained with 1 µg/ml DAPI and the coverslips were mounted with 
ProLong Gold (Molecular Probes). Images were acquired on a Zeiss Axio Imager 
M1 microscope using a Plan Neofluor 40x/1.3 oil objective lens equipped with an 
ORCA-ER camera (Hamamatsu) and controlled by Volocity 6.1. software 
(Improvision). Images were deconvolved using Volocity’s iterative restoration 
function. Distance measurements were performed in Volocity by locating the 
centres of each of the pair of centroids manually and measuring the distance along 
a straight line between the two centroids. In control and Sgol1 depleted cells, since 
the distances were often difficult to resolve because of the proximity of the dots. As 
a consequence, only cells where at least 2 out of the 3-centroid pairs were 
resolvable were considered for the analysis. In Sororin, MFAP1, NHP2L1 and 
SART1 depleted cells, the vast majority of paired signals were clearly resolved and 
could be measured.  
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2.11.3 Mitotic FISH experiment* 
To analyse the status of sister chromatid cohesion in intact mitotic cells without 
subjecting them to the harsh chromosome spread and synchronization processes, 
we performed mitotic FISH experiments on asynchronous cells. Cells were reverse 
transfected with indicated siRNAs onto 18 mm coverslips and grown for 24 or 48 
hrs. Subsequently, the cells on the coverslips were fixed with Carnoy's buffer for 15 
min at RT. FISH probes for the centromeres of chromosomes 6 (LPE 06G) and 
chromosome 8 (LPE 08R) (Cytocell aquarius) were used to probe the status of 
sister chromatid cohesion status. The FISH probes were diluted with hybridization 
buffer (Cytocell aquarius) at a ratio of 1:10 and subsequently added to the fixed 
coverslips. Denaturation was performed for 3 min at 75oC, and the slide was left to 
hybridize overnight at 37oC in a humidified and lightproof chamber. Following this, 
the coverslip was washed in 0.25 x SSC for 3 min at 73oC and subsequently in 2 x 
SSC with 0.05% Tween 20 for 30 secs at RT. The coverslips were then incubated 
in PBS containing 1µg/ml DAPI to counterstain DNA. Finally the coverslips were 
mounted using Prolong Gold mounting solution. Images were then acquired on a 
Zeiss Axio Imager M2 microscope using a Plan Neofluor 40x/1.3 oil objective lens 
equipped with an ORCA-ER camera (Hamamatsu) and controlled by Volocity 6.1 
software (Improvision). Distance measurements were performed in Volocity by 
locating the centres of each of the pair of centroids manually and measuring the 
distance along a straight line between the two centroids. Since HeLa Kyoto cells 
are trisomic for chromosome 6 and chromosome 8, three pairs of dots for each 
chromosome was present. The distance between each of the six paired FISH 
signals was estimated and if it was longer than 2 µm, they were considered not to 
be paired anymore. The value of 2 µm was used because this was the average 
distance between the centroids in metaphase of a control cell, where the centroids 
would be expected to be the furthest apart and still be paired. 
 
 
 
*Experiment performed in collaboration with  
Dr. Maria Dolores Vasquez Novelle  
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2.12   Inverse Fluorescence Recovery After Photobleaching 
(iFRAP) and image quantification 
iFRAP experiments were performed based on experiments described previously 
(Gerlich et al., 2006, Schmitz et al., 2007). Cells stably expressing SMC1-EGFP 
were obtained from Dr. Jan-Michael Peters (Schmitz et al., 2007) and were reverse 
transfected with the indicated siRNA duplexes at a final concentration of 37.5 nM in 
Labtek 2 chambered borosilicate coverglass chambers (Nunc, Thermo Scientific). 
2.5 mM thymidine was added either at the time of seeding or 24 h post seeding. 
Cells were released from thymidine arrest after 24 h by rinsing twice in DMEM and 
allowed to proceed through the cell cycle for 5 h. An hour before imaging, the 
medium was changed to CO2 independent medium without phenol red (Invitrogen) 
supplemented with 10% FCS, 0.2 mM L-glutamine, PenStrep, and 1 mM Na-
pyruvate (all Invitrogen). 1 mg/ml cycloheximide (Sigma) was added to avoid new 
synthesis of SMC1-EGFP. The imaging and bleaching was performed at 37 °C 
using a Olympus FV1000D (InvertedMicroscopeIX81) laser confocal scanning 
microscope equipped with a PlanApoN ×60/1.40 NA Oil Sc objective lens and 
controlled by FV10-ASW software (Olympus).  One half of the nuclear region was 
bleached leaving the other half intact. Repeated bleaching was performed every 10 
secs for 5 iterations in order to remove the soluble and dynamically bound pool of 
Smc1-EGFP. This resulted in a reduction in the fluorescence intensity of the 
unbleached nuclear area as well. The first post bleach frame used for the 
downstream analysis was acquired 2 min after photobleaching to allow for 
complete equilibration of bleached soluble SMC1-EGFP across the nucleus. 
ImageJ software (http://rsbweb.nih.gov/ij/) was used for the intensity 
measurements. EGFP intensities were measured by drawing a rectangular area of 
the same dimensions in the bleached and unbleached area followed by subtraction 
of the mean background signal outside of the cell. The iFRAP ratio was calculated 
as the ratio of the background corrected mean fluorescence intensity of the 
bleached versus unbleached area normalized to the first post bleach frame. The 
IFRAP ratio was plotted over time for the different siRNA treatments. 
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Chapter 3. Results 1-  A functional genomic screen to 
identify novel regulators of mitosis 
Mammalian tissue culture cells are a very good model system to understand a 
number of biological processes. With the optimization of the RNAi technology, it is 
now possible to perform a comprehensive analysis of all the genes in the genome 
to assess their roles in specific biological processes. Genome-wide screens aiming 
to identify cell cycle and cell division factors have been reported in Drosophila cells 
and C.elegans (Kamath et al., 2003, Eggert et al., 2004, Sonnichsen et al., 2005) 
and in mammalian cells. Proteomic studies have also been performed to identify 
novel components of the mammalian midbody, a structure that is crucial for the 
completion of cytokinesis by abscission (Skop et al., 2004, Guizetti and Gerlich, 
2010). The aim of my PhD project was to utilize existing genome-wide screening 
and proteomic datasets to identify novel regulators of cell division and upon 
identification of novel genes, to further characterize their biological roles. 
3.1 Establishing and optimizing an siRNA based screen to 
identify new genes that regulate mitosis 
The starting point for my project was to combine available functional genomics data 
to shortlist genes to be investigated for novel roles in regulating mitosis. We 
selected 851 genes that were either identified as causing mitotic failure upon 
depletion according to the genome wide screens or genes that were identified as 
midbody associated by the proteomics approach (Skop et al., 2004). Subsequently, 
a set of criteria was used to eliminate genes that were either well-characterized 
regulators of cell division, pseudogenes, ribosomal proteins and annotation 
mistakes. Based on this winnowing process, we ended up with a shortened 
candidate list of 718 genes as shown in Figure 9, that we went on to study in our 
screen (See section 2.2.1 and the appendix for a list of all the genes screened) 
Before ordering the siRNAs against the candidate genes that we selected, we 
proceeded to optimize the assay and the conditions that we would use for the 
screen. Firstly, regarding choice of the cell line to be used for the screen, we chose 
to use HeLa Kyoto cells, which is a human cervical cancer cell line derived from a 
patient who suffered from an aggressive adenocarninoma of the cervix (C, 1974). 
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HeLa Kyoto cells have been widely used for studying the cell cycle for a variety of 
reasons; they are easy to maintain and propagate and more importantly they are 
amenable to high throughput microscopic imaging and are an excellent for RNAi 
based depletion of genes, which were the mainstay of the project. However, it is 
worth noting that HeLa Kyoto cells suffer from chromosomal instability and are thus 
aneuploid thereby necessitating careful interpretation of the results obtained. 
We performed a series of optimization experiments wherein the effect of a number 
of parameters such as the choice of siRNA transfection reagent, its concentration, 
the concentration of siRNA, cell passage number, seeding density and method of 
cell fixation among others on the phenotypic penetrance and image quality were 
tested. As shown in Figure 10, we used siRNAs targeting known mitotic regulators 
such as Aurora Kinase B, ECT2 and RacGAP1 to test the assay firstly in 12-well 
plates. We used a liposome-based reverse transfection protocol to introduce the 
siRNA duplexes into HeLa Kyoto cells at a final concentration of 37.5 nM of the 
siRNA duplexes in the culture medium. 52 h post transfection, we fixed the cells 
and stained them with a whole cell stain for visualizing the cytoplasm and DAPI for 
the nucleus. Transfection with siRNAs targeting positive control genes led to the 
efficient depletion of the target protein and caused a penetrant nuclear morphology 
phenotype, as shown by DAPI staining (Figure 10). The presence of bi-nucleated 
or multi-nucleated cells indicated the requirement of the gene in cytokinesis 
whereas the presence of lobed or abnormally shaped nuclei indicated the 
requirement of the gene concerned in chromosome segregation. Based on these 
test results, we chose to use abnormalities in nuclear morphology in fixed 
interphase cells as the indicator for defective mitosis or cytokinesis and hence as a 
readout for our screen. 
Following this, we also optimized the assay in 96 well plates, which was the format 
that would be used for the screen. This was performed in collaboration with Dr. 
Michael Howell’s High Throughput Screening lab (HTS lab) at the London 
Research Institute (LRI). We obtained optimal results with a cell number of about 
2500 per well in a 96 well plate. We also decided to perform automated cell 
seeding and transfection using liquid handling robots at the HTS lab. Based on the 
optimization experiments, we further decided to use siGENOME smartpool siRNAs 
from Dharmacon that were arrayed in a 96 well plate format for the screen. The 21 
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nucleotide long siGENOME siRNAs carry ON-TARGET modifications in the sense 
strand that prevent its processing by the RISC complex thereby reducing off-target 
effects. In addition, the use of smartpools (4 different siRNAs against each gene) 
instead of individual duplexes reduces the effective concentration of individual 
duplex and is thought to further reduce chances of off-target effects. 
3.2 Primary siRNA screen for identifying novel mitotic genes 
After optimizing the assay for the screen, we performed the screen as follows, 
siRNA pools targeting the 718 genes were distributed across ten 96 well plates 
along with positive controls (known mitotic regulators such as AurKB, ECT2, 
MgcRacGAP, PRC1 etc.) and non-targeting negative controls (scrambled, RISC 
free siRNA etc.) as shown in Figure 11. We performed the screen in triplicate as 
shown in Figure 12. At 52 h post transfection, we fixed the cells in 100% ethanol at 
-20OC overnight, stained them and subjected them to automated image acquisition 
using an ArrayScan ATI microscope equipped with a 10X objective. The images 
were subsequently scored manually for abnormal nuclear morphology with over 
300 cells being counted for each well. Subsequently, the median value of the three 
biological repeats was determined for each siRNA pool.  The screen result is 
displayed in graph form in Figure 12. The negative controls used in the screen such 
as the scrambled control and the RISC free control scored less than 8% in terms of 
nuclear abnormalities. All positive control genes were detected with top scores 
ranging between 75-99% indicating that the screening assay had been successful. 
Based on visual confirmation and the feasibility of downstream processing, we 
selected genes that scored above an arbitrary cut-off of 23% for further analysis. 
3.3 Deconvolution screen for hits identified in primary reveal 
multiple off target hits 
Based on the primary screen data, we selected 50 genes for a subsequent 
deconvolution analysis. Since the primary screen was performed with smartpools of 
4 individual siRNAs targeting different regions within the same gene, we reasoned 
that performing a deconvolution analysis using the individual siRNAs that make up 
the pool would serve to determine how many and which individual siRNA duplex 
reproduces the phenotype observed in the original screen. This can give 
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indications as to whether a hit is more or less likely to be caused by depletion of the 
intended target. It serves to increase the confidence level in assigning a particular 
phenotype to the depletion of the gene concerned. While hits with only one siRNA 
producing the effect are more likely to be caused by off-target effects, genes for 
which two or more (out of 4) siRNA duplexes reproduce the phenotype observed 
with the pools are strong candidates for a causal link between the effect and loss of 
gene product. A definite test for phenotype-gene linkage requires RNAi-resistant 
transgenes (see later) or an inactivation of the candidate gene by gene targeting or 
genome editing. 
We performed the deconvolution analysis in three 96 well plates with positive 
(ECT2, MgcRacGAP, PRC1 etc.) and negative (scrambled RISC free) control 
siRNA duplexes distributed across the plates. Image acquisition and the 
subsequent manual scoring were done as described for the primary screen. The 
results from the deconvolution experiments are summarised in   
 
Gene 
%  Abnormal 
nuclei (siRNA 
Smartpools) 
Number of 
siRNAs scoring > 
20% abnormal 
nuclei 
MFAP1 24.63 4 
SNRPG 50.89 3 
DHPS 23.44 3 
ECT2 99.00 3 
CACNG4 46.71 2 
DPEP3 36.13 2 
MGC3036 38.26 2 
NEDD1 24.03 2 
RPAIN 36.76 2 
SDK2 61.22 2 
SON 49.22 2 
ARL5A 22.64 2 
C14ORF177 26.68 2 
TNP2 20.29 2 
CCDC17 20.76 2 
AKAP12 41.00 1 
BLES03 24.18 1 
CAMK2B 34.56 1 
FAM38A 21.24 1 
GPR19 27.43 1 
MFSD4 63.33 1 
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MGC4707 29.82 1 
NEURL 35.89 1 
OR51T1 17.47 1 
PDE4C 22.69 1 
SLCO4A1 20.73 1 
SMU1 33.55 1 
SNFT 46.69 1 
SVOPL 65.05 1 
TUBA4A 35.24 1 
CORO1C 41.24 1 
FAM101A 54.57 1 
P2RY10 26.50 1 
PRG2 35.46 1 
np_981947.1 67.90 1 
TSPYL1 26.43 1 
AAK1 4.00 1 
CCL28 4.00 1 
CXORF58 22.62 1 
TJP2 7.00 0 
FAM131A 19.24 0 
ITSN2 18.23 0 
PDK2 25.89 0 
TAS1R2 24.72 0 
ZBTB40 24.16 0 
TREML4 18.11 0 
PDK1 18.38 0 
USP52 18.49 0 
DGAT2 21.00 0 
STRN 20.50 0 
CORO1B 22.68 0 
Table 7 Results of secondary deconvolution siRNA screen.  
Highlighted in green are the genes that could reproduce the screen phenotype in at 
least 2 out of the 4 siRNAs tested 
 
We observed that while 14 out of the 50 genes showing a nuclear morphology 
phenotype for at least two out of the four siRNAs tested (Table 7), we could 
reproduce the screen (Smartpool phenotype) in only 7 out of the 50 genes 
suggesting that about 90% of the hits that emerged from the screen are likely to be 
caused by off-target effects linked to one of the pool’s siRNA duplexes.  
Based on the deconvolution experiments, we observed that MFAP1 (4 out of 4 
oligos positive) represented the strongest hit. Also, we observed that depletion of 
ARL5A (3 out of 7 oligos positive) led to an interphase phenotype that was 
reminiscent of an abscission defect (Persistence of tubulin bridges between 
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interphase cells) and therefore we decided to focus our attention on ARL5A for a 
start. 
3.4 The cytokinesis defect observed upon transfection of 
ARL5A siRNAs is an off-target effect 
One of the top hits to emerge from the siRNA screen was ARL5A or ADP 
ribosylation factor-like 5A. ARLs belong to a subfamily of ARF-like proteins that are 
Ras related GTPases (Tamkun et al., 1991). ARL5A is a member of the ARL family 
of proteins and while its crystal structure has been solved (Wang et al., 2005), its 
function within the cell remains unknown. Transfection of two siRNA duplexes 
targeting ARL5A resulted in a penetrant and interesting phenotype; we observed 
more than 55% multi-nucleated cells indicating a defect in undergoing cytokinesis 
(Figure 13). Excitingly, we observed that even cells with a single nucleus were 
often connected to their neighbouring cells by tubulin bridges indicating a severe 
defect in cytokinetic abscission (Figure 13). Tubulin bridges exist in normal cells in 
the 1 to 2 h time window between cleavage furrow ingression and abscission. 
However, a higher proportion of cells with tubulin bridges was apparent upon 
transfection of ARL5A siRNAs retained a tubulin bridge. Closer inspection revealed 
that the staining pattern of tubulin in the intercellular bridges that we observed was 
different for ARL5A siRNA (Figure 13). Because the dense midbody structure that 
forms in the centre of the intercellular bridge acts as an impermeable barrier for the 
tubulin antibody, control cells usually present a staining pattern where the tubulin 
bridge is visualized with a small gap in the middle (Matuliene and Kuriyama, 2002, 
Zhao et al., 2006). This gap was absent in about 88% of anaphase and telophase 
cells treated with ARL5A siRNAs suggesting that midbody integrity was affected in 
cells devoid of ARL5A. We confirmed this by staining cells for the kinesin MKLP1, a 
component of the Centralspindlin complex and a key part of the midbody in animal 
cells (Matuliene and Kuriyama, 2002). The MKLP1 staining was significantly 
diminished in cells depleted of ARL5A (Figure 13) again suggesting that the 
midbody structure was poorly formed if cells were treated with siRNAs targeting 
ARL5A. 
Because of the proclivity of siRNA screens to produce off target effects, we decided 
to perform quantitative real time PCR (qRT-PCR) experiments to assess the 
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correlation between the phenotype observed and the depletion efficiency of the 
target mRNA. We performed the qRT-PCR experiment using primers that were 
specific for ARL5A and used GAPDH primers as controls for the assay. Based on 
our imaging experiments, we observed the multi-nucleation and tubulin bridge 
phenotype in 2 out of the 6 siRNAs used against ARL5A. However, qRT-PCR 
results revealed that all 6 siRNAs were able to reduce ARL5A mRNA levels to a 
similar extent (Figure 13). Thus, the cellular phenotype of ARL5A siRNAs does not 
appear to correlate with the depletion efficiency of ARL5A mRNA. Closer inspection 
of the sequences of the two ARL5A siRNA duplexes that caused defective 
cytokinesis revealed a sequence overlap. This finding combined with the lack of 
correlation between depletion efficiency and the cellular phenotype strongly 
indicated that the observed cytokinesis phenotype was the result of an off-target 
effect.  
We subsequently compared the sequence of the two effective ARL5A against the 
sequence of genes that were already known to regulate abscission. We observed 
that both ARL5A siRNAs that caused a cytokinesis defect (ARL5A siRNA 1 and 2) 
had sequence complementarity with the mRNA encoding CEP55 (Figure 14A). 
CEP55 is a midbody-associated protein that is required for midbody integrity and 
for recruiting the ESCRT machinery for abscission (Fabbro et al., 2005, Zhao, 2006, 
Lee et al., 2008, Bastos and Barr, 2010). Depletion of CEP55 causes late 
cytokinesis failure and strikingly causes midbody defects including the absence of 
the gap in tubulin staining. Thus, it is possible that the two ARL5A siRNA duplexes 
that cause cell division defects target CEP55 in addition to ARL5A. We tested this 
possibility by performing qRT-PCR using CEP55 specific primers for cells treated 
with all 6 siRNAs that were designed to target ARL5A. We observed that the 2 
siRNAs that were causing the multi-nucleation and tubulin bridge phenotype in cells 
reduced CEP55 mRNA levels while the other 4 siRNAs did not (Figure 14B). We 
subsequently obtained similar results by performing immunoblotting for CEP55 
protein levels (Figure 14C).  Based on these data, we conclude that the cytokinesis 
phenotype that we observed after transfection of ARL5A siRNA duplexes is caused 
by an off-target effect, namely the depletion of the known cytokinesis regulator 
CEP55. 
Chapter 3 Results  
 
 102 
3.5 Depletion of MFAP1 causes abnormal nuclear morphology 
in interphase cells 
Another hit to emerge from the primary siRNA screen was MFAP1, Microfibrillar 
Associated Protein 1. MFAP1 is protein that was found to be part of the tri-snRNP 
complex of the spliceosome (See section 1.3.2.1)(Jurica and Moore, 2003). 
Drosophila MFAP1 was shown to be essential for pre-mRNA splicing and 
interestingly, for G2/M transition (Andersen and Tapon, 2008). Depletion of MFAP1 
resulted in fragmented and multilobed interphase nuclei indicating a defect in 
mitotic chromosome segregation (Figure 15). All 4 siRNA duplexes targeting 
MFAP1 efficiently depleted the protein as evidenced by qRT-PCR experiments 
using MFAP1 specific primers and also by immunoblotting experiments using 
MFAP1 antibodies and caused a cellular phenotype (Figure 15). These data 
strongly suggest that, unlike ARL5A above, the phenotype observed is caused by 
the loss of MFAP1 protein. 
To decisively test the hypothesis that loss of MFAP1 causes nuclear morphology 
defects, we decided to develop a genetic complementation system using an siRNA-
resistant transgenic allele of MFAP1. We obtained the cDNA coding for MFAP1 
(Source Bioscience) and introduced the silent mutations in the target sequence of 
siRNA3 (See section 2.2.2 and 2.3.2 for methodology used) creating MFAP1-r. We 
also added a tandem N-terminal AcGFP-FLAG (Aequorea coerulescens Green 
Fluorescent Protein-FLAG, referred to as AcFL henceforth) tag to MFAP1-r. Using 
the resulting transgene, we generated a clonal stable cell line that expressed the 
transgene in more than 95% of the cells and at a level comparable to the 
endogenous counterpart (Figure 16). Subsequently, we tested the ability of the 
transgene to rescue the nuclear morphology defect upon depletion of the 
endogenous protein by siRNA transfection. Depletion of endogenous MFAP1 
disrupted nuclear morphology in more than 50% of cells expressing only the AcFL 
tag. Expression of the RNAi-resistant MFAP1 transgene potently suppressed the 
interphase phenotype (Figure 16). Interestingly, we also observed that the level of 
endogenous MFAP1 is reduced in the MFAP1 transgenic cell line indicating the 
action of protein copy number or stability control mechanisms. Our experiments 
establish that loss of MFAP1 causes an interphase nuclear morphology defect. 
Chapter 3 Results  
 
 103 
This finding prompted us to investigate the underlying reason for this cellular defect 
and to probe the function of MFAP1 in maintaining nuclear integrity.
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Figure 9 Workflow scheme for the functional genomic screen using genome-wide 
screens and proteomic datasets as a starting point  
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Figure 10 Penetrant mitotic defects in HeLa Kyoto cells transfected with siRNAs 
targeting known cell division factors  
HeLa Kyoto cells transfected with indicated siRNA duplexes (37.5 nM) were analyzed 
48 h post transfection. Quantification of the percentage of nuclear abnormalities (upper 
left panel) (n > 200 cells, error bars represent mean ± SD of 3 independent 
experiments). Whole cell extracts were analyzed by immunoblotting using the indicated 
antibodies (upper right panel). Immunofluorescence image of mono-nucleate control 
cells and ECT2-depleted multinucleated cells (lower panel, scale bar = 16 µm). 
Chapter 3 Results 
 
 106 
 
Figure 11 Arrangement of candidate genes for siRNA screen  
Illustrative plate arrangement map used in the siRNA screen. siRNA smartpools 
directed against the 718 genes were distributed across ten 96-well plates (in green). 
Positive controls against known regulators of mitosis and cytokinesis were randomly 
distributed across all ten plates (shown here in black). Also, the positions D7 and D8 
were reserved for siRNA smartpools against ECT2 and RacGAP1 respectively in all 
ten plates. During the dilution of the master siRNA plate and the subsequent aliquoting 
process, the liquid handling robot deposited siRNA smartpools in all the wells except 
for the first two columns, which were left blank. At the time of transfection, siRNA 
duplxes against Plk1 (well A2, in orange), ECT2 (wells D1 and E2, in purple), 
RacGAP1 (wells D2 and E1, in blue) and non-targeting control siRNAs (either RISC 
free or SiGENOME control siRNAs, in white), were added manually. 
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Figure 12 Primary siRNA screen results  
(A) HeLa Kyoto cells were seeded onto 96 well plates pre-spotted with the siRNA 
duplexes (37.5 nM) and transfection reagent. Cells were grown for 52 h and then 
analyzed by fluorescence microscopy. Quantification of the percentage of 
multinucleate cells or cells with abnormal nuclei (n > 300 cells. Data points represent 
the median value from three independent experiments). For a detailed list of genes 
targeted and phenotypic penetrance, please refer to the appendix. (B) Representative 
images from the screen shows mononucleate control cells, ECT2-depleted positive 
control cells as well as cells treated with siRNAs against ARL5A and MFAP1.  
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Figure 13 Depletion of ARL5A leads to multinucleation and cells connected by 
tubulin bridges  
(A) HeLa Kyoto cells transfected with indicated siRNA duplexes (37.5 nM) were 
analyzed 52 h post transfection. Immunofluorescence images. Scale bar = 10 µm. (B) 
Cells treated as above were stained for a midbody marker MKLP1, tubulin and DAPI to 
assess midbody stability. (C) HeLa Kyoto cells treated with indicated siRNAs were 
grown for 52 h and processed for qRT-PCR analysis. Quantification of the mRNA 
levels as assessed using ARL5A specific primers. ARL5A siRNAs1 and 2 but not 3-6 
show cytokinesis defect 
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Figure 14 ARL5A siRNAs1 and 2 also deplete CEP55.  
(A) Sequence alignment of the recognition sequence of ARL5A siRNA1 with CEP55 
reveals strong similarity between the two raising the possibility of an off-target effect. 
(B) HeLa Kyoto cells transfected with indicated siRNA duplexes (37.5 nM) were grown 
for 48 h and then processed for qRT-PCR analysis. CEP55 mRNA levels were 
quantified using CEP55 specific primers. (B) Cells were treated with the indicated 
siRNAs and after 48 h, were treated with 50 nM of nocodazole overnight to 
synchronize them in mitosis. Whole cell extracts of mitotic cells so isolated were 
analyzed by immunoblotting using the indicated antibodies. 
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Figure 15 Depletion of MFAP1 results in abnormal nuclear morphology in 
interphase cells  
(A) HeLa Kyoto cells transfected with indicated siRNA duplexes (37.5 nM) were 
analyzed 72 h post transfection. Immunofluorescence image of mono-nucleate control 
cells and MFAP1 depleted cells. Scale bar = 10 µm. (B) Quantification of the 
percentage of nuclear abnormalities of cells treated as above (n > 200 cells, bars 
represent mean ± SD of 3 independent experiments). (C) Whole cell extracts of cells 
treated as in (A) were analyzed by immunoblotting using the indicated antibodies 72 h 
post transfection of the indicated siRNAs.  
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Figure 16 A genetic complementation system for MFAP1   
(A) A clonal cell line stably expressing a siRNA resistant transgenic copy of MFAP1 
was generated by introducing silent mutations within the MFAP1 siRNA 3 recognition 
sequence of MFAP1 cDNA. After transient transfection into HeLa Kyoto cells, a clonal 
cell line was generated through selection with puromycin (0.4 µg/mL). 
Immunofluorescence image of the above mentioned cell line fixed and stained for GFP 
to reveal percentage of cells expressing transgene (n> 200 cells, scale bar = 10 µm). 
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(B) The clonal cell lines expressing either the tagged MFAP1 transgene or the tag 
alone were transfected with indicated siRNA duplexes (37.5 nM) for 48 h after which 
they were treated with 50 nM of nocodazole overnight to synchronize them in mitosis. 
Whole cell extracts of mitotic cells so isolated were analyzed by immunoblotting using 
the antibodies against MFAP1 and β-tubulin as a loading control (middle panel). 
Endogenous MFAP1 and transgenic AcGFP-FLAG tagged MFAP1 are indicated by 
open and filled arrowheads respectively. (C) Quantification of the percentage of 
nuclear abnormalities in the clonal cell lines treated with the indicated siRNAs cells (n > 
200 cells, N=3 independent experiments). 
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Chapter 4. Results 2- Elucidating the mitotic 
consequences of MFAP1 loss 
4.1 Depletion of MFAP1 causes a spindle assembly checkpoint 
dependent mitotic arrest 
The striking interphase nuclear morphology defect observed upon depletion of 
MFAP1 indicates that errors during mitotic chromosome segregation could be the 
underlying cause. To test this hypothesis, we decided to investigate the timing and 
the dynamics of mitosis in cells lacking MFAP1. We recorded HeLa Kyoto cells that 
were transfected with either individual siRNAs targeting MFAP1 or control siRNA 
duplexes using bright-field time-lapse microscopy. Cells that were treated with 
control siRNA entered mitosis and exited successfully with an average duration of 
45 min (Figure 17B). Cells transfected with siRNA against MFAP1 on the other 
hand spent over 12.5 h on average in mitosis. Accompanying the long mitotic arrest, 
most cells depleted of MFAP1 either underwent cell death during mitosis or an 
abnormal mitotic exit characterized by a failure to separate daughter cells (Figure 
17B). The latter is likely the result of mitotic slippage (Brito and Rieder, 2006). 
These results demonstrate that MFAP1 is required for the timely execution of 
mitosis and that loss of the protein causes cells to arrest in mitosis for long periods 
of time. The corollary of these observations is that the interphase defect observed 
in MFAP1-depleted cells in our screen, could be the consequence of mitotic defects. 
Progression through mitosis and mitotic exit requires the proteolytic destruction of 
cyclin B that is initiated by the E3 ubiquitin ligase APC/C (Golan et al., 2002, 
Kramer et al., 2000, Pines, 2011) (Also See section 1.1.4.2). APC/C activity is 
controlled by the spindle assembly checkpoint (SAC), that inhibits the complex’s 
activity in response to chromosomes that have to establish bipolar attachment to 
the mitotic spindle (Musacchio and Salmon, 2007). Defects in several processes 
and pathways during mitosis, e.g. spindle formation, kinetochore function and sister 
chromatid cohesion, can trigger a SAC response and arrest cells in mitosis. The 
mitotic arrest in MFAP1-depleted cells could be caused by compromised APC/C 
activity and maybe due to the engagement of the SAC. To test this hypothesis, we 
depleted MFAP1 in combination with a key component of the SAC, Mad2. 
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Depletion of Mad2 alone reduced the average duration of mitosis from 45 min in 
control cells to less than 20 min (Figure 17C). Importantly, co-depletion of MFAP1 
and Mad2 reduced the average duration in mitosis from 12.5 h to less than 20 min 
(Figure 17A and Figure 17C). This demonstrates that the mitotic arrest in cells 
lacking MFAP1 is dependent on the SAC. Furthermore, this observation suggests 
that the underlying aberration in cells lacking MFAP1 is a potent trigger for the 
engagement of the SAC.  
4.2 Loss of MFAP1 abrogates chromosome alignment at the 
metaphase plate. 
Given the SAC-dependent mitotic arrest observed upon depletion of MFAP1 
(Figure 17), we tested the ability of MFAP1-depleted cells to align their 
chromosomes at the metaphase plate. While a failure to align chromosomes at the 
metaphase plate could arise because of a number of reasons, it can often act as a 
potent inducer of an SAC response. We transfected HeLa Kyoto cells with either 
control or MFAP1 siRNA and tested their ability to form a metaphase plate using 
immunofluorescence microscopy (Figure 18). Control cells were distributed at 
prometaphase, metaphase and anaphase, as judged by staining for DNA, Aurora-B 
kinase and the kinetochore/centromere marker CREST (Figure 18). Strikingly, 
MFAP1 siRNA treated cells were trapped in prometaphase and never managed to 
progress through to metaphase or anaphase (Figure 18). We could reliably 
distinguish between prometaphase and anaphase stages based on the localization 
pattern of Aurora B that shifts from the centromeres in prometaphase to the 
midzone in anaphase (Gruneberg et al., 2004).  
Prior to fixation, a subset of cells were also treated with the proteasome inhibitor 
MG132, which traps cells at metaphase due the inability to degrade mitotic APC/C 
substrates such as cyclin B and securin (Pines, 2011). MG132 addition to control 
cells caused an accumulation of metaphase cells with aligned chromosomes 
(Figure 18). However, no such enrichment was evident in MFAP1 siRNA-treated 
cells, in which chromosome remained scattered throughout the mitotic cell (Figure 
18). These results suggest that cells lacking MFAP1 were unable to align their 
chromosomes at the metaphase plate, even when provided with ample time by 
blocking mitotic progression using MG132. We speculate that this could be the 
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reason for triggering the spindle assembly checkpoint culminating a prominent 
mitotic arrest. 
 
4.3 Depletion of MFAP1 causes precocious loss of sister 
chromatid cohesion  
 
The inability of MFAP1 depleted cells to align their chromosomes at the metaphase 
plate suggested to us that either the mitotic spindle was malformed or that integrity 
of the chromosomal or kinetochore architecture was affected. Sister chromatid 
cohesion is essential for chromosome bi-orientation and alignment at the 
metaphase plate (Nasmyth and Haering, 2009, Peters and Nishiyama, 2012). To 
scrutinize the state of sister chromatid cohesion, we decided to perform metaphase 
chromosome spreads in control siRNA and MFAP1 siRNA-transfected cells (Figure 
19). HeLa Kyoto cells were grown for 52 h after siRNA transfection and treated with 
330 nM of nocodazole for 4 h prior to processing for chromosome spreads. An 
siRNA targeting Sgol1, a protein known to protect centromeric sister chromatid 
cohesion in mitotic cells (Salic et al., 2004, McGuinness et al., 2005, Goulding and 
Earnshaw, 2005, Wang and Dai, 2005, Watanabe and Kitajima, 2005, Tang et al., 
2006) was used as a positive control for loss of sister chromatid cohesion (Figure 
19). The vast majority of cells that were transfected with control siRNAs displayed 
the characteristic X-shaped chromosome structure, in which the sister chromatids 
remain physically connected at the centromeres (Figure 19). In contrast, depletion 
of Sgol1 potently abrogated sister chromatid cohesion (Figure 19). Interestingly, 
depletion of MFAP1 using four different siRNA duplexes led to severe defects in 
sister chromatid cohesion (Figure 19). More than half of spreads originating from 
cells transfected with MFAP1 siRNA duplexes 1 and 3 showed individualized sister 
chromatids that have lost the characteristic chromosomal X-shape (Figure 19).  
The fact that 4 independent siRNA duplexes resulted in a cohesion phenotype and 
the correlation between depletion efficiency and phenotypic penetrance (Figure 15) 
suggests that MFAP1 is required for sister chromatid cohesion. Our data 
furthermore indicates that the loss of sister chromatid cohesion could be the 
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underlying cause for the mitotic arrest and chromosome alignment phenotype of 
MFAP1-depleted cells. 
4.4 FISH in mitotic cells confirms loss of sister chromatid 
cohesion following depletion of MFAP1  
In order to complement the chromosome spread assays, we decided to test the 
status of sister chromatid cohesion by performing fluorescent in situ hybridization 
(FISH) in intact fixed mitotic cells. HeLa Kyoto cells were treated with negative 
control siRNA or siRNAs targeting MFAP1, Sgol1 and also Sororin, a gene required 
for sister chromatid cohesion maintenance in mammalian cells (Rankin et al., 2005, 
Schmitz et al., 2007, Nishiyama et al., 2010). FISH probes recognizing the 
centromeres of chromosome 6 and 8 were used for assessing the status of 
cohesion. Since HeLa Kyoto cells are trisomic for chromosome 6 and 8, control 
siRNA treated cells displayed 3 pairs of dots for each of the 2 probes used.  In 
more than 84% of control cells, paired sister chromatid signals were never more 
than 2 µm apart even at metaphase, the stage where they were likely to be farthest 
apart due to the tension exerted by the mitotic spindle (Figure 20A). FISH analysis 
of cells transfected with Sororin and Sgol1 siRNA duplexes revealed that most 
sister centromeres were separated by more than 2 µm (Figure 20), indicative of a 
loss of sister chromatid cohesion. Similarly, depletion of MFAP1 also led to a 
majority of cells to displaying sister centromeres separated by more than 2 µm 
(Figure 20). These results confirm our observations made by chromosome 
spreading analysis (Figure 19) and suggest the loss of MFAP1 disrupts cohesion 
between sister chromatids also in intact mitotic cells. 
4.5 An siRNA resistant MFAP1 transgene can rescue loss of 
sister chromatid cohesion caused by loss of endogenous 
MFAP1 
As shown in Figure 16, we developed a genetic complementation system for 
MFAP1, wherein we could demonstrate that a cell line stably expressing a siRNA-
resistant transgene of MFAP1 could rescue the abnormal nuclear morphology in 
interphase cells lacking endogenous MFAP1. Having identified a severe loss of 
sister chromatid cohesion in cells lacking MFAP1, we tested the ability of the 
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siRNA-resistant transgene to suppress this phenotype. Expression of siRNA-
resistant AcFL-MFAP1-r but not the AcFL tag alone reduced substantially but not 
completely restored sister chromatid cohesion in cells transfected with siRNA 
targeting endogenous MFAP1 (Figure 21). Together with our finding that 4 
independent siRNA duplexes targeting MFAP1 disrupt cohesion (Figure 19), this 
result strongly suggests that the loss of sister chromatid cohesion is caused by 
depletion of MFAP1 and not by an off-target effect. The failure of the transgene to 
completely restore the state of sister chromatid cohesion (Figure 21) could be due 
to the AcFL tag interfering with protein functionality. 
 
4.6 Conclusions: Results 2- Elucidating the mitotic effect of 
MFAP1 depletion 
Based on the experiments discussed above, we have established that the loss of 
MFAP1 in HeLa Kyoto cells can cause a spindle assembly checkpoint-dependent 
mitotic arrest that eventually leads to cell death or to cells exiting mitosis in an 
abnormal manner. The abnormal mitotic exit could explain the irregular interphase 
nuclear morphology observed in these cells. We have further deciphered that the 
prolonged mitotic arrest is accompanied by the inability of MFAP1 depleted cells to 
form a metaphase plate. Our chromosome spreads and FISH analysis suggest that 
a precocious loss of sister chromatid cohesion is likely to be responsible for this 
phenomenon. Through our experiments, we have uncovered a novel regulator of 
sister chromatid cohesion in mammalian cells. Further work described in the 
subsequent sections led us to an in-depth investigation and analysis of the 
molecular mechanism underlying this novel finding. 
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Figure 17 Depletion of MFAP1 leads to SAC-mediated mitotic arrest  
(A) HeLa Kyoto cells treated with the indicated combination of siRNAs for 24 h were 
subjected to low-resolution time-lapse microscopy (time in min). The images so 
acquired were analysed using the mitotic duration plugin in ImageJ. (B) Cells were 
scored for duration between mitotic cell rounding and anaphase onset (middle panel). 
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The x-axis of the graph represents time (h) after siRNA transfection. In the graph, the 
cells are arranged according to their time of mitotic entry. Each bar in the graph 
represents one cell and the length of the bar denotes the duration that each cell 
spends in mitosis. Green bars = successful division, black bars = unsuccessful and 
abnormal mitotic exit) and red bars = cell death. (n=50 cells, N=1) (C) Cells that were 
treated with a combination of siRNAs against MFAP1, Mad2 and control were recorded 
over time and analysed with the mitotic duration plugin as above. Each dot represents 
mitotic duration in one cell (Lower panel, n=50 cells, N=1. Bars represents mean ± SD). 
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Figure 18 MFAP1 depletion prevents chromosome alignment at the metaphase 
plate  
(A) In order to test the ability of siRNA treated cells to form a metaphase plate, HeLa 
Kyoto cells transfected with indicated siRNAs were grown for 48 h following which they 
were treated with either DMSO or MG132 (10 µM) for 3 h, fixed and stained for Aurora 
B kinase, CREST and DAPI. Immunofluorescence images of cells treated with control 
or MFAP1 siRNA with or without MG132 treatment are shown. Scale bar = 10 µm. (B) 
Samples treated as above were scored for proportion of cells in different mitotic phases 
as indicated (lower panel, n> 50 cells, N=1) 
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Figure 19 Precocious loss of sister chromatid cohesion is evident upon loss of 
MFAP1  
(A) Hela Kyoto cells transfected with the indicated siRNAs were grown for 52 h and 
then treated with nocodazole (330nM) for 4 h prior to processing them for chromosome 
spreads. Images of DAPI stained chromosome spreads from cells treated with the 
indicated siRNAs are shown. Scale bar = 10 µm. (B) Samples treated as above were 
scored for the proportion of cells in different states of sister chromatid cohesion. Sgol1 
was a positive control for loss of sister chromatid cohesion while ECT2 was a control 
for transfection efficiency (n> 100 cells, N=1) 
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Figure 20 Mitotic FISH confirms the loss of sister chromatid cohesion in MFAP1 
depleted cells  
(A) HeLa Kyoto cells were transfected with the Control and MFAP1 siRNA3 (37.5 nM) 
for 48 hrs and with Sgol1 and Sororin (37.5 nM) for 24 hrs following which they were 
fixed and processed for fluorescence in situ hybridization (FISH). Centromeric probes 
against chromosomes 6 and 8 and DAPI as a counterstain for the DNA were used. 
Images of cells treated as above were acquired. Scale bar = 10µm. (B) Images so 
acquired were scored for proportion of cells in different states of sister chromatid 
cohesion using the number of paired FISH signals as proxies. More than 84% of 
control cells exhibited a distance no more than 2 µm between paired FISH signals even 
in metaphase, where they are likely to be farthest apart. Cells wherein the distance 
between FISH signals was longer than 2 µm were considered to have split sisters. This 
criteria was applied to cells treated with the indicated siRNA duplexes and the 
proportion of split sisters in each treatment condition was plotted as shown (n> 30 cells, 
N=1). 
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Figure 21 An siRNA-resistant transgene of MFAP1 suppresses the loss of sister 
chromatid cohesion in cells lacking endogenous MFAP1  
(A) Stable cell lines expressing either an AcGFP-FLAG (AcFL) tagged siRNA resistant 
MFAP1 (AcFL-MFAP1-r) or the AcFL tag alone were transfected with the indicated 
siRNAs at a final concentration of 37.5 nM. Following transfection, they were grown for 
52 h and then treated with nocodazole (330nM) for 4 h and then processed for 
chromosome spreads. Images of DAPI-stained chromosome spreads from cells treated 
with the indicated siRNAs (upper panel, scale bar = 10 µm). (B) Samples treated as 
above were scored for the state of sister chromatid cohesion. (n> 100 cells, Bars 
represent mean from 3 independent experiments). 
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Chapter 5. Results 3- Subset of genes regulating pre-
mRNA processing also regulate sister chromatid 
cohesion 
Based on the experiments described before, we have uncovered a novel role for 
MFAP1 in regulating sister chromatid cohesion in human cells. MFAP1 is known to 
be a key part of the tri-snRNP complex that is required for the formation of the 
spliceosomal B complex (Jurica and Moore, 2003, Zhou et al., 2002) and was also 
shown to regulate pre-mRNA splicing and G2-M transition in drosophila cells 
(Andersen and Tapon, 2008). Interestingly, a large number of splicing components 
have been identified in the Mitocheck genome-wide analysis of cell division as 
genes, which cause mitotic abnormalities, in particular a mitotic arrest, when 
depleted (Neumann et al., 2010). This has led to speculations as to the underlying 
molecular defect and function of splicing components during cell division (Hofmann 
et al., 2010). Our finding that depletion of MFAP1 disrupts sister chromatid 
cohesion raised the possibility that additional spliceosome-associated factors 
control mitosis through sister chromatid cohesion. This could provide an 
explanation for their prevalence as hits in mitotic screens. Based on these 
considerations, we decided to test whether spliceosome components other than 
MFAP1 are required for cohesion by expanding our analysis to a bigger set of 
splicing factors. The components of the spliceosome have been uncovered by 
using mass spectrometry techniques (Zhou et al., 2002). After comparing the list of 
splicing factors identified by mass spectrometry with the data from the Mitocheck 
screen, we compiled a list of 33 splicing factors of interest (Neumann et al., 2010, 
Hofmann et al., 2010). Initial characterization of these genes and detailed 
characterization of a subset of these genes will be described in the following 
sections. 
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5.1 Chromosome spread screen identifies a further group of 
splicing factors that regulate sister chromatid cohesion in 
human cells 
Based on the list of 33 splicing factors that we generated, we used siGENOME 
smartpool siRNAs to deplete the corresponding proteins and investigated the state 
of sister chromatid cohesion by chromosome spread analysis (Figure 22). Known 
regulators of sister chromatid cohesion such as Sgol1 (Kitajima et al., 2004, Salic 
et al., 2004, Goulding and Earnshaw, 2005, McGuinness et al., 2005, Watanabe 
and Kitajima, 2005) and the core cohesion subunit Scc1 (Sonoda et al., 2001, 
Uhlmann et al., 1999, Gruber et al., 2003, Adachi et al., 2008, Nasmyth and 
Haering, 2009, Peters and Nishiyama, 2012) were used as positive controls for the 
assay. Strikingly, depletion of all but 3 of the 33 spliceosome-associated proteins 
led to significant loss of sister chromatid cohesion (Figure 22 and Figure 23).  Our 
results using siRNA smartpools suggest a widespread requirement of splicing 
factors in sister chromatid cohesion. The phenotypic penetrance of many gene 
depletions was comparable to the loss of a core cohesin subunit, such as Scc1 
(Figure 22). This further emphasizes the importance of investigating the role of 
these genes and splicing in general in sister chromatid. Additionally we observed 
that the splicing factors whose depletion affected sister chromatid cohesion were 
not restricted to a particular sub-complex of the spliceosome and were not involved 
in a specific step of spliceosome assembly. Instead, they were distributed 
throughout the spliceosome assembly process and were each part of multiple 
snRNP complex. This suggests the requirement of not only a specific complex but 
generally of pre-mRNA splicing in sister chromatid cohesion (Figure 24). 
 
5.2 Deconvolution analysis supports the role of a number of 
splicing factors in sister chromatid cohesion 
The chromosome spread screen of spliceosome components as described above 
revealed that the majority of the splicing factors that we selected and tested, 
disrupted the connection between sister chromatids. Next, we decided to use 
deconvolution analysis to evaluate whether the observed phenotypes were likely 
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caused by depletion of the intended target than an off-target effect. In that direction, 
we first classified the genes that we identified based on the particular step of the 
pre-mRNA splicing that they were thought to be a part of (Figure 24). Based on the 
distribution and the relative phenotypic penetrance of the hits, we selected the top 
2 hits from each spliceosome sub complex (shown in Figure 24) for further analysis. 
Using the individual siRNA duplexes that make up the smartpool mixture for the 10 
genes selected as per the criteria set above, we performed chromosome spread 
analyses. We observed that for 9 out of the 10 genes tested two or more out of the 
4 siRNA duplexes caused defects in sister chromatid cohesion (Figure 25). This 
suggests a causal relationship between the observed chromosomal phenotype and 
the loss of the intended target. Subsequently, we selected NHP2L1, SART1 and 
CDC5L to be further analysed using assays similar to MFAP1 as they represented 
the top 3 hits in terms of phenotypic penetrance. NHP2L1 (non histone 
chromosome protein 2-like1) and SART1 (Squamous cell carcinoma Antigen 
Recognized by T cells 1) are known, along with MFAP1, to be part of the U4/U6, 
U5 tri-snRNP complex of the spliceosome (Jurica and Moore, 2003, Will and 
Luhrmann, 2011). CDC5L is a component of the nineteen containing complex 
which is crucial for the conversion of the active spliceosome from the B* complex to 
the C complex (Ajuh et al., 2000, Ajuh et al., 2001, Grote et al., 2010). 
 
5.3 Depletion of NHP2L1 & SART1 causes a SAC-dependent 
mitotic arrest 
In addition to the chromosome spread experiments, we performed time-lapse 
microscopy to test the effect of depletion of SART1 and NHP2L1 on mitotic 
progression and duration in these cells. Cells were transfected with siRNAs 
targeting SART1 or NHP2L1. In addition, the essential SAC component Mad2 was 
co-depleted with SART1 or NHP2L1. While control siRNA treated cells spent on 
average about 45 mins between cell rounding and anaphase onset, cells treated 
with Mad2 siRNA alone required less than 25 mins for progression through mitosis 
(Figure 26). Cells transfected with SART1 or NHP2L1 siRNAs alone spent more 
than 7.5 hr and 18 hr in mitosis, respectively, and often underwent mitotic cell 
death or an abnormal division (Figure 26 and data not shown). Co-depletion of 
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Mad2 along with either SART1 or NHP2L1 reduced the average duration of mitosis 
to less than 25 minutes. Consistent with a role for SART1 and NHP2L1 in sister 
chromatid cohesion, these result show that depletion of the two proteins causes a 
SAC-dependent arrest in mitosis. 
 
5.4 A genetic complementation system for NHP2L1 and SART1 
In addition to performing deconvolution experiments to test for off target effects 
(Figure 25), we decided to develop a genetic complementation system for NHP2L1 
and SART1 similar to the one that we developed for MFAP1 (Figure 16). To this 
end, generated stable clonal cell lines expressing AcFL-tagged siRNA-resistant 
transgenes of NHP2L1 or SART1. Following depletion of the endogenous 
counterparts, the ability of these siRNA-resistant transgenes to restore sister 
chromatid cohesion was tested by chromosome spread analysis (Figure 27). While 
depletion of SART1 and NHP2L1 caused the splitting of sister chromatids only in 
cells expressing the tag AcFL but not in cells expressing RNAi-resistant transgenes 
(Figure 27). The SART1 and NHP2L1 transgenes potently restored sister 
chromatid cohesion to a normal status in cells lacking the endogenous proteins. 
This experiment eliminates off-target concerns and firmly establishes that SART1 
and NHP2L1 are required for sister chromatid cohesion. 
 
5.5 The splicing factors MFAP1, SART1 and NHP2L1 are 
required for sister chromatid cohesion in HCT116 cells 
Before embarking on deciphering the molecular mechanism for the unusual 
observation that loss of splicing factors affects sister chromatid cohesion, we tested 
whether this phenomenon was restricted to chromosomally unstable and aneuploid 
HeLa Kyoto cells. To do this, we performed a chromosome spread analysis 
following depletion of splicing factors in HCT116 cells, a diploid human colon 
cancinoma cell line (Figure 28). Transfection of siRNA duplexes targeting NHP2L1, 
MFAP1 and SART1 caused a strong increase in the fraction of cells with split sister 
chromatids in HCT116 cells (Figure 28).  The phenotypic penetrance that we 
observed for depletion of the same gene in HCT116 cells was lower than in HeLa 
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Kyoto cells (Figure 25). Although the reason for this difference is currently unclear, 
transfection efficiency, protein endurance or differential protein requirements in 
different cell types are likely candidate causes. Nevertheless, the occurrence of 
approximately 40 to 60% of HCT116 cells with split sister chromatids upon 
depletion of splicing factors compared to the control cells suggests that the 
requirement of splicing components for sister chromatid cohesion is not restricted 
to aneuploid HeLa Kyoto cells but also found in diploid cells. 
 
5.6 Conclusions: A subset of genes regulating pre-mRNA 
splicing is required for sister chromatid cohesion 
Based on the experiments that I have described in this section, we have concluded 
that the depletion of not just MFAP1 but a whole subset of splicing factors leads to 
a loss of sister chromatid cohesion. Transgenic rescue experiments revealed that 
the defects in cohesion are not the result of siRNA off-target effects. The effect of 
pre-mRNA splicing genes on sister chromatid cohesion is not a HeLa Kyoto cell 
specific phenomenon but also observed in HCT116 cells. Furthermore, the splicing 
genes that we show to mediate cohesion are not restricted to any particular step in 
the spliceosome assembly process but are distributed throughout the assembly 
pathway. This raises the possibility that pre-mRNA splicing in general is directly or 
indirectly required for sister chromatid cohesion. It also argues against a specific 
second function of a particular spliceosome complex in sister chromatid cohesion. 
Further work in the upcoming sections will lead to a better understanding of the 
molecular basis behind these observations.  
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Figure 22 Chromosome spread analysis identifies a role for mediators of pre-
mRNA splicing in sister chromatid cohesion  
HeLa Kyoto cells transfected with the indicated siRNA smartpools were grown for 52 h 
and then treated with nocodazole (330nM) for 4 h and processed for chromosome 
spread analysis. Samples were scored for proportion of cells in different states of sister 
chromatid cohesion. Sgol1 and Scc1 were positive controls for loss of sister chromatid 
cohesion (n> 100 cells for each condition). 
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Figure 23 Representative images from the chromosome spread analysis of pre-
mRNA splicing genes required for sister chromatid cohesion 
HeLa Kyoto cells transfected with the indicated siRNAs were grown for 52 h and then 
treated with nocodazole (330nM) for 4 h following which they were processed for 
chromosome spreads and stained for DAPI. Samples treated as above were scored for 
proportion of cells with split sister chromatids Scc1 was a positive control for loss of 
sister chromatid cohesion. Representative images from chromosome spread screen 
with the positive and negative controls along with a few of the hits from the screen are 
displayed (scale bar = 10 µm, n> 100 cells) 
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Figure 24 Schematic representation of spliceosome assembly and splicing 
reaction pathway highlighting spliceosome components that were identified to 
regulate sister chromatid cohesion  
The genes that were identified to regulate sister chromatid cohesion in HeLa Kyoto 
cells are arranged in a colour-coded manner according to the specific part of the 
spliceosome assembly step that they have been implicated in (Zhou et al., 2002, Jurica 
and Moore, 2003, Will and Luhrmann, 2011).  
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Figure 25 Deconvolution chromosome spreads of splicing factors confirm loss 
of sister chromatid cohesion upon their depletion 
The top 10 hits from the primary chromosome spread analysis that was done using the 
siRNA smartpools were selected and were subjected to chromosome spread analysis 
with the individual siRNAs that constitute the smartpool. HeLa Kyoto cells transfected 
with the indicated siRNA smartpools were grown for 52 h and then treated with 
nocodazole (330nM) for 4 h and processed for chromosome spread analysis. Samples 
were scored for proportion of cells in different states of sister chromatid cohesion. 
SGOL1 was a positive controls for loss of sister chromatid cohesion (n> 100 cells for 
each condition) 
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Figure 26 Depletion of SART1 and NHP2L1 results in an SAC-dependent mitotic 
arrest  
HeLa Kyoto cells transfected with the indicated siRNA combinations were recorded 
using time-lapse microscopy. Mitotic duration, the time from mitotic cell rounding to 
anaphase onset, was determined from 24 hr post transfection. Each dot represents 
mitotic duration of a single cell (bars represents mean± SD) 
 
Chapter 5. Results 
 
 134 
 
Figure 27 siRNA resistant SART1 and NHP2L1 transgenes can rescue the loss of 
sister chromatid cohesion caused by depletion of the endegenous counterparts 
(A) Stable cell lines expressing AcFL and AcFL-tagged siRNA resistant transgene 
encoding SART1 (upper panel) or (B) NHP2L1 (lower panel) were transfected with the 
indicated siRNAs (37.5 nM). After 52 hrs, the cells were treated with nocodazole 
(330nM) for 4 h followed by processing for chromosome spread analysis. Images of 
DAPI-stained chromosome spreads from cells treated with the indicated siRNAs (left 
panels, scale bar = 10 µm). Samples treated as above were scored for the proportion 
of cells with the indicated status of sister chromatid cohesion. (n> 100 cells, bars 
represent mean from 3 independent experiments).  
Chapter 5. Results 
 
 135 
 
 
Figure 28 Depletion of splicing factors causes sister chromatid cohesion defects 
in HCT116 cells 
HCT116 cells were transfected with the indicated siRNAs for either 24 h (Sororin and 
NHP2L1 siRNAs) or for 52 h (Control, MFAP1 and SART1 siRNAs) and then treated 
with nocodazole (330nM) for 4 h before processing for chromosome spread analysis. 
Spreads were scored for proportion of cells with indicated status of sister chromatid 
cohesion. Representative images are shown (scale bar = 10 µm, n> 100 cells, N=1). 
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Chapter 6. Results 4- Characterization of cohesin 
and sister chromatid cohesion properties upon loss 
of splicing factors 
In the previous sections, I have described experiments that we performed in order 
to understand the basis behind the observation of irregular interphase nuclear 
morphology upon depletion of the splicing factor MFAP1 in HeLa Kyoto cells. We 
have found that the depletion of MFAP1 and a number of additional splicing factors 
leads to a premature loss of sister chromatid cohesion as revealed by chromosome 
spreads and mitotic FISH experiments. Further experiments were necessary to 
understand the effects of splicing factor depletion on the establishment and 
maintenance of sister chromatid cohesion and on the properties and dynamics of 
cohesin, the complex responsible for holding sister chromatids together. These 
experiments were designed to investigate the mechanistic basis for the 
requirements of splicing factors for sister chromatid cohesion. Pre-mRNA splicing 
components could influence sister chromatid cohesion through different 
mechanisms in a direct or indirect manner (Figure 29). First, disruption of co-
transcriptional splicing could lead to faulty and stalled transcription bubbles leading 
to the formation of extensive RNA-DNA hybrids also known as R-loops (Helmrich et 
al., 2011, Skourti-Stathaki et al., 2011, Wahba et al., 2011). These R-loops might 
act as a physical hindrance for the establishment or maintenance of sister 
chromatid cohesion. A second possibility is that splicing components and 
complexes might have a splicing independent function in directly promoting the 
establishment or maintenance of sister chromatid cohesion. A third possibility is 
that splicing factors might indirectly influence sister chromatid cohesion by 
mediating the pre-mRNA processing one of multiple essential and rate-limiting 
cohesin subunits, thereby influencing cohesion indirectly. We sought to perform a 
series of experiments to test each of these possibilities. 
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6.1 Depletion of splicing factors results in loss of sister 
chromatid cohesion in interphase 
In previous chromosome spread and FISH experiments, we established that cells 
depleted of splicing factors suffered from defective sister chromatid cohesion 
during mitosis. Sister chromatid cohesion is established during DNA replication in 
interphase (Uhlmann and Nasmyth, 1998). Thus, our mitotic experiments did not 
address whether cohesion was lost only as cells entered mitosis or whether sister 
chromatid cohesion was never established properly during S phase. Distinguishing 
between these possibilities could help us to narrow down possible mechanisms by 
which splicing proteins influence cohesion. This is possible because different sets 
of proteins and pathways control cohesion establishment, its maintenance through 
interphase and its ordered dissolution in mitosis. For instance, in vertebrate cells, 
Sororin is required for maintenance of sister chromatid cohesion after cohesion 
establishment but not earlier or during mitosis (Rankin et al., 2005, Nishiyama et al., 
2010, Schmitz et al., 2007). Similarly, Sgol1 is required for protecting centromeric 
cohesion during early mitosis but does not seem to be crucial earlier (Nasmyth and 
Haering, 2009, Peters and Nishiyama, 2012). In order to scrutinize sister chromatid 
cohesion during interphase, we performed a FISH experiment in interphase cells 
using a probe that is specific for the tff1 locus on chromosome 21, a trisomic 
chromosome in HeLa Kyoto cells. This probe has been successfully used to 
investigate the state of interphase cohesion in human cells (Schmitz et al., 2007). 
Cells were synchronized using a single thymidine arrest initiated either at the time 
of siRNA transfection (SGOL1, Sororin and NHP2L1 siRNA duplexes) or 24 h post 
siRNA transfection (MFAP1, SART1 and CDC5L siRNA duplexes). Subsequently, 
cells were released from thymidine for 5 h at which point they were processed for 
FISH analysis. The distance between sister chromatids was determined by 
measuring the distance between the tff1 FISH signal centroids for each of the three 
copies of chromosome 21. In control siRNA treated cells, the sister chromatid FISH 
signals were very close to each other and the average distance between the FISH 
signal centroids was 0.49 µm, in line with published observations (Nishiyama et al., 
2010, Schmitz et al., 2007) (Figure 30). Depletion of SGOL1 did not affect the 
average distance between FISH signals in interphase. This is consistent with its 
mitosis-specific role in protecting centromeric sister chromatid cohesion during 
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prophase and prometaphase (Kitajima et al., 2004, Goulding and Earnshaw, 2005, 
McGuinness et al., 2005, Watanabe and Kitajima, 2005). Depletion of the cohesin 
stability factor Sororin on the other hand increased the distance between the dots 
to 0.85 µm (Figure 30). Importantly, depletion of all the splicing factors tested, 
namely NHP2L1, SART1 and MFAP1 resulted in a similar and significant increase 
in the distance between the sister chromatid signals in interphase cells (Figure 30). 
These results suggest that the role of splicing factors in controlling cohesion is not 
restricted to mitotic cells. It indicates that loss of splicing proteins abrogates sister 
chromatid cohesion already in interphase cells soon after DNA replication. The 
corollary of this interpretation is that the role of splicing factors in cohesion is 
unlikely to be mediated or connected to the Sgol1/PP2A pathway that protects 
cohesion at centromeres specifically in mitosis. The interphase FISH experiments 
rather point towards an important function of splicing components during the 
establishment or maintenance phase of sister chromatid cohesion. 
6.2 Cohesin loading onto chromatin is unaffected by depletion 
of splicing factors 
Cohesin loading in late telophase and early G1 phase represents the first essential 
step in the cohesin cycle (See section 1.2.4). Given that the onset of the sister 
chromatid cohesion loss phenotype in cells depleted of splicing factors is in 
interphase, we investigated the loading of cohesion onto chromatin in interphase. 
To do this, we used a cytological assay to quantify the amount of extraction-
resistant nuclear cohesin as a proxy for the amount of cohesin associated with 
chromatin. This assay was successfully used to demonstrate the function of the 
cohesin loading complex SCC2/SCC4 (Watrin et al., 2006). The extraction step 
prior to fixation is essential to remove the soluble fraction of cohesin. To track the 
properties of cohesin we used immunofluorescence staining of the kleisin subunit 
Scc1. To control for subtle variations in immunofluorescence staining across 
different slides or within a single slide, differentially marked control and depleted 
cells were co-seeded on the same coverslip and assayed side-by-side. In short, 
HeLa Kyoto cells were transfected with siRNAs for either 18 h (Sororin and 
NHP2L1) or for 42 h (control, Scc4, MFAP1 and SART1). Cells were subsequently 
trypsinized, mixed with a HeLa Kyoto cells stably expressing H2B-mCherry in a 1:1 
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ratio and reseeded onto poly-L lysine coated coverslips. The cells were allowed to 
grow for 8 h before they were subjected to detergent extraction step, fixation and 
staining for SCC1. Finally, SCC1 intensity was quantified in neighbouring depleted 
and control H2B-mCherry-positive cells. Depletion of SCC4, an essential subunit of 
the cohesin (Watrin et al., 2006), severely reduced the intensity of extraction-
resistant SCC1 in the nucleus (Figure 31) indicating that the assay can assess 
loading of cohesin complexes onto chromatin. Depletion of neither Sororin nor any 
of the splicing factors tested significantly reduced the staining intensity of SCC1. 
This result suggests that while splicing components are required for cohesion in 
interphase they are dispensable for cohesin loading onto chromatin. 
 
6.3 SMC3 acetylation, a key step denoting cohesion 
establishment is not abrogated by the depletion of splicing 
factors 
Following cohesin loading, the establishment of sister chromatid cohesion 
represents the next key event in the cohesin cycle. Thus, we decided to probe the 
role of the splicing factors in the establishment of cohesion. Cohesion 
establishment happens during DNA replication (Uhlmann and Nasmyth, 1998). One 
of the key steps signifying this process is the acetylation of the SMC3 subunit of 
cohesin (Rolef Ben-Shahar et al., 2008, Zhang et al., 2008a). An antibody that 
specifically detects SMC3 acetylated at K105 and K106 (Nishiyama et al., 2010) 
was used to measure the acetylation status of SMC3. HeLa Kyoto cells transfected 
with siRNAs in duplicates plates were arrested with thymidine added either 6 h 
after siRNA transfection (NHP2L1 and Sororin siRNAs) or 24 h after transfection 
(Control, ESCO1 & ESCO2, MFAP1, SART1 and CDC5L siRNAs). Cells released 
from thymidine were allowed to proceed through the cell cycle for 3 h before being 
processed for immunoblotting and flow cytometry analysis (Figure 32). Co-
depletion of the two acetyl transferase paralogues ESCO1 and ESCO2 together 
that are responsible for SMC3 acetylation in humans (Zhang et al., 2008a, Hou and 
Zou, 2005) abrogated the acetylated fraction of SMC3. Depletion of the splicing 
factors revealed a minor reduction in SMC3 acetylation (Figure 32). Comparing the 
flow cytometry profiles, cells treated with siRNA duplexes targeting the splicing 
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factors show a slightly delayed progression through S phase compared to control 
or ESCO1 and ESCO2-depleted cells (Figure 32). Since SMC3 acetylation 
increases as cells progress from G1 to S phase, this delay may contribute to the 
reduction of SMC3’s modification. Co-depletion of ESCO1 and ESCO2 severely 
compromises SMC3 acetylation but has a far less penetrant effect on sister 
chromatid cohesion than depletion of the splicing factors MFAP1, NHP2L1 and 
SART1 (data not shown). This circumstantial evidence suggests that the minor 
reduction in SMC3 acetylation is not causally linked to the loss of sister chromatid 
cohesion in cells depleted of splicing proteins. 
  
6.4 Loss of splicing factors increases the turnover of cohesin 
from chromatin  
Having failed to detect a major impact of splicing factors on cohesin loading and a 
marker for the establishment of sister chromatid cohesion, we investigated whether 
the depletion of splicing factors had any effect on the stability of cohesin-chromatin 
interactions during interphase. Experiments to characterize the interaction between 
cohesin and chromatin in interphase have relied on the use of a variant of 
fluorescence recovery after photobleaching (FRAP) technique, called inverse 
FRAP or iFRAP (Gerlich et al., 2006, Schmitz et al., 2007).  iFRAP involves 
bleaching part of the GFP signal in a cell line stably expressing a cohesin subunit 
that is tagged with GFP and then monitoring the loss of GFP fluorescence in the 
unbleached area. Using this technique, it was revealed that cohesin-chromatin 
interactions are significantly stronger in G2 cells compared to G1 cells, reflecting 
the fact that cohesion establishment happens in S phase (Gerlich et al., 2006). This 
technique was also used to demonstrate the requirement of Sororin for 
maintenance of cohesion through G2 phase (Schmitz et al., 2007). For our 
experiments, a stable cell line expressing SMC1-EGFP was synchronized using 
thymidine added either at the time of siRNA transfection (Sororin siRNAs) or 24 h 
post siRNA transfection (MFAP1 and control siRNAs). Four h after release from 
thymidine, cells were treated with cycloheximide to prevent synthesis of new 
SMC1-EGFP. Following this, the cells were subjected to a photobleaching 
experiment in which SMC1-EGFP nuclear fluorescence was bleached with a laser 
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in half of the nucleus. In order to eliminate the contribution of soluble cohesin to the 
measurements, the initial photobleaching in one half of the nucleus was reiterated 
5 times within 50 sec and the first post bleach frame was acquired 2 min post 
bleaching. This allowed for equilibration of bleached soluble SMC1-EGFP across 
the nuclear volume and its efficient bleaching. The difference in fluorescence 
intensity between the unbleached and the bleached area was measured and 
expressed as a ratio of the first post-bleach frame. This ratio, also known as the 
iFRAP ratio, was plotted over time. In control cells, the iFRAP ratio dropped 
gradually and a clear difference in fluorescence intensity between the bleached and 
unbleached area was apparent even 60 min into the experiment (Figure 33). In 
cells depleted of Sororin or MFAP1, the iFRAP ratio decreased rapidly with the 
fluorescence in the bleached and unbleached area equilibrating less than 30 min 
into the experiment (Figure 33). Strikingly, the loss of Sororin, a protein that 
antagonizes the activity of cohesin release mechanism (Nishiyama et al., 2010), 
and loss of the splicing component MFAP1 had a similarly penetrant effect on 
cohesin dynamics in vivo. This suggests that cohesin complexes dissociate from 
chromatin faster in cells lacking MFAP1 than in control cells. Thus, MFAP1 and 
possibly other splicing factors may control sister chromatid cohesion by ensuring 
the stable association of cohesin with chromatin. Failure to do so may explain the 
loss of sister chromatid cohesion observed in interphase cells following depletion of 
splicing proteins. 
 
6.5 Overexpression of RNaseH1, an enzyme known to resolve 
R-loops, does not rescue the sister chromatid cohesion 
caused by depletion of splicing factors 
One possibility that could explain how the loss of splicing components could hinder 
sister chromatid cohesion is that extensive RNA-DNA hybrids (R-loops) that might 
have been generated through defective or absent splicing reactions could block 
cohesin’s ability to hold sister chromatids together. One way of testing this 
hypothesis was to use an enzyme that targets and removes R-loops by specifically 
cleaving the RNA moiety of RNA-DNA hybrids. Overexpression of RNaseH1 has 
been shown previously to resolve RNA-DNA hybrids (Skourti-Stathaki et al., 2011, 
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Cerritelli et al., 2003). Thus, we generated a stable clonal cell line expressing a 
GFP-tagged version of RNaseH1 that was targeted specifically to the nucleus. The 
transgene is expressed in 80% of the cells. We transfected control HeLa Kyoto 
cells and cells expressing RNase H1-EGFP with siRNAs targeting the splicing 
factors. Chromosome spread analysis revealed no difference in the severity of the 
sister chromatid cohesion loss in control cells as compared to cells expressing 
RNase H1 (Figure 34). These observations suggest that R-loops caused by a 
compromised splicing machinery are not responsible for the sister chromatid 
cohesion defect observed in cells lacking splicing components. A drawback of our 
experiments with RNase H1 and their interpretation is that we currently lack data 
demonstrating the efficacy of the enzyme in removing R-loops in the cell line used. 
 
6.6 Depletion of splicing factors reduces protein levels of 
Sororin but not core cohesin subunits 
The experiments described in the sections above indicated that the depletion of 
splicing factors did not affect either cohesin loading or cohesion establishment to a 
level commensurate with the cohesion loss phenotype observed. Our 
measurements of cohesin dynamics suggested that splicing components influence 
cohesin’s association with chromatin. Next, we decided to test whether inhibition of 
splicing lead to reduced levels of the mature and functional form of a cohesin 
subunits or regulators that are indispensible for cohesin function during interphase. 
We transfected HeLa Kyoto cells with siRNAs targeting the splicing factors and 
synchronized their cell cycle using a single thymidine arrest. 5 h after release from 
thymidine, cells were processed for immunoblotting (fluorescent detection) with 
antibodies against SMC1, SMC3, SCC1/Rad21, SA2 and Sororin (Figure 35). The 
relative amounts of specific proteins were normalized to the levels of α-tubulin, 
which served as the loading control. Analysis of the band intensities revealed that 
there was no significant drop in protein levels of SMC1, SMC3, SCC1 or SA2 
(Figure 35). However, we detected a 5-fold or higher reduction in the levels of 
Sororin upon depletion of all the splicing factors tested (Figure 35). This raises the 
possibility that the loss of splicing machinery components impacts on sister 
chromatid cohesion by compromising the level of the essential cohesin stabilizing 
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factor Sororin. The immunoblotting revealed that depletion of splicing factors led to 
strong drop in Sororin levels suggesting that the loss of sister chromatid cohesion 
upon depletion of the splicing factors is caused by loss of mature and functional 
Sororin. Depletion of Sororin and the splicing factors did not lead to a drop in the 
levels of core cohesin subunits SMC3 and SA2. SMC1 levels on the other hand 
increased upon depletion of the splicing factors although this was also seen in cells 
depleted of Sororin. Surprisingly, Scc1 levels showed a corresponding reduction 
compared to control cells upon depletion of the splicing factors with the depletion of 
Sororin also leading to a strong reduction in Scc1 levels. 
 
6.7 Conclusion: Characterization of properties of cohesion 
upon loss of splicing factors 
Through the experiments that I have described in this section, we have obtained a 
deeper understanding into the molecular mechanisms through which mediators of 
pre-mRNA splicing regulate sister chromatid cohesion. Depletion of splicing factors 
abrogated cohesion already in interphase although neither cohesin loading nor a 
marker for cohesion establishment was affected. Importantly, we found that the 
depletion of splicing factors caused an increased dissociation of cohesin from 
chromatin during interphase. While levels of core cohesin subunits did not diminish, 
levels of Sororin, a protein required for maintenance of cohesion through S–G2 
phase into mitosis and the stable association of cohesin with chromatin, was 
significantly reduced in cells lacking splicing components. This suggests that 
splicing genes exert their effect on sister chromatid cohesion by regulating the 
levels of Sororin. Consistent with this idea, the loss of Sororin and the loss of 
splicing factors have similar phenotypic consequences: loss of cohesion during 
interphase and increased cohesin turnover on chromatin. We sought to perform 
more additional experiments to further test the link between splicing factors and 
Sororin in the next section. 
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Figure 29 Schematic representation of possible mechanisms by which splicing 
can affect sister chromatid cohesion. 
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Figure 30 Depletion of splicing factors leads to an increased distance between 
sister chromatids in interphase  
HeLa Kyoto cells were arrested in thymidine at the time of siRNA transfection (NHP2L1, 
Sgol1 and Sororin siRNAs) or 24 h post siRNA transfection (MFAP1, SART1, CDC5L 
and control siRNAs). 5 h after release from thymidine, cells were fixed, processed for 
fluorescence in situ hybridization (FISH) with a cy3-labelledprobe targeting the tff1 loci 
on chromosome 21. DNA was stained with DAPI. Images of cells as treated above 
were acquired (upper panel, scale bar = 10µm) and the distance between the paired 
FISH signal centroids was determined (lower panel, n> 30 cells, N=1. Bars represent 
standard error of measurement at 95% confidence interval, asterisks denote a 
significant difference according to student’s t test p< 0.01). 
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Figure 31 Splicing factors are not required for association of cohesin with 
chromatin  
HeLa Kyoto cells were transfected with siRNAs for either 18 hrs (NHP2L1 and sororin) 
or for 42 h (Control, SCC4, MFAP1 and SART1 siRNAs) following which they were, 
mixed with HeLa Kyoto cells stably expressing H2B-mCherry, and seeded onto 
coverslips that were coated with poly-L-Lysine. 8 hrs later, cells were extracted (to 
remove the soluble fraction of cohesion), fixed and stained for Scc1 and DNA (blue). 
Representative images from the experiment are displayed (upper panel, Scale bar = 10 
µm). Scc1 integrated fluorescence intensities of siRNA-transfected interphase cells 
were normalized to Scc1 integrated fluorescence intensities of neighboring 
untransfected interphase cells marked by H2B-mCherry (lower panel, bars represent 
mean ± SD; n>25 siRNA transfected cells per condition). 
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Figure 32 Acetylation of SMC3, a key marker for cohesion establishment is not 
severely reduced by depletion of splicing factors 
(A) HeLa Kyoto cells were transfected with siRNAs (37.5 nM) for either 6 hrs (NHP2L1 
and Sororin) or for 24 h (Blank, ESCO 1&2, Control, MFAP1, SART1 and CDC5L 
siRNAs) following which the cells were arrested in thymidine (2.5mM) for 24 h and 
released into DMEM. 3 hrs after release, the cells were harvested and processed for 
immunoblotting using AcSMC3 and SMC3 specific antibodies. (B) Concurrently, cells 
transfected and synchronized as above were processed for flow cytometry. Sorting was 
performed on a FACSCalibur (Beckton Dickinson), after staining with propidium iodide  
(5μg/ml, 1h at 370 C). Cell cycle profiles analyzed using FlowJo (Tree Star softwares) 
were then plotted as shown. 
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Figure 33 Inverse FRAP experiments (iFRAP) reveal enhanced dissociation of 
cohesin from chromatin in mFAP1-depleted cells 
 HeLa Kyoto cells stably expressing SMC1-EGFP were synchronized by thymidine 
arrest for 24 h either at the time of siRNA transfection (Sororin) or 24 h after 
transfection (control and MFAP1 siRNA). 5 h after release from the thymidine arrest, 
SMC1-EGFP fluorescence was repeatedly bleached in approximately half of the 
nucleus. The fluorescence intensities in the bleached and unbleached nuclear regions 
were followed by time-lapse microscopy with images being recorded every minute. 
Representative images of control Sororin and MFAP1-depleted cells are displayed. 
The difference in mean fluorescence intensity between bleached and unbleached 
nuclear regions was expressed as a ratio of the difference in fluorescence in the first 
post-bleach frame and plotted over time (bars represent mean ± SEM n=6 cells from 2 
independent experiments).  
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Figure 34 Overexpression of RNaseH1 does not rescue loss of sister chromatid 
cohesion upon depletion of splicing factors  
(A) A stable cell line expressing RNaseH1-EGFP (>80% cells GFP positive) was 
generated.  (B) This cell line and control HeLa Kyoto cells were transfected with the 
indicated siRNAs for 52 h and then treated with nocodazole (330nM) for 4 h before 
processing for chromosome spread analysis. Representative images from the assay 
are displayed (upper panel, scale bar = 10 µm). (C) The samples treated as above 
were scored for the status of sister chromatid cohesion defects and quantified as 
shown (lower panel, n> 100 cells, bars represent mean from 3 independent 
experiments). 
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Figure 35 Depletion of splicing factors reduces protein levels of Sororin but not 
any other core cohesin subunit 
HeLa Kyoto cells were transfected with siRNAs for either 6 h (NHP2L1 and Sororin) or 
for 24 h (Blank, Control, MFAP1, SART1 and CDC5L siRNAs) following which the cells 
were arrested in thymidine (2.5mM) for 24 h and released into DMEM. 5 h after release, 
the cells were harvested and processed for immunoblotting using the indicated 
antibodies. Secondary antibodies coupled to fluorescent tags were used and were 
detected using an Odyssey Imaging System. The relative protein content was 
normalized to the loading control α-Tubulin and the percentage of Sororin in cells 
treated with the indicated siRNA was plotted.         
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Chapter 7. Results 5- Mediators of pre-mRNA splicing 
regulate sister chromatid cohesion through Sororin 
In the previous section, I have described experiments through which we could 
demonstrate that that depletion of splicing factors disrupted sister chromatid 
cohesion and at the same time caused a strong reduction in the levels of Sororin. 
We performed further experiments to test if the defect in cohesion observed was 
causally linked to the reduction in Sororin levels.  
 
7.1 Pre-mRNA splicing of Sororin is perturbed upon depletion 
of splicing factors 
Previously, I described experiments wherein we depleted splicing factors and 
inspected the protein levels of core cohesin subunits. We discovered that Sororin 
was the only protein whose levels were significantly reduced. In order to investigate 
whether the depletion of the splicing factors that are required for cohesion 
interfered with the pre-mRNA processing of Sororin, we decided to perform qRT-
PCR experiments. For these experiments, HeLa Kyoto cells transfected with 
siRNAs targeting Sororin, NHP2L1, MFAP1, SART1 and CDC5L were released 
from a thymidine arrest. Five h after release, total RNA was extracted and was 
used to perform a reverse transcription reaction to generate the corresponding 
cDNAs using random hexamers as primers. A real time PCR reaction was then 
performed using primers that were designed as shown in Figure 36. Briefly, three 
sets of primers were used for Sororin, the first pair produced a product within exon 
2 (to measure Sororin transcript level) the second one amplified across exon 1 and 
exon 2 and the third primer within intron 1. Primers within GAPDH were used as a 
control for the qRT-PCR reaction and the relative mRNA levels were normalized to 
control siRNA treated samples. Depletion of Sororin reduced Sororin mRNA levels 
to less than 12% when tested using exon specific primers and to about 23% using 
intron specific primers (Figure 36). These results validate the utility of the qRT-PCR 
assay to scrutinize Soririn mRNA status. In contrast to Sororin loss, depletion of all 
4 splicing factors tested, resulted in a specific and substantial increase in the 
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amplification of the primer pair within intron 1. The increase in intron 1 signal 
ranged from a 2-fold to a 5-fold change. These observations suggest that depletion 
of splicing factors that are required for cohesion compromises splicing of Sororin 
pre-mRNA at least for intron 1. Failure to undergo correct splicing could lead to 
irregular transcription and translation resulting in a drop in the protein levels of 
Sororin.  
7.2 A genetic complementation system for Sororin 
The reduction in Sororin protein level and alteration of Sororin pre-mRNA structure 
raised the possibility that defective Sororin expression could represents the 
molecular mechanism underlying the cohesion defect in cells lacking splicing 
mediators. To test this possibility, we decided to use an intron-less Sororin 
transgene whose expression would not require pre-mRNA splicing. This transgene 
allowed us to test for a rescue the loss of sister chromatid cohesion in cells lacking 
splicing factors. As a first step towards this, we sought to establish a genetic 
complementation system using an AcFL-tagged Sororin cDNA that was engineered 
to be resistant to Sororin siRNA (Figure 37). This system allowed us to test whether 
the Sororin transgene was able to replace the function of the endogenous 
counterpart. Since stable cell lines generated by plasmid transfection strongly 
overexpressed the transgene, we chose lentiviral transduction with a minimal virus 
titre for engineering Sororin cell lines. This was necessary as over expression of 
Sororin at a high level could lead to an artificial stabilization of cohesin on 
chromatin and thereby cause by-pass suppression or other artefacts. Using 
lentiviral transduction, we were able to generate a cell line that expressed siRNA 
resistant and intron-less AcFL-Sororin at about 3-fold the endogenous level (Figure 
37). Importantly, the Sororin transgene in this cell line was to completely restore 
normal mitotic progression and sister chromatid cohesion in cells depleted of the 
endogenous protein (Figure 38 and see below). We could further demonstrate that 
the intron-less Sororin transgene was immune to the depletion of the splicing 
factors whereas their endogenous counterparts were not (Figure 39). These 
observations suggest that the protein encoded by the engineered transgene is fully 
functional and that its expression is not dependent on the status of the pre-mRNA 
splicing machinery (Figure 39C). 
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7.3 Expression of the Sororin transgene cannot bypass the 
requirement of Scc1 and Sgol1 for sister chromatid 
cohesion  
 
Having generated a transgenic complementation system for Sororin, we tested the 
ability of this cell line to rescue the loss of sister chromatid cohesion triggered by 
depletion of Sororin itself as well as of the core cohesin subunit Scc1 and the 
protector of centromeric cohesion SGOL1. Sororin antagonizes the cohesin-
releasing anti-establishment activity of WAPL (Nishiyama et al., 2010). Depletion of 
SGOL1 and SCC1 served as important controls as a strong rescue of cohesion 
loss induced by depletion of either protein in a cell line overexpressing Sororin 
would indicate bypass suppression through ectopic stabilization of residual cohesin 
on chromatin, a phenomenon (‘over-cohesion’) that can also be induced by 
depletion of WAPL (Nishiyama et al., 2010, Peters and Nishiyama, 2012, Eichinger 
et al., 2013). Expression of siRNA-resistant AcFL-Sororin potently restored sister 
chromatid cohesion upon depletion of the endogenous counterpart (Figure 38). In 
contrast, expression of the transgene had only a minor impact on the severity of 
sister chromatid cohesion loss induced by depletion of Scc1 or Sgol1 (Figure 40). 
These observations suggest that the level of Sororin expression in our transgenic 
model cannot efficiently bypass the loss of Scc1 or Sgol1 by providing ectopic 
stabilization of remaining cohesin complexes. Together with the finding that the 
transgene is able to provide Sororin function, this observation indicates that the 
transgenic model is suitable for testing the hypothesis that splicing factors impact 
on cohesion through expression of Sororin.  
 
7.4 Overexpression of intron-less Sororin rescues the loss of 
sister chromatid cohesion upon depletion of splicing 
factors 
Having established an siRNA complementation system for Sororin and having 
demonstrated that the level of overexpression was low enough to prevent artefacts 
of Sororin over expression, we proceeded to test the ability of an intron-less Sororin 
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transgene to rescue the sister chromatid cohesion loss that occurs upon depletion 
of the splicing factors. We transfected cells expressing AcFL-Sororin-r or the AcFL 
tag alone with siRNAs duplexes targeting Sororin or the splicing factors MFAP1, 
NHP2L1, SART1 and CDC5L (Figure 41). Following transfection, cells were grown 
for 24 h (NHP2L1 and Sororin siRNAs), 44 h (MFAP1 and SART1 siRNAs) and 52 
h (Control and CDC5L siRNAs) before being analysed by chromosome spread 
assays. Importantly, expression of the intron-less Sororin transgene strongly 
reduced the fraction of cells with split sister chromatids (Figure 41). Depending on 
splicing factor analysed, the defect was reduced 3 to 6-fold (Figure 41). Expression 
of the intron-less Sororin transgene however did not restore mitotic progression in 
cells depleted of splicing factors: cells were still not able to exit mitosis and 
eventually sustained apoptosis (data not shown). Based on these observations, we 
can conclude that the loss of sister chromatid cohesion in cells depleted of splicing 
factors is almost exclusively caused by a failure to supply sufficient Sororin protein. 
Thus, the main target of splicing factors in mediating sister chromatid cohesion is 
Sororin. 
 
7.5 Conclusions: mediators of pre-mRNA splicing regulate 
sister chromatid cohesion through Sororin 
In this section, I have demonstrated that depletion of selected splicing factors leads 
to a defect in pre-mRNA splicing of Sororin, a key regulator of sister chromatid 
cohesion. Since Sororin is critical for cohesion maintenance throughout interphase 
through to mitosis, a strong reduction in Sororin protein levels could disrupt sister 
chromatid cohesion in interphase cells which would eventually cause an SAC-
dependent mitotic arrest as cells enter mitosis with split sister chromatids. 
Importantly, we have also shown that expression of an intron-less Sororin 
transgene can largely restore sister chromatid cohesion in cells depleted of splicing 
mediators. The same transgene does not rescue the loss of sister chromatid 
cohesion caused by depletion of other cohesin subunits. These experiments 
suggest that amongst cohesion regulators, Sororin is the major target of pre-mRNA 
splicing in the regulation of sister chromatid cohesion. Our study also reveals that 
the connection between sister chromatids is exquisitely sensitive to the Sororin 
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levels suggesting that cells have to maintain a delicate balance between the 
antagonizing functions of WAPL and Sororin (see discussion). Finally, the fact that 
Sororin transgene expression does not restore mitotic progression in cells lacking 
splicing factors strongly suggests that splicing contributes to the successful 
execution of mitosis by other as yet undefined mechanisms (see discussion).
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Figure 36 Sororin mRNA splicing is perturbed upon depletion of splicing factors 
 (A) Schematic depicting the exons and introns within the Sororin open reading frame. 
Sororin specific primers were chosen for qRT-PCR experiments that either amplify 
within exon 2 (white arrows) or across exon 1 and exon 2 (Grey arrows) or within Intron 
1 (black arrows) of Sororin. (B) HeLa Kyoto cells were transfected with siRNAs for 
either 6 hrs (NHP2L1 and Sororin) or for 24 h (Control, MFAP1, SART1 and CDC5L 
siRNAs) following which the cells were arrested in thymidine (2.5mM) for 24 h and 
released into DMEM. 5 hrs after release, the cells were harvested and total RNA was 
extracted. cDNA generated from these RNA samples using random hexamers priming 
were processed for qRT-PCR using primers that either amplify within exon 2 (white 
arrows) or across exon 1 and exon 2 (Grey arrows) or within Intron 1 (black arrows) of 
Sororin. Quantification of relative mRNA levels by ΔΔCT method was performed as 
described (Section 2.6) and the data was normalized to mRNA levels in control siRNA 
sample Data represents average of 3 experimental repeats. 
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Figure 37 A genetic complementation system for Sororin  
A clonal stable cell line expressing a siRNA-resistant transgenic copy of Sororin was 
generated by introducing silent mutations within the siRNA recognition sequence of 
Sororin cDNA which was tagged with AcGFP-FLAG (AcFL) at the N terminus. A 
lentiviral vector was generated incorporating the above-mentioned construct. Viral 
particles harbouring the construct were generated in 293FT cells and used to infect 
HeLa Kyoto cells. The clonal cell line was then generated through selection with 
puromycin (0.4 µg/mL). Schematic representation of the transgene (upper panel). 
clonal cell lines expressing either AcFL-Sororin-r or the AcFL tag alone were 
transfected with indicated siRNA duplexes (37.5 nM) along with thymidine (2.5mM). 
Cells were released after 24 h of thymidine arrest, harvested about 5 h after release 
and processed for immunoblotting with the indicated antibodies. Endogeneous Sororin 
and transgenic AcFL -Sororin-r are indicated by open and filled arrowheads 
respectively. 
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Figure 38 siRNA resistant transgenic Sororin can rescue mitotic arrest caused 
by depletion of endogenous Sororin  
Clonal stable cell lines expressing either an AcFL tag alone or AcFL-Sororin-r were 
transfected with Sororin siRNA duplexes (37.5 nM) and were subjected to time-lapse 
microscopy 16 h post siRNA transfection. Images were acquired at 40X magnification 
with an interval of 10 min between acquisitions. Representative images from the two 
conditions that were imaged are shown. 
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Figure 39 Depletion of splicing factors affects the levels of endogenous Sororin 
but not the transgenic intron-less Sororin  
Clonal stable cell lines expressing either (A) an AcFL tag alone or (B) AcFL-Sororin-r 
were transfected with siRNAs for either 6 h (NHP2L1 and Sororin) or for 24 h (Control, 
MFAP1, SART1 and CDC5L siRNAs) following which the cells were arrested in 2.5 mM 
thymidine for 24 h and then released into DMEM. 5 h after release, the cells were 
harvested and processed for immunoblotting (fluorescent detection) using the indicated 
antibodies. Secondary antibodies coupled to fluorescent tags were used and detected 
using an Odyssey Imaging System. (C) The relative protein content from the 
immunoblot (B) was normalized to the loading control tubulin and the percentage of 
either endogenous (black arrowhead in immunoblot) or transgenic intron-less (white 
arrowhead) Sororin protein in cells treated with the indicated siRNAs was plotted. 
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Figure 40 Transgenic expression of siRNA-resistant Sororin does not efficiently 
compensate for loss of Scc1 or Sgol1 
Stable cell lines expressing either the AcFL tag alone or siRNA resistant AcFL-Sororin-
r were transfected with the indicated siRNAs (37.5 nM) and were grown for 24 h 
(Sororin and Sgol1 siRNAs) or 44 h (Control siRNA) or 52 h (Scc1 siRNA). 
Subsequently, cells were treated with nocodazole (330nM) for 4 h and processed for 
chromosome spread analysis. Images of chromosome spreads from cells treated with 
the indicated siRNAs (upper panel, scale bar = 10 µm). Samples treated as above 
were scored for proportion of cells in different states of sister chromatid cohesion. 
(lower panels, n> 100 cells, bars represent mean from 3 independent experiments).  
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Figure 41 Expression of intron-less Sororin potently suppresses sister chromatid 
cohesion loss caused by depletion of splicing factors 
Stable cell lines expressing either the AcFL tag alone or AcFL-Sororin-r were 
transfected with the indicated siRNAs (37.5 nM) and were grown for 24 hrs (NHP2L1 
siRNA) or 44 h (Control, MFAP1 and SART1 siRNAs) or 52 h (CDC5L siRNA). 
Subsequently, cells were treated with nocodazole (330nM) for 4 h and processed for 
chromosome spread analysis. (A) Images of chromosome spreads from cells treated 
with the indicated siRNAs (scale bar = 10 µm). (B) Samples treated as above were 
scored for the status of sister chromatid cohesion. (n> 100 cells, bars represent mean 
from 3 independent experiments). 
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Chapter 8. Discussion 
8.1 Off-target effects, the bane of functional genomic screens  
The main aim of my project was to identify novel regulators of mitosis and 
cytokinesis using previously published genome-wide RNAi (Kittler et al., 2007, 
Mukherji et al., 2006, Neumann et al., 2010) and proteomic datasets (Skop et al., 
2004) as an enriched source of candidate genes. Of the 718 genes chosen for the 
screen, the overlap among the different screens was less than 10%. Though at first 
glance, the lack of overlap amongst the screens is surprising, it is worth noting that 
the above-mentioned screens used different siRNA reagents, vastly dissimilar 
readouts and most importantly unique criteria to discern whether a particular gene 
was a hit. Another important factor that could explain the lack of correspondence 
between the screens is the existence of off-target effects mediated by the siRNA 
reducing the mRNA levels of intended as well as unintended targets. While one of 
the genome-wide siRNA screens used endonuclease-prepared siRNAs (esiRNAs) 
that are transcribed in vitro from DNA templates, effectively leading to a mixture of 
multiple siRNAs targeting each gene (Kittler et al., 2007), the other screens used 
individual siRNAs for the primary screen followed by validation with multiple 
siRNAs. It has been noted that using ‘pools’ of siRNAs targeting a particular gene 
rather than individual siRNA increases from 80% to 95%, the probability of 
knockdown of the target mRNA to <1/3 of its level (Echeverri and Perrimon, 2006). 
Off-target effects can be elicited by partial or complete homology between the seed 
region of the siRNA (nucleotides 2-8 of the antisense strand) and an unintended 
target mRNA leading to non-specific mRNA degradation (Birmingham et al., 2006, 
Jackson et al., 2003). Additionally siRNAs have been known to function through the 
miRNA pathway causing translational inhibition of non-specific targets (Doench et 
al., 2003, Scacheri et al., 2004).  
In our screen workflow, we sought to perform the primary screen with siGENOME 
SMARTpools of 4 individual siRNAs against each gene. This increases the 
probability of target mRNA knockdown and reduces the effective concentration of 
the individual siRNA used. Additionally, it being a demonstrably efficient 
methodology to combat off-target effects, we performed downstream deconvolution 
screens to test the ability of individual siRNAs that constitute the pools to reproduce 
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the phenotype we obtained with the pools. Subsequent to the deconvolution 
analysis, we performed depletion experiments for selected genes with siRNAs from 
multiple manufacturers targeting a different stretch of sequence within each gene. 
This was done in order to increase the confidence about the conclusions drawn 
from the primary and the deconvolution screens. In summary, we decided to 
pursue an initial three-pronged system of assessing the hits from the primary 
screen before performing further assays.  
In our primary siRNA screen with SMARTpools, we observed that the negative 
controls scored less than 8% while the positive controls scored upwards of 80% in 
terms of percentage nuclear abnormalities. Of the 50 hits chosen from the primary 
screen for further analysis, only 7 (as shown in Table 7) could reproducibly 
replicate the phenotype of the corresponding SMARTpool in at least two out of the 
four siRNA duplexes (See Table 7). This suggests that ~90% of the hits from the 
screen are probably due to off-target effects mediated by one of the four siRNAs 
that constitute the pool. This brings us to question why we were able to only detect 
such a meagre number of genuine hits while having started with an enriched 
dataset of cell cycle regulatory genes. Firstly, the cut-off in phenotypic assays that 
was used to classify an siRNA target as a hit was not the same in the different 
screens and in some cases was as low as the negative controls in our screen. 
Secondly, the use of automated readouts as necessitated by high throughput 
screens themselves could have contributed to the detection of false positives. 
Thirdly, it is possible that the siRNA duplexes, transfection protocol and duration of 
siRNA treatment that we used for our screen may not have been sufficient to 
reduce the protein levels of many candidate genes to levels that would have 
resulted in a discernible phenotype. Last but not least, given that about 90% of the 
top hits from our screen are likely off-target effect hits, it is possible that a vast 
majority of the hits from genome-wide screens suffer from the same problem.   
From our primary siRNA screen, depletion of a gene named ARL5A led to a 
penetrant cytokinesis failure and persistence of abnormal tubulin bridges between 
interphase cells (Figure 13). However, further examination revealed that the 
phenotype was reproduced in only 2 out of 6 siRNAs tested although all six siRNA 
duplexes could significantly reduce the mRNA levels of ARL5A. This combined with 
the demonstrated off-target activity of the siRNAs against CEP55 suggested that 
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the cytokinesis defect observed in cells transfected with siRNAs targeting ARL5A 
were most likely caused by an off-target effect on CEP55.  
Another hit to emerge from our siRNA screen was MFAP1, a known regulator of 
the tri-snRNP complex of the spliceosome. Contrary to ARL5A, the interphase 
nuclear morphology phenotype caused by MFAP1 SMARTpools in the primary 
screen was reproducibly observed in all 4 out of the 4 siRNAs tested (Figure 15). 
RT-PCR experiments with MFAP1 specific primers and immunoblotting 
experiments with MFAP1 specific antibody revealed the reduction of MFAP1 mRNA 
and the protein levels respectively upon transfection with MFAP1 siRNA duplexes.  
The gold standard among strategies to winnow out off-target effects from genuine 
hits is phenotypic rescue by using a genetic complementation system. In this 
system, a cell line that stably expresses a transgenic copy of the gene concerned 
with silent mutations in the siRNA recognition sequence is generated. The 
immunity of this transgenic construct to the siRNA, as assessed by its ability to 
rescue the phenotype caused by the siRNA is a test of the genuineness of a 
particular hit. It is however critical to perform and interpret these complementation 
experiments carefully as failure to express the transgene at near physiological 
levels can lead to false ‘rescues’ (Hübner et al., 2009). A cell line stably expressing 
an siRNA resistant transgene of MFAP1 at near endogenous levels could potently 
suppress the interphase nuclear morphology defect (Figure 16). The specificity of 
MFAP1 specific siRNAs and the interesting interphase nuclear phenotype 
encouraged us to probe in more detail the role of MFAP1 in maintaining nuclear 
morphology.  
Our experience working with hits from the screen such as ARL5A, MFAP1 and 
others suggests that a majority of hits emerging from siRNA screens suffer from the 
problem of off target effects and that robust downstream analyses such as 
performing depletion experiments with multiple siRNA duplexes and the use of a 
genetic complementation system together serve to separate the wheat from the 
chaff in terms of novel hits from siRNA screens. The pitfalls with siRNAs and the 
inherent off-target effects associated with them necessitate the development of 
better gene targeting approaches. Highly efficient genome editing approaches like 
the CRISPR/CAS system (Wang et al., 2009, Cong et al., 2013) holds much 
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promise and in the future, siRNA-based studies should be supplemented with such 
techniques. 
8.2 Depletion of pre-mRNA splicing mediators leads to the loss 
of sister chromatid cohesion and cell division failure  
After having established a causative link between the observed interphase nuclear 
morphology phenotype and the loss of MFAP1 protein, we sought to understand 
the molecular basis underlying this phenomenon. We could demonstrate that 
MFAP1-depleted cells arrested in mitosis in a spindle assembly checkpoint (SAC) 
dependent manner. Furthermore, mitotic chromosome spreads and FISH 
experiments revealed that MFAP1-depleted cells exhibited premature sister 
chromatid cohesion loss. We hypothesised that the lack of cohesion between sister 
chromatids in these cells could be the underlying cause behind their inability to 
align their chromosomes at the metaphase plate and to execute mitosis 
successfully.  
Using a mass spectrometry dataset of spliceosome components (Zhou et al., 2002) 
and the MitoCheck phenotypic profile database (http://www.mitocheck.org), we 
identified 33 pre-mRNA splicing genes whose depletion led to abnormal mitosis 
and cell death. Remarkably, we could show that the depletion of 30 out of the 33 
genes by siRNA duplexes led to a premature loss of sister chromatid cohesion. For 
the depletion of many splicing factors, the severity of the sister chromatid cohesion 
defect was comparable to the loss of a core cohesin function, such as depletion of 
the ring subunit SCC1. We sought to understand the molecular basis behind the 
unusual link between pre-mRNA splicing and sister chromatid cohesion. Crucially, 
we could show that depletion of four distinct splicing factors namely MFAP1, 
NHP2L1, CDC5L and SART1 resulted in a loss of sister chromatid cohesion in 
interphase soon after DNA replication already in S-phase that is different from the 
mitosis specific loss of sister chromatid cohesion that cells sustain upon loss of 
Sgol1, a well-known regulator of centromeric cohesion in mitosis (Kitajima et al., 
2004, McGuinness et al., 2005, Watanabe and Kitajima, 2005).  
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8.3 Loss of pre-mRNA splicing factors perturb the levels of 
Sororin, a protein required for sister chromatid cohesion 
In order to decipher the molecular mechanism by which pre-mRNA splicing factors 
control sister chromatid cohesion, we pursued several distinct possibilities. Defects 
in viability caused by the depletion of a splicing factor ASF/SF2 in chicken DT40 
cells were shown to be rescued by expressing RNaseH1 in these cells (Li and 
Manley, 2005). Based on this we hypothesised that R-loops (RNA-DNA hybrids) 
that might be generated by faulty co-transcriptional splicing processes could act as 
a physical hindrance for the cohesin ring to encircle chromatin. Since expression of 
the enzymes RNaseH1 is known to remove the RNA component of the R-loops, we 
tested if expression of RNaseH1 could rescue the loss of sister chromatid cohesion 
upon the depletion of the splicing factors. We observed no change in the proportion 
of cells that exhibited split sisters in cells that express RNaseH1 or not. One caveat 
of our experiments using transgenic RNase H1 is that we have no evidence as yet 
to demonstrate that the RNaseH1 is functional in the cells when we deplete the 
pre-mRNA splicing factors. Nevertheless, the very same RNaseH1-EGFP construct 
that we used to generate the transgenic cell line has been successfully used to 
resolve R-loops in the past (Cerritelli et al., 2003, Skourti-Stathaki et al., 2011). 
Depletion of the splicing factors did not measurably affect the loading of cohesin 
onto chromatin. However, it resulted in an increased dissociation of cohesin from 
chromatin as demonstrated by iFRAP experiments (Figure 33). As a next step, we 
hypothesised an indirect and gene expression-mediated role of pre-mRNA splicing 
factors in sister chromatid cohesion. The idea was that the inhibition of pre-mRNA 
splicing led to a defect in cohesin maintenance during interphase through a 
perturbation in the protein levels of either the core cohesin subunits, SMC1, SMC3, 
SCC1 and SA2 or of Sororin, a protein required for cohesion maintenance in post-
replicative cells. Through immunoblotting experiments, we observed that the levels 
of Sororin dropped 5-fold or higher upon depletion of the splicing factors suggesting 
that it was the primary target of the pre-mRNA splicing factors among the proteins 
regulating sister chromatid cohesion. We also observed smaller perturbations in the 
levels of SMC1, SCC1 and SA2 although this was evident in cells depleted of 
Sororin as well. We do not yet know if the fluctuation in the levels of the core 
cohesin subunits contributes to the loss of sister chromatid cohesion upon 
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depletion of the splicing factors and more interestingly upon depletion of Sororin. 
We hypothesise that the depletion of pre-mRNA splicing factors results in reduced 
maintenance of cohesin on chromatin because of lack of availability of Sororin. 
 
Figure 42 Model for Sororin-mediated regulation of sister chromatid cohesion by 
effectors of pre-mRNA splicing  
In control cells, pre-mRNA splicing of Sororin ensures the presence of functional 
Sororin protein at the S-phase of every cell cycle. Upon depletion of pre-mRNA splicing 
factors, levels of Sororin protein drops steeply as there is no new Sororin protein being 
producedd to replenish the ones that are degraded during the G1-phase of every cell 
cycle. The lack of Sororin, a factor necessary for cohesion maintenance leads to a a 
reduced association between cohesin and chromatin and thereby to a premature loss 
of sister chromatid cohesion. 
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In addition to measuring the protein levels of mature Sororin, we performed RT-
PCR experiments using Sororin specific primers that either amplify within intron 1 
or across exon 1 and exon 2. We observed that depletion of splicing factors led to a 
2-5-fold increase in the presence of the intron compared to the control although 
levels of exon1-2 either stayed the same or reduced by 1 fold. This suggests that 
pre-mRNA splicing of Sororin is defective upon depletion of the splicing factors. 
This raises the possibility that lack of pre-mRNA splicing of Sororin could lead to 
the production of an erroneous truncated Sororin protein. Interestingly, intron 1 
does not contain an in-frame stop codon although it introduces a frame shift that 
leads to a premature stop codon in exon 3 irrespective of the splicing status of 
intron 2. This suggests that an erroneous and non-functional Sororin protein that is 
made up of just exon1-intron1-exon2-intron2-exon3 or exon1-intron1-exon2-exon3 
might be produced. Since the Sororin antibody that we have, was raised against a 
stretch of amino acids in the N terminus of the protein, it is possible that this non-
functional Sororin protein might still be detectable in samples where pre-mRNA 
splicing is affected. We are currently pursuing this idea. It is also worth mentioning 
that we only use primers specific for intron 1 for the RT-PCR experiment. In the 
near future, we will expand this analysis to detect the levels of the other 4 introns in 
Sororin upon depletion of the splicing factors. 
Having demonstrated a steep fall in the levels of mature and functional Sororin 
protein and a perturbation in the pre-mRNA splicing status of Sororin mRNA in cells 
transfected with siRNAs against the splicing factors, the logical step forward was to 
determine if supplying an intron-less transgene of Sororin could rescue the sister 
chromatid cohesion in cells depleted of the splicing factors. We observed that a cell 
line expressing an intron-less Sororin transgene could rescue the loss of sister 
chromatid cohesion that was caused by the depletion of the splicing factors. 
However, the mitotic arrest persisted even in the presence of the intron-less 
Sororin. Since the expression of an intron-less transgene of Sororin only rescues 
the loss of sister chromatid cohesion but not mitotic progression, leaving cells 
transfected with siRNAs against the splicing factors for prolonged duration in 
mitosis could lead to an artificial loss of sister chromatid cohesion caused by 
cohesion fatigue (Daum et al., 2011, Stevens et al., 2011). This suggests cohesion 
fatigue may contribute to the fact that we only observe an incomplete (yet strong) 
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rescue in sister chromatid cohesion by expressing an intron-less Sororin transgene. 
Changing the timing of cell growth and mitotic arrest prior to performing 
chromosome spreads can address this possibility. 
The intron-less Sororin rescue experiment firstly reveals that the loss of sister 
chromatid cohesion that is caused by the depletion of the splicing factors is most 
likely caused by a precipitous drop in Sororin levels. Secondly, it tells us that the 
loss of pre-mRNA splicing factors affects the execution of mitosis not just through a 
Sororin dependent loss of sister chromatid cohesion but also through an as yet 
unknown mechanism. Kathleen Gould and colleagues demonstrated the 
requirement of pre-mRNA splicing of α-tubulin for the proper functioning of the 
mitotic spindle in yeast cells (Burns et al., 2002). Taken together with our 
observation that the mitotic arrest triggered in cells depleted of the splicing factors 
is dependent on the spindle assembly checkpoint, it is possible that in addition to 
the loss of sister chromatid cohesion mediated through Sororin, defects in pre-
mRNA splicing could affect the formation of the mitotic spindle in mammalian cells. 
This could be through pre-mRNA splicing of a number of possible targets such as α 
or β-tubulin isoforms, centrosomal components etc. In addition to the mitotic 
spindle, it is also possible that depletion of pre-mRNA splicing components could 
cause mis-splicing of targets that are critical for mitotic exit such as components of 
the APC/C, mitotic phosphatases, components of the kinetochore etc. The SAC 
dependence of the mitotic arrest however suggests a reduced probability for the 
target of the pre-mRNA splicing machinery to be mitotic phosphatases or a 
component of the APC/C although this possibility cannot be completely ruled out. 
Further work is necessary to uncover the other potential targets of the pre-mRNA 
splicing machinery to understand the molecular mechanisms behind the mitotic 
arrest triggered in cells defective in pre-mRNA splicing.  
It is interesting that Sororin is one of the primary targets of the splicing machinery in 
regulating sister chromatid cohesion, why might this be the case? About 90% of the 
cohesin complexes are removed intact without the need for separase mediated 
cleavage through the prophase pathway (Peters et al., 2008). This ensures that a 
steady supply of cohesin ring complexes abound in the cell thereby rendering the 
core subunits refractory to the loss of pre-mRNA splicing. Sororin on the other hand, 
is degraded at the end of every cell cycle through APC/CCdh1 mediated proteasomal 
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degradation at G1-phase (Rankin et al., 2005, Wu et al., 2011, Peters and 
Nishiyama, 2012, Zhang and Pati, 2012) thereby necessitates renewed Sororin 
translation and possibly transcription of Sororin mRNA for production of mature 
Sororin protein at every S-phase of the cell cycle. We hypothesize that this opens 
up Sororin to defects in pre-mRNA splicing errors. Given the delicate balance 
maintained by the cohesion-maintaining activity of Sororin and the anti-
establishment effect mediated by WAPL, it is conceivable that any perturbations in 
the relative amounts of these proteins impacts sister chromatid cohesion 
dramatically. Thus, Sororin while being an indispensable factor for cohesion 
maintenance, is also a protein whose levels fluctuate through cell cycle thereby 
possibly creating a strict dependence on gene expression competence. This 
hypothesis makes a testable prediction that the critical factor behind the premature 
loss of sister chromatid cohesion upon depletion of the splicing factors is that the 
anti-establishment effect of WAPL is relatively unchecked by the drop in levels of 
Sororin. Therefore, its stands to suggest that, removing the anti-establishment 
effect by depleting WAPL should make the cells immune to not only loss of Sororin 
as has been demonstrated before (Nishiyama et al., 2010) but also to loss of pre-
mRNA splicing regulators. Secondly, the need for transcription and post-
transcriptional processing of Sororin mRNA at every cell cycle happens because of 
the APC/CCdh1 mediated degradation of Sororin in the G1-phase of the cell cycle. Is 
it possible to prevent this degradation of Sororin? Previously it has been shown that 
the KEN box domain in Sororin makes it a target for APC/CCdh1 mediated 
degradation (Rankin et al., 2005). To date it is not known why Sororin has to be 
degraded at the end of mitosis. It is thought that the presence of Sororin before 
replication could create cohesion artefacts that might have unforeseen 
consequences on sister chromatid cohesion and thereby for DNA damage repair 
processes (Peters and Nishiyama, 2012, Zhang et al., 2011, Rankin et al., 2005, 
Rankin, 2005). However, it is known that Sororin binding to cohesin requires DNA 
replication and SMC3 acetylation that happen only in S-phase. Thus Sororin cannot 
cause cohesion artefacts before S-phase and there seems to be no requirement for 
it to be degraded by the APC/C. Even though there is an indication that mutating 
the KEN box domain of Sororin, rendering it resistant to APC/CCdh1 mediated 
degradation affects cell growth, this idea has never been reportedly tested (Rankin, 
2005, Zhang and Pati, 2012). It is therefore possible to test if the absence of 
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Sororin pre-mRNA splicing caused by the depletion of splicing factors, can be 
offset by preventing the degradation of Sororin by either mutating the KEN box 
domain or by depleting Cdh1 from cells. We will test these ideas in the lab in the 
near future.  
 
8.4 Are mitotic defects the primary effect of pre-mRNA 
processing defects? 
A number of recent reports suggest that perturbing pre-mRNA processing 
pathways through siRNA based depletion results in a protracted mitotic arrest, 
some accompanied by a premature loss of sister chromatid cohesion (Yamazaki et 
al., 2010, Matsunaga et al., 2012, Hofmann et al., 2010). Additionally a number of 
pre-mRNA processing components have been identified as regulators of the cell 
cycle in the genome-wide siRNA screens for novel regulators of the cell 
cycle(Neumann et al., 2010, Kittler et al., 2007). Also, it was shown a while ago, 
that a temperature sensitive mutant of Cdc5 in fission yeast was defective in pre-
mRNA splicing of α-tubulin and resulted in defects in mitosis. Furthermore, these 
defects in nuclear division could be ameliorated by the removal of the single intron 
from α-tubulin although the cells still suffered from the global loss of splicing (Burns 
et al., 2002). This raises the interesting question as to why a defect in the pre-
mRNA processing pathways manifests primarily through defects in mitosis. Though 
it is currently not known if and why this might be the case, we have made some 
observations that could shed some light into this phenomenon. We have observed 
that inhibiting global splicing in human cells by using spliceostatin A, a potent 
inhibitor of pre-mRNA splicing (Kaida et al., 2007, Roybal and Jurica, 2010) at 
concentrations (50-250 nM) that are known to inhibit pre-mRNA splicing, prevents 
mitotic entry in HeLa cells (Data not shown). Reducing the spliceostain A 
concentration to less than 2 nM led to a mitotic arrest that was not accompanied by 
defects in sister chromatid cohesion. It thus raises the possibility that differential 
sensitivity amongst targets for the requirement of pre-mRNA processing pathways 
is reflected as varied phenotypes within cells. This suggests that pharmacologically 
inhibiting pre-mRNA splicing globally can lead to an arrest in cell cycle progression 
in interphase whereas a less potent mode of splicing inhibition by siRNA mediated 
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depletion of some spliceosome components allows cell cycle progression but 
inhibits successful mitosis by affecting either sister chromatid cohesion, the mitotic 
spindle, mitotic exit components or all or some of them. This hypothesis could be 
tested perhaps by imposing a gradient of splicing competence in cells by using 
different concentrations of global splicing inhibitors and assessing the functionality 
or the pre-mRNA splicing status of specific mitotic target proteins using RNA-Seq 
experiments.  
The experiments with spliceostatin A also raises the possibility that using 
concentrations of spliceostatin A that prevent mitotic entry can still affect sister 
chromatid cohesion in interphase cells. We are testing this hypothesis by 
performing FISH experiments in interphase cells to test for the status of sister 
chromatid cohesion upon treatment with different doses of spliceostatin A. 
8.5 SF3B1 mutations in hematopoietic malignancies; A 
connection to sister chromatid cohesion  and cohesin 
turnover on chromatin? 
Through our chromosome spread analysis for spliceosome components, we have 
observed that one of the splicing factors whose depletion by siRNA causes a 
dramatic loss of sister chromatid cohesion during mitosis is SF3B1. SF3B1 is a 
component of the U2 snRNP complex that is required for the assembly of the pre-
spliceosomal E complex. Recently, SF3B1 has emerged as one of the most 
frequently mutated genes in Chronic Lymphocytic Leukemia (CLL) patients, ahead 
of even the tumour suppressor TP53 (Wang et al., 2011, Rossi et al., 2012, 
Quesada et al., 2012, Landau and Wu, 2013). Somatic SF3B1 mutations were also 
detected at high frequency in individuals affected by myelodyplastic syndrome 
(MDS), reaching 65% penetrance in MDS with ringed sideroblasts, a variant of 
MDS (Papaemmanuil et al., 2011, Yoshida et al., 2011). The most frequent 
recurrent mutation in CLL and MDS patients is K700E (more than 50% of cases). 
The recurrent nature of somatic SF3B1 mutations in MDS and CLL strongly 
suggest that these mutations act as key driver events in these diseases. Despite 
the overwhelming association of SF3B1 mutations with myeloid neoplasms and 
leukemias, the mechanisms by which these mutations contribute to pathogenesis 
at the cellular level and the specific targets of SF3B1 that are perturbed remain 
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unclear. Our finding that SF3B1 is essential for sister chromatid cohesion raises the 
possibility that mutations in SF3B1 could contribute to CLL and MDS pathology by 
affecting the turnover of cohesin on chromatin. In addition to SF3B1, Depletion of 
another pre-mRNA splicing factor, U2AF1 which is also mutated in MDS (Yoshida 
et al., 2011), also severely impairs sister chromatid cohesion. We will test the 
above-mentioned hypothesis by determining the properties of cohesin and the state 
of sister chromatid cohesion in cells carrying the SF3B1 disease mutation K700E. 
In addition to using a HeLa cell line expressing a transgenic copy of SF3B1 with the 
K700E mutation, we plan to assess the state of sister chromatid cohesion in 
peripheral blood mononuclear fractions of CLL patients carrying the K700E 
mutation (provided by Dr. Elías Campo and Dr. Carlos López-Otín, Univ. of 
Barcelona Hospital Clinic and Univ. of Oviedo, Spain). Based on our finding that 
the expression of an intron-less transgene of Sororin can rescue the sister 
chromatid cohesion loss caused by depletion of a number of splicing factors, we 
will test whether expression of this transgene can restore cohesin-related cellular or 
molecular defects in SF3B1-K700E models.  
 
8.6 Other novel hits from the siRNA screen beyond MFAP1 
In order to facilitate downstream analysis, we used an arbitrary cut-off of 23% 
nuclear abnormalities in the primary screen to shortlist genes for further analysis. 
However, further experiments demonstrated that low scoring genes based on the 
readout that we used in the primary screen, might have a much more potent impact 
on mitosis than revealed by nuclear abnormalities observed in interphase. 
Illustratively, while MFAP1 registered a score only of 23% nuclear abnormalities in 
the primary screen, downstream experiments revealed that depletion of MFAP1 
resulted in almost all cells failing to undergo successful mitosis with more than 75-
90% of cells suffering from premature loss of sister chromatid cohesion. The 
discrepancy between phenotypic penetrance in interphase versus mitosis is 
probably caused by the loss of severely defective and arrested mitotic cells by 
apoptosis. The use of live cell imaging as primary screen readout could have 
ameliorated this problem. These considerations warrant the further investigation of 
seemingly low scoring hits (below 23% nuclear abnormalities) from our primary 
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screen. Gene depletions in this category might potentially have far stronger 
consequences for mitosis than is revealed by the interphase readout. This will be 
pursued in the lab in the future with a special emphasis on the mitotic index 
measurements upon knockdown of specific genes. 
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Appendix 
The full list of candidate genes, the details of the Dharmacon siRNA smartpools 
used to target them and the percentage nuclear abnormalities that the siRNA 
duplexes elicit in cells is shown in the table below.  
Plate Well Pool Catalog Number 
Gene 
Symbol 
GENE 
ID Gene Accession 
% nuclear 
abnormalities 
Plate 1 A04 M-015921-01 ABC1 63897 NM_022070 3.06 
Plate 1 A05 M-011320-01 ABLIM1 3983 NM_006720 2.96 
Plate 1 A06 M-013586-01 ABTB1 80325 NM_172028 5.42 
Plate 8 A03 M-009002-00 ACAD9 28976 NM_014049 8.90 
Plate 8 A06 M-004929-02 ACVR1C 130399 NM_001111033 14.20 
Plate 8 G08 M-013315-01 AD-017 55830 NM_152932 9.12 
Plate 1 A09 M-005757-01 ADAM19 8728 NM_023038 10.00 
Plate 1 A10 M-004525-00 ADAM33 80332 NM_025220 10.03 
Plate 2 A04 M-015673-01 AF15Q14 57082 NM_144508 24.50 
Plate 8 A07 M-008696-00 AGXT2L1 64850 NM_031279 6.01 
Plate 1 A12 M-010232-00 AKAP12 9590 NM_005100 41.00 
Plate 1 B03 M-011954-02 AKAP5 9495 NM_004857 3.13 
Plate 1 B04 M-004041-02 AKR1C4 1109 NM_001818 8.04 
Plate 1 B05 M-003002-02 AKT3 10000 NM_005465 5.04 
Plate 1 B06 M-008379-02 ALDH9A1 223 NM_000696 6.12 
Plate 8 A08 M-009026-01 ALOX15B 247 NM_001141 6.70 
Plate 1 B08 M-010174-01 AMPD3 272 NM_001025389 4.25 
Plate 9 F08 M-011206-01 ANG 283 NM_001097577 11.28 
Plate 1 B09 M-008417-02 ANK2 287 NM_020977 5.08 
Plate 1 B11 M-013755-00 ANKRD2 26287 NM_020349 8.00 
Plate 1 B12 M-016466-00 ANKRD5 63926 NM_022096 4.31 
Plate 1 C03 M-020957-01 ANKRD7 56311 NM_019644 1.85 
Plate 8 A09 M-006838-03 ANLN 54443 NM_018685 82.92 
Plate 1 G12 M-006838-03 ANLN 54443 NM_018685 88.50 
Plate 1 C04 M-011212-00 ANXA11 311 NM_001157 6.48 
Plate 1 C05 M-011209-01 ANXA5 308 NM_001154 4.77 
Plate 1 C06 M-011210-01 ANXA6 309 NM_004033 13.24 
Plate 1 C07 M-010760-01 ANXA7 310 NM_001156 16.52 
Plate 1 C08 M-019183-01 AP1G1 164 NM_001128 1.82 
Plate 1 C09 M-008170-01 AP2M1 1173 NM_001025205 2.78 
Plate 1 C10 M-008335-01 ARHGAP17 55114 NM_018054 5.21 
Plate 8 A10 M-010360-00 ARHGEF11 9826 NM_014784 17.24 
Plate 8 A11 M-012083-01 ARL4A 10124 NM_212460 24.13 
Plate 8 A12 M-012408-01 ARL5 26225 NM_177985 22.64 
Plate 8 A04 M-020372-01 ARP3BETA 57180 NM_001040135 9.27 
Plate 8 B03 M-012081-00 ARPC2 10109 NM_005731 4.20 
Plate 8 A05 M-019043-01 ARPM2 140625 NM_080431 10.97 
Plate 8 B04 M-013180-00 ASB12 142689 NM_130388 3.85 
Plate 3 C11 M-016064-01 ASPRV1 151516 NM_152792 10.77 
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Plate 1 D03 M-003326-08 AURKB 9212 NM_004217 74.49 
Plate 10 A10 M-003326-08 AURKB 9212 NM_004217 78.53 
Plate 9 C11 M-003326-08 AURKB 9212 NM_004217 80.97 
Plate 1 D04 M-005432-00 AVPR2 554 NM_000054 5.16 
Plate 8 B05 M-019319-01 B3GTL 145173 NM_194318 8.96 
Plate 1 A08 M-008243-02 BAF53A 86 NM_177989 11.53 
Plate 1 D06 M-003873-02 BARD1 580 NM_000465 8.71 
Plate 1 D09 M-020487-01 BAZ2B 29994 NM_013450 6.36 
Plate 10 A06 M-013536-00 BBP 83941 NM_032027 5.94 
Plate 8 B06 M-012708-00 BCAS2 10286 NM_005872 11.71 
Plate 1 D10 M-004386-01 BFAR 51283 NM_016561 3.99 
Plate 1 D12 M-011219-01 BMP2 650 NM_001200 10.47 
Plate 1 E03 M-004933-04 BMPR1A 657 NM_004329 3.93 
Plate 8 B07 M-015957-00 BTBD14A 138151 NM_144653 6.80 
Plate 1 E04 M-019161-01 BTN3A2 11118 NM_007047 5.81 
Plate 1 E08 M-014732-00 C10ORF45 83641 NM_031453 6.81 
Plate 1 E09 M-018851-02 C10ORF53 282966 NM_001042427 5.94 
Plate 10 A03 M-013900-02 C10ORF61 26123 NM_015631 6.59 
Plate 1 E10 M-014035-01 C11ORF24 53838 NM_022338 2.80 
Plate 10 C05 M-017741-00 C13ORF22 10208 NM_005800 15.71 
Plate 1 E12 M-012952-01 C13ORF23 80209 NM_170719 8.86 
Plate 7 E11 M-015254-01 C14ORF150 112840 NM_080666 21.24 
Plate 8 B11 M-007044-00 C14ORF4 64207 NM_024496 10.00 
Plate 1 F03 M-018521-01 C14ORF54 161142 NM_173526 3.79 
Plate 1 F04 M-020807-00 C14ORF94 54930 NM_017815 15.48 
Plate 1 F05 M-015917-01 C18ORF24 220134 NM_145060 21.71 
Plate 8 B12 M-023865-01 C19ORF7 23211 NM_015168 6.83 
Plate 8 C03 M-020490-00 C1GALT1 56913 NM_020156 8.17 
Plate 8 C06 M-033644-00 C1orf178 440603 NM_001010922 6.67 
Plate 1 F10 M-017146-01 C1QTNF2 114898 NM_031908 9.84 
Plate 1 F11 M-013787-01 C20ORF77 58490 NM_021215 14.20 
Plate 2 G10 M-019909-00 C21ORF5 9980 NM_005128 5.35 
Plate 1 F12 M-020812-01 C21ORF91 54149 NM_001100421 11.91 
Plate 1 G03 M-018422-01 C2ORF17 79137 NM_024293 4.26 
Plate 1 G04 M-013862-00 C2ORF25 27249 NM_015702 5.25 
Plate 1 G05 M-010273-01 C3F 10162 NM_005768 11.99 
Plate 1 G07 M-011122-01 C4B 721 NM_001002029 3.82 
Plate 1 G08 M-025105-01 C6ORF110 55362 NM_018426 4.14 
Plate 1 G09 M-027225-01 C6ORF167 253714 NM_198468 13.24 
Plate 1 G10 M-015508-01 C6ORF51 112495 NM_138408 14.90 
Plate 6 C06 M-016343-00 C8ORF20 80346 NM_025232 7.91 
Plate 10 C09 M-016561-01 C9ORF112 92715 NM_138778 6.19 
Plate 1 H03 M-014311-01 C9ORF16 79095 NM_024112 12.75 
Plate 1 H05 M-003634-01 CA12 771 NM_001218 3.32 
Plate 1 H06 M-018982-00 CABP7 164633 NM_182527 4.13 
Plate 1 H07 M-012519-01 CACNG4 27092 NM_014405 46.71 
Plate 1 H09 M-008197-01 CALR 811 NM_004343 8.29 
Plate 1 H10 M-004940-00 CAMK1 8536 NM_003656 6.07 
Plate 1 H11 M-004943-04 CAMK2B 816 NM_172084 34.56 
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Plate 2 A03 M-003636-03 CANX 821 NM_001024649 8.06 
Plate 8 C10 M-012212-01 CAPZA1 829 NM_006135 8.67 
Plate 5 B12 M-004398-00 CARD4 10392 NM_006092 13.11 
Plate 2 A05 M-003465-03 CASP2 835 NM_032983 5.73 
Plate 8 C11 M-009561-02 CBX7 23492 NM_175709 13.23 
Plate 2 A07 M-014775-01 CCDC8 83987 NM_032040 12.78 
Plate 8 C12 M-020279-00 CCDC9 26093 NM_015603 8.92 
Plate 2 A12 M-020147-00 CCT4 10575 NM_006430 4.65 
Plate 9 C06 M-004687-02 CDC2L1 984 NM_033487 26.84 
Plate 2 B03 M-011237-00 CDC5L 988 NM_001253 32.11 
Plate 2 B04 M-003233-03 CDC6 990 NM_001254 10.60 
Plate 2 B05 M-003238-02 CDK4 1019 NM_000075 3.18 
Plate 2 B06 M-003242-02 CDK8 1024 NM_001260 4.97 
Plate 2 B07 M-004797-01 CDKL2 8999 NM_003948 3.96 
Plate 2 B08 M-004799-03 CDKL5 6792 NM_001037343 6.29 
Plate 2 B09 M-003248-01 CDT1 81620 NM_030928 12.57 
Plate 2 B10 M-008755-01 CDYL2 124359 NM_152342 5.75 
Plate 2 B11 M-003252-02 CENPE 1062 NM_001813 19.24 
Plate 2 C04 M-032250-01 CEP192 55125 NM_032142 17.57 
Plate 2 C03 M-006893-01 CEP55 55165 NM_018131 86.13 
Plate 7 F10 M-020317-00 CGI-127 51646 NM_016061 6.60 
Plate 6 E03 M-020992-01 CGI-49 51097 NM_016002 6.56 
Plate 3 B11 M-021013-01 CGI-90 51115 NM_016033 6.69 
Plate 7 D11 M-021018-01 CGI-94 51118 NM_016037 7.84 
Plate 2 C05 M-015779-01 CHRDL1 91851 NM_145234 8.01 
Plate 8 D04 M-006139-01 CHRNA5 1138 NM_000745 9.55 
Plate 8 D05 M-004613-00 CIT 11113 NM_007174 86.90 
Plate 4 A07 M-004613-00 CIT 11113 NM_007174 93.98 
Plate 8 D06 M-017099-02 CKAP2 26586 NM_018204 15.71 
Plate 2 C06 M-006847-02 CKAP5 9793 NM_014756 78.43 
Plate 2 C07 M-007678-00 CKS2 1164 NM_001827 6.85 
Plate 2 C08 M-006831-01 CLASP1 23332 NM_015282 3.40 
Plate 2 C09 M-006157-02 CLCNKB 1188 NM_000085 17.63 
Plate 2 C10 M-012294-01 CLDN16 10686 NM_006580 8.79 
Plate 2 C12 M-004800-01 CLK1 1195 NM_004071 8.90 
Plate 8 D11 M-007856-00 CNTFR 1271 NM_001842 6.19 
Plate 2 D03 M-009725-01 CNTNAP1 8506 NM_003632 7.50 
Plate 2 D04 M-015904-00 COG7 91949 NM_153603 5.12 
Plate 2 D05 M-011009-01 COL10A1 1300 NM_000493 7.37 
Plate 2 D06 M-011835-01 COPA 1314 NM_004371 11.88 
Plate 2 D09 M-017940-00 COPB 1315 NM_016451 11.90 
Plate 2 D10 M-010493-01 CORO1B 57175 NM_001018070 22.68 
Plate 8 D12 M-017331-00 CORO1C 23603 NM_014325 41.25 
Plate 2 D11 M-013104-00 COTL1 23406 NM_021149 14.06 
Plate 2 D12 M-013179-00 COX7A2L 9167 NM_004718 4.67 
Plate 8 E03 M-005819-02 CPA5 93979 NM_080385 3.10 
Plate 2 E03 M-008754-00 CRABP1 1381 NM_004378 7.44 
Plate 8 E04 M-004412-01 CRADD 8738 NM_003805 6.30 
Plate 2 E04 M-019757-01 CRISP2 7180 NM_003296 4.28 
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Plate 2 E05 M-017044-02 CRYGN 155051 NM_144727 8.07 
Plate 2 E06 M-003110-02 CSK 1445 NM_004383 4.36 
Plate 2 E07 M-019940-02 CSN3 1448 NM_005212 9.88 
Plate 2 E08 M-007679-00 CSNK2B 1460 NM_001320 11.85 
Plate 2 E09 M-020003-01 CTDSPL 10217 NM_005808 14.15 
Plate 2 E10 M-016267-02 CTLA4 1493 NM_001037631 7.74 
Plate 2 E11 M-017535-00 CTNNBL1 56259 NM_030877 10.43 
Plate 2 E12 M-012572-01 CTNND1 1500 NM_001085469 19.23 
Plate 8 E05 M-005833-01 CTRC 11330 NM_007272 3.72 
Plate 8 E06 M-005834-00 CTRL 1506 NM_001907 5.23 
Plate 2 F03 M-004086-01 CUL1 8454 NM_003592 48.39 
Plate 6 A10 M-015828-01 CX40.1 219770 NM_153368 8.00 
Plate 2 F05 M-016697-01 CYC1 1537 NM_001916 16.67 
Plate 8 E07 M-008736-00 CYP2C19 1557 NM_000769 7.67 
Plate 2 F07 M-011841-01 DBN1 1627 NM_004395 8.02 
Plate 2 F09 M-004269-02 DCLRE1C 64421 NM_022487 7.06 
Plate 2 F10 M-012874-00 DCTN1 1639 NM_004082 5.10 
Plate 2 F11 M-012218-00 DCTN2 10540 NM_006400 3.81 
Plate 8 E08 M-010397-01 DDX24 57062 NM_020414 4.64 
Plate 2 F12 M-009333-00 DGAT2 84649 NM_032564 21.05 
Plate 8 E10 M-006717-01 DGKI 9162 NM_004717 4.13 
Plate 8 E11 M-006670-01 DHPS 1725 NM_013407 23.44 
Plate 2 G03 M-010506-02 DHX8 1659 NM_004941 21.19 
Plate 2 A10 M-014708-01 DKFZP434K1
172 83446 
NM_031290 
9.14 
Plate 2 A06 M-019301-02 DKFZP434O0
527 255101 
NM_152389 
7.69 
Plate 2 G04 M-014787-00 DKFZP434P0
316 84074 
NM_032134 
6.27 
Plate 3 A08 M-013812-01 DKFZP547C1
76 55531 
NM_018712 
7.03 
Plate 2 G05 M-020539-01 DKFZP564C1
86 26155 
NM_015658 
7.44 
Plate 10 D09 M-019325-00 DKFZP686L1
814 132660 
NM_194282 
16.23 
Plate 4 E06 M-019325-00 DKFZP686L1
814 132660 
NM_194282 
23.72 
Plate 7 G11 M-016535-01 DKFZP761B1
28 144348 
NM_152437 
9.35 
Plate 1 C11 M-017365-00 DKFZP761H0
79 200894 
NM_144996 
5.65 
Plate 4 G08 M-018560-01 DKFZP761N1
114 148808 
NM_181644 
63.33 
Plate 8 E12 M-015059-01 DMRTC1 63947 NM_033053 5.98 
Plate 2 G06 M-005281-02 DNCL1 8655 NM_003746 8.81 
Plate 2 G07 M-012092-01 DNM1L 10059 NM_005690 8.64 
Plate 2 G08 M-019915-00 DOCK2 1794 NM_004946 4.53 
Plate 2 G09 M-014040-00 DOCK9 23348 NM_015296 6.01 
Plate 2 G11 M-008343-00 DPEP3 64180 NM_022357 36.14 
Plate 2 G12 M-005477-01 DRD1 
1812 
NM_000794 
6.80 
Plate 9 F03 M-020467-02 DSCR1L2 11123 NM_013441 3.56 
Plate 2 H04 M-007892-01 DUSP19 142679 NM_080876 1.96 
Plate 2 H05 M-003568-01 DUSP8 1850 NM_004420 12.66 
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Plate 2 H06 M-006828-02 DYNC1H1 1778 NM_001376 3.65 
Plate 2 H07 M-004730-03 DYRK2 8445 NM_003583 5.92 
Plate 7 B07 M-011023-01 DYT1 1861 NM_000113 10.30 
Plate 2 H08 M-006450-00 ECT2 1894 NM_018098 99.34 
    M-006450-00 ECT2 1894 NM_018098 99.34 
Plate 2 H11 M-004012-02 EEA1 8411 NM_003566 7.42 
Plate 8 F04 M-015668-00 EGFL7 51162 NM_016215 4.81 
Plate 3 A03 M-004276-02 EGLN1 54583 NM_022051 5.36 
Plate 3 A04 M-004277-00 EGLN2 112398 NM_053046 9.78 
Plate 3 A05 M-019022-02 EHD1 10938 NM_006795 4.19 
Plate 3 A06 M-004883-03 EIF2AK3 9451 NM_004836 5.79 
Plate 8 F05 M-005864-02 ELA3B 23436 NM_007352 5.56 
Plate 3 A07 M-015640-02 ELAC2 60528 NM_018127 9.46 
Plate 3 A09 M-021932-02 ENAH 55740 NM_018212 2.57 
Plate 8 D03 M-008893-01 ENC1 8507 NM_003633 4.10 
Plate 3 A10 M-009805-01 ENPP5 59084 NM_021572 9.17 
Plate 9 A12 M-010663-01 EPLIN 51474 NM_016357 3.29 
Plate 3 A11 M-012670-01 ERH 2079 NM_004450 5.69 
Plate 4 F09 M-004807-02 ERK8 225689 NM_139021 5.16 
Plate 3 B04 M-005491-01 F2RL2 2151 NM_004101 3.50 
Plate 7 A12 M-014908-00 FAM11A 84548 NM_032508 14.15 
Plate 3 B09 M-020870-00 FAM38A 9780 NM_014745 21.24 
Plate 3 B12 M-011033-01 FANCC 2176 NM_000136 6.29 
Plate 8 F08 M-013991-01 FANCE 2178 NM_021922 12.06 
Plate 8 F09 M-015068-01 FATE1 89885 NM_033085 10.09 
Plate 8 F10 M-017621-00 FBLN5 10516 NM_006329 9.02 
Plate 3 C04 M-012423-02 FBXL3P 26223 NM_012159 7.09 
Plate 7 H10   FBXO5     94.77 
Plate 5 A05 M-013584-01 FER1L3 26509 NM_133337 17.63 
Plate 8 F12 M-013145-01 FGF12 2257 NM_021032 10.86 
Plate 3 C06 M-003132-04 FGFR2 2263 NM_000141 4.29 
Plate 8 G03 M-009426-01 FKBP6 8468 NM_003602 5.02 
Plate 3 C07 M-018143-01 FLJ10276 55108 NM_018045 5.45 
Plate 6 G10 M-018144-00 FLJ10379 55133 NM_018079 11.94 
Plate 3 C03 M-022320-01 FLJ10719 55215 NM_018193 3.61 
Plate 9 E12 M-020984-00 FLJ11016 55285 NM_018301 2.33 
Plate 6 C12 M-021241-01 FLJ11164 55316 NM_018346 5.59 
Plate 1 G11 M-021056-00 FLJ11267 56260 NM_019607 3.19 
Plate 4 G04 M-008447-02 FLJ12847 79648 NM_024596 5.00 
Plate 2 B12 M-014577-02 FLJ13111 80152 NM_025082 11.66 
Plate 7 G12 M-014417-01 FLJ13841 79755 NM_024702 18.73 
Plate 5 D06 M-018156-00 FLJ14001 79730 NM_024677 5.61 
Plate 3 B08 M-015007-00 FLJ14668 84908 NM_032822 13.86 
Plate 7 B11 M-009655-02 FLJ20244 55621 NM_017722 17.30 
Plate 1 H04 M-020707-01 FLJ20245 54863 NM_017723 14.97 
Plate 3 C08 M-018096-01 FLJ20397 54919 NM_017802 6.36 
Plate 8 C04 M-020836-01 FLJ20508 54955 NM_017850 7.36 
Plate 3 B06 M-014365-01 FLJ21103 
79607 
NM_024556 
7.19 
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Plate 3 C09 M-016327-00 FLJ22318 64777 NM_022762 5.20 
Plate 6 F03 M-005321-00 FLJ23356 84197 NM_032237 12.35 
Plate 3 C10 M-018406-00 FLJ23657 152816 NM_178497 5.35 
Plate 2 F04 M-017083-00 FLJ25444 254158 NM_152761 22.63 
Plate 10 D03 M-016739-00 FLJ25476 149076 NM_152493 8.98 
Plate 8 B10 M-018954-01 FLJ25773 283598 NM_182560 26.69 
Plate 1 A11 M-008134-00 FLJ30473 150209 NM_144704 13.00 
Plate 3 G11 M-015913-01 FLJ30678 139324 NM_144657 5.42 
Plate 10 C12 M-016831-01 FLJ30726 124961 NM_153018 8.23 
Plate 10 D06 M-007122-01 FLJ31295 121274 NM_152320 5.66 
Plate 3 E09 M-015840-01 FLJ31978 144423 NM_144669 5.66 
Plate 1 E05 M-017181-00 FLJ32001 163882 NM_152609 7.40 
Plate 5 B04 M-004052-02 FLJ32685 152110 NM_152534 3.95 
Plate 1 F08 M-019223-01 FLJ32940 126859 NM_182766 6.99 
Plate 3 C12 M-016597-00 FLJ33008 145748 NM_152449 5.85 
Plate 2 A08 M-016956-01 FLJ33084 149483 NM_152500 20.76 
Plate 4 D05 M-017970-01 FLJ33207 339855 NM_178554 7.95 
Plate 10 C08 M-016825-01 FLJ33817 124997 NM_152348 8.50 
Plate 8 C08 M-015548-00 FLJ35725 152992 NM_152544 12.74 
Plate 5 C08 M-016639-00 FLJ35773 162387 NM_152599 2.35 
Plate 3 B10 M-016939-00 FLJ35782 170062 NM_152631 5.60 
Plate 8 H08 M-018861-00 FLJ35834 154865 NM_178827 4.62 
Plate 2 A11 M-015467-00 FLJ38159 220388 NM_152723 8.04 
Plate 1 B10 M-016498-01 FLJ38335 162282 NM_153228 15.88 
Plate 1 F07 M-027230-01 FLJ41131 284325 NM_198476 16.45 
Plate 1 F06 M-027257-01 FLJ45778 374872 NM_198532 6.11 
Plate 3 D04 M-010636-00 FLOT1 10211 NM_005803 5.18 
Plate 8 G04 M-004110-00 FOSL2 2355 NM_005253 6.25 
Plate 2 F06 M-005498-02 FY 2532 NM_002036 7.50 
Plate 8 G05 M-003962-01 FZD8 8325 NM_031866 10.23 
Plate 3 D05 M-006178-01 GABRR1 2569 NM_002042 10.93 
Plate 7 F06 M-017496-02 GAGED3 9502 NM_130777 11.21 
Plate 3 D06 M-014197-00 GALNT5 11227 NM_014568 6.38 
Plate 3 D09 M-004141-01 GALR3 8484 NM_003614 4.60 
Plate 3 D10 M-011665-00 GAS1 2619 NM_002048 7.30 
Plate 7 F09 M-005280-00 GAS41 8089 NM_006530 7.89 
Plate 8 G06 M-012040-01 GDF9 2661 NM_005260 8.64 
Plate 3 D11 M-011286-01 GDI1 2664 NM_001493 4.25 
Plate 3 D12 M-008717-00 GEM 2669 NM_005261 6.89 
Plate 3 E03 M-013342-01 GIMAP5 55340 NM_018384 6.94 
Plate 3 E04 M-019997-02 GIPC1 10755 NM_202494 6.85 
Plate 3 E05 M-017368-01 GJA5 2702 NM_181703 11.00 
Plate 8 G07 M-017887-01 GJB1 2705 NM_001097642 12.74 
Plate 3 E06 M-019948-02 GJB3 2707 NM_001005752 3.79 
Plate 3 E07 M-018750-00 GJE1 349149 NM_181538 7.83 
Plate 3 E08 M-012634-01 GLRX 2745 NM_002064 2.83 
Plate 3 E10 M-008561-00 GNA14 9630 NM_004297 8.43 
Plate 3 E11 M-003897-00 GNAI2 2771 NM_002070 6.30 
Plate 3 E12 M-010825-02 GNAS 2778 NM_001077488 3.83 
Appendix 
 
 209 
Plate 3 F03 M-017241-00 GNB2 2783 NM_005273 7.26 
Plate 3 F04 M-006876-01 GNB2L1 10399 NM_006098 10.90 
Plate 3 F05 M-012699-01 GNG5 2787 NM_005274 4.53 
Plate 3 F06 M-006413-01 GOLPH3L 55204 NM_018178 4.94 
Plate 3 F07 M-013510-00 GORASP1 64689 NM_031899 3.42 
Plate 3 F08 M-019045-01 GORASP2 26003 NM_015530 5.50 
Plate 3 F09 M-010980-02 GOSR2 9570 NM_054022 6.43 
Plate 3 F10 M-016826-00 GPATC1 55094 NM_018025 4.89 
Plate 3 F11 M-005553-01 GPR19 2842 NM_006143 27.43 
Plate 3 C05 M-005572-00 GPR41 2865 NM_005304 5.39 
Plate 3 F12 M-005581-02 GPR55 9290 NM_005683 5.88 
Plate 3 G03 M-005591-02 GPR68 8111 NM_003485 8.96 
Plate 3 G05 M-009445-01 GPX5 2880 NM_003996 5.59 
Plate 3 G06 M-004626-01 GRK5 2869 NM_005308 5.75 
Plate 8 G09 M-017321-01 GTPBP1 9567 NM_004286 5.23 
Plate 3 G07 M-006733-00 GUCY1B3 2983 NM_000857 17.81 
Plate 8 G10 M-005888-02 GZMA 3001 NM_006144 8.24 
Plate 3 G08 M-016696-00 HAVCR2 84868 NM_032782 7.57 
Plate 3 G09 M-012168-01 HAX1 10456 NM_001018837 7.67 
Plate 9 A06 M-007025-00 HCA127 55906 NM_018684 12.91 
Plate 3 G10 M-019953-01 HCFC1 3054 NM_005334 4.34 
Plate 6 D11 M-016834-01 HCNGP 29115 NM_013260 17.45 
Plate 3 G12 M-011049-01 HEXA 3073 NM_000520 5.62 
Plate 3 H03 M-013018-00 HHIP 64399 NM_022475 6.62 
Plate 6 B08 M-021212-02 HHL 9910 NM_001035230 7.37 
Plate 2 F08 M-016867-01 HIP-55 28988 NM_001014436 14.88 
Plate 3 H04 M-009431-01 HIP2 3093 NM_001111113 7.10 
Plate 3 H06 M-013126-00 HIST1H2AJ 8331 NM_021066 7.21 
Plate 3 H07 M-019163-02 HIST3H2A 92815 NM_033445 4.00 
Plate 8 G11 M-013228-02 HLA-DQA1 3117 NM_002122 9.87 
Plate 5 D04 M-008848-00 HMP19 51617 NM_015980 23.99 
Plate 8 G12 M-008488-01 HNMT 3176 NM_001024074 7.45 
Plate 3 H08 M-016845-01 HOOK1 51361 NM_015888 7.93 
Plate 3 H09 M-012911-00 HOXD1 3231 NM_024501 9.88 
Plate 3 H10 M-020867-01 HP1-BP74 50809 NM_016287 7.74 
Plate 6 A03 M-010102-01 HRMT1L2 3276 NM_198318 12.01 
Plate 6 A05 M-007773-00 HRMT1L6 55170 NM_018137 5.37 
Plate 3 H11 M-008140-02 HSD17B7 51478 NM_016371 8.55 
Plate 3 H12 M-021084-01 HSPA14 51182 NM_016299 4.40 
Plate 4 A03 M-008198-02 HSPA5 3309 NM_005347 7.76 
Plate 8 H03 M-004287-01 HSPBAP1 79663 NM_024610 11.88 
Plate 2 A09 M-020558-01 HSPC009 28958 NM_001040431 6.85 
Plate 4 H12 M-021196-01 HSPC242 51537 NM_001003704 5.80 
Plate 1 E07 M-017892-00 HT021 57415 NM_020685 7.72 
Plate 4 A04 M-016762-01 HTF9C 27037 NM_182984 14.24 
Plate 8 H04 M-005642-03 HTR5A 3361 NM_024012 12.99 
Plate 4 A05 M-012014-00 IBSP 3381 NM_004967 6.56 
Plate 4 A06 M-013217-01 IFNK 56832 NM_020124 14.61 
Plate 8 H05 M-012638-00 IFNW1 3467 NM_002177 4.89 
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Plate 8 H06 M-012190-01 IK 3550 NM_006083 12.89 
Plate 7 H11   IKIP     10.26 
Plate 8 H07 M-007990-01 IL4R 3566 NM_001008699 6.75 
Plate 4 A08 M-006823-01 INCENP 3619 NM_020238 97.40 
Plate 8 H09 M-006823-01 INCENP 3619 NM_020238 97.92 
Plate 4 A09 M-011701-02 INHBA 3624 NM_002192 5.47 
Plate 4 A10 M-003302-01 IRAK4 51135 NM_016123 3.70 
Plate 4 A11 M-004506-00 ITGB1 3688 NM_002211 6.52 
Plate 4 A12 M-009841-00 ITSN2 50618 NM_006277 18.24 
Plate 8 H10 M-017187-00 JAG2 3714 NM_002226 5.52 
Plate 4 B03 M-003145-02 JAK1 3716 NM_002227 7.89 
Plate 4 B04 M-011708-00 JUP 3728 NM_002230 13.21 
Plate 7 H12   KALRN     6.73 
Plate 8 H11 M-008846-01 KCNAB3 9196 NM_004732 5.30 
Plate 8 H12 M-006251-00 KCNJ6 3763 NM_002240 7.40 
Plate 4 B06 M-009140-01 KCNK18 338567 NM_181840 8.18 
Plate 9 A03 M-006264-01 KCNK5 8645 NM_003740 8.28 
Plate 4 B07 M-006265-00 KCNK6 9424 NM_004823 8.50 
Plate 4 B08 M-004461-01 KCNN4 3783 NM_002250 4.73 
Plate 4 B09 M-027333-00 KCNT2 343450 NM_198503 4.04 
Plate 9 A04 M-017862-00 KCTD13 253980 NM_178863 5.66 
Plate 4 B10 M-021199-01 KCTD5 54442 NM_018992 15.99 
Plate 4 B11 M-012453-00 KEAP1 9817 NM_012289 13.91 
Plate 7 C05 M-014094-01 KIAA0153 23170 NM_015140 14.01 
Plate 4 B12 M-022485-01 KIAA0350 23274 NM_015226 19.38 
Plate 4 C03 M-026188-01 KIAA0368 23392 NM_001080398 10.71 
Plate 3 H05 M-004786-00 KIAA0377 9677 NM_014659 10.70 
Plate 7 F12 M-006919-01 KIAA0478 9923 NM_014870 24.16 
Plate 9 A05 M-021259-00 KIAA0649 9858 NM_014811 10.29 
Plate 4 C04 M-025319-01 KIAA0895 23366 NM_001100425 7.30 
Plate 1 B07 M-021515-01 KIAA1163 57463 NM_020703 6.69 
Plate 5 E10 M-023583-02 KIAA1268 54625 NM_017554 6.65 
Plate 1 D05 M-023331-01 KIAA1447 57597 NM_001080519 7.42 
Plate 3 G04 M-015158-01 KIAA1893 114787 NM_052899 8.76 
Plate 4 C05 M-008252-01 KIF12 113220 NM_138424 13.49 
Plate 9 A09 M-004959-02 KIF2 3796 NM_004520 7.84 
Plate 9 A08 M-004957-01 KIF20A 10112 NM_005733 99.38 
Plate 4 C06 M-004957-01 KIF20A 10112 NM_005733 99.39 
Plate 4 C07 M-004962-00 KIF22 3835 NM_007317 6.07 
Plate 10 D10 M-004956-01 KIF23 9493 NM_004856 98.10 
Plate 4 C08 M-004956-01 KIF23 9493 NM_004856 100.00 
Plate 4 C09 M-004955-01 KIF2C 11004 NM_006845 14.58 
Plate 4 C10 M-008867-00 KIF5B 3799 NM_004521 7.88 
Plate 4 C11 M-004958-02 KIFC1 3833 NM_002263 18.01 
Plate 4 C12 M-008338-02 KIFC3 3801 NM_005550 13.29 
Plate 4 D03 M-014218-02 KLC2 64837 NM_022822 5.71 
Plate 4 D04 M-005906-01 KLK1 3816 NM_002257 4.64 
Plate 9 A10 M-018761-01 KRT25D 162605 NM_181535 4.30 
Plate 4 D06 M-017231-00 LAD1 3898 NM_005558 9.66 
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Plate 7 B08 M-013913-00 LAP1B 26092 NM_015602 5.66 
Plate 4 D10 M-019015-00 LCE1B 353132 NM_178349 15.16 
Plate 4 D09 M-003151-02 LCK 3932 NM_001042771 4.08 
Plate 9 A11 M-033067-00 LCN9 392399 NM_001001676 5.28 
Plate 4 D11 M-011718-01 LGALS1 3956 NM_002305 16.03 
Plate 9 F12 M-005615-01 LGR8 122042 NM_130806 4.43 
Plate 4 D12 M-031935-01 LIMD1 8994 NM_014240 14.84 
Plate 4 E03 M-007730-02 LIMK1 3984 NM_002314 3.46 
Plate 4 E04 M-011999-01 LIMS1 3987 NM_004987 9.90 
Plate 4 E05 M-018918-01 LIN9 286826 NM_173083 12.05 
Plate 4 E07 M-004978-01 LMNA 4000 NM_005572 12.54 
Plate 4 E08 M-005270-01 LMNB1 4001 NM_005573 5.45 
Plate 7 F05 M-023639-01 LOC126374 126374 NM_001080436 8.04 
Plate 8 D10 M-018979-01 LOC134147 134147 NM_138809 6.18 
Plate 5 C06 M-025360-01 LOC136242 136242 NM_001008270 9.66 
Plate 6 H08 M-007346-00 LOC136306 136306 NM_174959 65.05 
Plate 7 F07 M-032755-01 LOC139604 139604 NM_001099921 3.91 
Plate 8 F06 M-018737-01 LOC144347 144347 NM_181709 54.57 
Plate 10 D08 M-007139-02 LOC146542 146542 NM_001024683 7.57 
Plate 10 D12 M-010460-01 LOC146909 146909 NM_001080443 7.06 
Plate 4 E09 M-023794-01 LOC147645 147645 XM_085831 8.85 
Plate 9 C07 M-031931-00 LOC161247 161247 NM_203402 67.90 
Plate 7 D03 M-017807-00 LOC167127 167127 NM_174914 15.49 
Plate 9 A07 M-031748-00 LOC284058 284058 NM_015443 12.50 
Plate 3 D03 M-024742-01 LOC340152 340152 NM_207360 17.98 
Plate 8 F11 M-022374-01 LOC343413 343413 NM_001004310 2.62 
Plate 9 C05 M-034898-00 LOC492311 492311 NM_001007189 7.63 
Plate 8 B09 M-015521-01 LOC90668 90668 NM_138360 7.35 
Plate 8 E09 M-016878-01 LOC91614 91614 NM_001077242 13.49 
Plate 7 A11 M-015539-01 LOC92305 92305 NM_138385 12.20 
Plate 4 E10 M-008021-00 LOXL3 84695 NM_032603 6.05 
Plate 9 B03 M-004721-01 LRP1 4035 NM_002332 9.72 
Plate 9 B04 M-027194-01 LRP4 4038 NM_002334 6.93 
Plate 4 E11 M-003844-02 LRP5 4041 NM_002335 7.14 
Plate 4 E12 M-180353-00 LRTM2 654429 NM_001039029 12.35 
Plate 4 F03 M-019866-01 LY86 9450 NM_004271 10.78 
Plate 4 F04 M-008388-01 LYPLAL1 127018 NM_138794 14.59 
Plate 4 F05 M-010611-01 M6PR 4074 NM_002355 6.91 
Plate 4 F06 M-011327-00 MAGOH 4116 NM_002370 8.55 
Plate 9 B05 M-009369-01 MAOA 4128 NM_000240 7.29 
Plate 4 F10 M-003572-02 MAP2K1IP1 8649 NM_021970 5.79 
Plate 4 F07 M-003966-05 MAP2K5 5607 NM_002757 13.86 
Plate 4 F08 M-003587-01 MAP4K2 5871 NM_004579 4.46 
Plate 9 B06 M-004020-03 MASTL 84930 NM_032844 4.61 
Plate 4 F11 M-005659-02 MC3R 4159 NM_019888 20.79 
Plate 4 F12 M-005661-00 MC5R 4161 NM_005913 18.18 
Plate 4 G03 M-004570-00 MCP 4179 NM_002389 8.92 
Plate 7 D06 M-021121-01 MDS032 55850 NM_018467 8.75 
Plate 4 G05 M-014896-01 MEGF11 84465 NM_032445 6.82 
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Plate 4 G07 M-020071-01 MFAP1 4236 NM_005926 24.63 
Plate 4 G06 M-012177-01 MFI2 4241 NM_033316 6.18 
Plate 4 G09 M-012503-01 MGAT4B 11282 NM_014275 12.82 
Plate 1 E11 M-014628-01 MGC10946 80763 NM_030572 9.24 
Plate 4 G10 M-014850-00 MGC11061 84272 NM_032312 8.68 
Plate 4 G11 M-014974-00 MGC13125 84811 NM_032725 7.00 
Plate 4 G12 M-010186-01 MGC15763 92106 NM_138381 14.44 
Plate 7 G05 M-015908-00 MGC17986 163071 NM_153608 10.70 
Plate 4 H03 M-015142-01 MGC20398 91603 NM_052857 7.74 
Plate 10 B10 M-016109-01 MGC20470 143630 NM_145053 8.71 
Plate 3 B07 M-018738-01 MGC21688 131408 NM_144635 19.24 
Plate 8 C09 M-016181-01 MGC22793 221908 NM_145030 5.42 
Plate 9 C12 M-003978-02 MGC24137 143503 NM_152430 3.27 
Plate 5 C09 M-017069-00 MGC26647 219557 NM_152706 5.90 
Plate 4 H04 M-014261-00 MGC3036 65999 NM_023942 38.26 
Plate 8 F07 M-015721-01 MGC33371 143684 NM_144664 5.26 
Plate 6 C11 M-014848-01 MGC4189 84268 NM_001033002 36.76 
Plate 2 H12 M-014958-00 MGC4266 84766 NM_032680 11.31 
Plate 3 B05 M-019315-01 MGC45871 359845 NM_182705 12.42 
Plate 4 H05 M-014312-01 MGC4707 79096 NM_001003678 29.82 
Plate 8 C07 M-018640-01 MGC52423 149466 NM_182517 8.06 
Plate 1 H12 M-005349-02 MGC8407 79012 NM_024046 16.62 
Plate 8 C05 M-015087-00 MGC9084 92342 NM_033418 9.24 
Plate 1 F09 M-014303-00 MGC955 79078 NM_024097 7.21 
Plate 9 B07 M-009403-01 MGLL 11343 NM_001003794 11.73 
Plate 4 H06 M-024432-01 MICAL3 57553 NM_015241 9.65 
Plate 4 H07 M-019104-02 MKLN1 4289 NM_013255 9.25 
Plate 4 H08 M-010580-02 MLL5 55904 NM_018682 4.55 
Plate 4 H09 M-005954-01 MMP12 4321 NM_002426 12.12 
Plate 4 H10 M-012214-01 MS4A1 931 NM_021950 12.20 
Plate 4 H11 M-011732-02 MSN 4478 NM_002444 11.37 
Plate 9 B08 M-013953-01 MTBP 27085 NM_022045 4.23 
Plate 9 B09 M-004769-01 MYD88 4615 NM_002468 6.51 
Plate 5 A03 M-007668-01 MYH9 4627 NM_002473 10.97 
Plate 5 A04 M-006355-00 MYO6 4646 NM_004999 6.40 
Plate 5 A06 M-015642-00 MYOZ1 58529 NM_021245 9.63 
Plate 5 A07 M-014800-00 MYST1 84148 NM_032188 8.98 
Plate 9 B10 M-008648-01 NAGS 162417 NM_153006 8.31 
Plate 5 A09 M-019107-02 NCOA6 23054 NM_014071 9.51 
Plate 5 A10 M-020145-02 NCOR2 9612 NM_001077261 8.56 
Plate 9 B11 M-012675-01 NDUFB10 4716 NM_004548 9.27 
Plate 5 A11 M-019815-01 NDUFS3 4722 NM_004551 10.10 
Plate 5 A12 M-008306-00 NEDD1 121441 NM_152905 24.04 
Plate 5 B03 M-007178-02 NEDD4 4734 NM_006154 6.51 
Plate 9 B12 M-007187-02 NEDD4L 23327 NM_015277 15.08 
Plate 9 C03 M-018345-01 NEGR1 257194 NM_173808 7.69 
Plate 5 B05 M-004867-02 NEK3 4752 NM_152720 4.55 
Plate 5 B06 M-011092-00 NEU1 4758 NM_000434 7.82 
Plate 5 B07 M-016715-00 NEURL 9148 NM_004210 35.90 
Plate 5 B08 M-004766-01 NFKBIE 4794 NM_004556 5.21 
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Plate 5 B09 M-019900-01 NHP2L1 4809 NM_001003796 35.20 
Plate 5 B10 M-011489-00 NIPSNAP1 8508 NM_003634 10.51 
Plate 5 B11 M-009835-02 NKTR 4820 NM_005385 4.00 
Plate 5 C03 M-018267-01 NLRC5 84166 NM_032206 6.23 
Plate 9 C04 M-008951-01 NMNAT1 64802 NM_022787 3.83 
Plate 5 C04 M-012059-00 NOG 9241 NM_005450 6.05 
Plate 1 E06 M-016554-00 NOR1 127700 NM_145047 10.45 
Plate 5 C05 M-010194-00 NOX4 50507 NM_016931 3.95 
Plate 5 C10 M-015737-01 NPM1 4869 NM_001037738 5.03 
Plate 9 C08 M-012347-00 NPM3 10360 NM_006993 8.54 
Plate 5 C11 M-003429-00 NR5A1 2516 NM_004959 4.56 
Plate 5 C12 M-013871-00 NRIP3 56675 NM_020645 5.69 
Plate 5 D03 M-009401-01 NSF 4905 NM_006178 4.06 
Plate 5 D09 M-003161-02 NTRK3 4916 NM_002530 6.41 
Plate 5 D10 M-011980-00 NUP214 8021 NM_005085 5.84 
Plate 5 D11 M-012132-00 NUTF2 10204 NM_005796 11.46 
Plate 5 D12 M-024101-01 ODZ3 55714 NM_001080477 6.91 
Plate 5 E03 M-005147-03 OGG1 4968 NM_016827 7.07 
Plate 9 C09 M-012783-00 OIP5 11339 NM_007280 6.40 
Plate 9 C10 M-017475-02 OPRS1 10280 NM_147157 8.18 
Plate 6 F06 M-017475-02 OPRS1 10280 NM_147157 19.52 
Plate 6 A11 M-023248-01 OR4D1 26689 NM_012374 13.86 
Plate 5 E04 M-030003-00 OR51T1 401665 NM_001004759 17.48 
Plate 5 E05 M-030022-02 OR52E4 390081 NM_001005165 7.21 
Plate 5 E06 M-010528-00 OSM 5008 NM_020530 6.15 
Plate 9 D03 M-005690-01 P2RY10 27334 NM_198333 26.51 
Plate 1 D11 M-018580-00 P5326 83638 NM_031450 24.18 
Plate 5 E07 M-010027-02 PAEP 5047 NM_002571 9.57 
Plate 5 E08 M-010330-02 PAFAH1B1 5048 NM_000430 15.29 
Plate 9 D04 M-019597-01 PALM 5064 NM_001040134 11.76 
Plate 5 E09 M-005130-02 PAPPA 5069 NM_002581 16.72 
Plate 5 E12 M-011349-00 PCDH8 5100 NM_002590 9.42 
Plate 5 E11 M-032620-01 PCLO 27445 NM_014510 16.15 
Plate 9 D05 M-007648-01 PDE4B 5142 NM_001037339 5.08 
Plate 5 F03 M-007649-02 PDE4C 5143 NM_001098818 22.70 
Plate 9 D09 M-005019-00 PDK1 5163 NM_002610 3.32 
Plate 5 F04 M-005020-00 PDK2 5164 NM_002611 25.89 
Plate 5 F05 M-013081-01 PDLIM7 9260 NM_213636 8.50 
Plate 9 D06 M-003017-02 PDPK1 5170 NM_031268 18.39 
Plate 5 F06 M-017120-01 PDXP 57026 NM_020315 3.86 
Plate 9 D10 M-014911-00 PDZK4 57595 NM_032512 12.25 
Plate 5 F07 M-006545-00 PEX10 5192 NM_002617 5.57 
Plate 5 F08 M-012591-02 PEX13 5194 NM_002618 2.99 
Plate 5 F09 M-020445-02 PHACTR2 9749 NM_001100166 16.67 
Plate 9 D11 M-016904-01 PHPT1 29085 NM_014172 7.59 
Plate 5 F10 M-004004-03 PICALM 8301 NM_001008660 16.41 
Plate 9 D12 M-006777-03 PIK4CB 5298 NM_002651 10.76 
Plate 10 B09 M-003291-03 PIN1 5300 NM_006221 13.88 
Plate 10 E03 M-004030-02 PINK1 65018 NM_032409 7.38 
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Plate 5 F11 M-004904-00 PIP 5304 NM_002652 16.14 
Plate 5 F12 M-004535-00 PIP5K2C 79837 NM_024779 9.57 
Plate 5 G03 M-006916-00 PJA2 9867 NM_014819 2.62 
Plate 5 G04 M-008274-02 PLCB2 5330 NM_004573 4.19 
Plate 5 G05 M-004201-01 PLCE1 51196 NM_016341 3.92 
Plate 5 G06 M-003945-03 PLEC1 5339 NM_201378 8.17 
Plate 5 G07 M-003257-02 PLK3 1263 NM_004073 7.08 
Plate 9 E03 M-019593-01 PLRG1 5356 NM_002669 7.02 
Plate 5 G08 M-031971-01 PLXNA1 5361 NM_032242 12.27 
Plate 5 G09 M-006547-01 PML 5371 NM_033247 10.03 
Plate 5 G10 M-011886-00 PNUTL2 5414 NM_004574 6.71 
Plate 5 G11 M-012649-00 POLG 5428 NM_002693 8.85 
Plate 5 G12 M-016449-00 POP5 51367 NM_015918 8.15 
Plate 9 E04 M-019690-01 POU2F2 5452 NM_002698 4.13 
Plate 5 H04 M-011500-00 PPAP2C 8612 NM_003712 12.50 
Plate 5 H05 M-008907-00 PPIH 10465 NM_006347 12.01 
Plate 5 H06 M-016820-00 PPIL5 122769 NM_152329 6.58 
Plate 5 H07 M-008679-01 PPM1L 151742 NM_139245 8.81 
Plate 5 H03 M-008927-01 PPP1CA 5499 NM_206873 5.97 
Plate 5 H08 M-008685-00 PPP1CB 5500 NM_002709 6.83 
Plate 5 H09 M-011340-01 PPP1R12A 4659 NM_002480 11.99 
Plate 5 H10 M-004824-01 PPP2R2A 5520 NM_002717 5.79 
Plate 5 H11 M-003022-02 PPP2R2B 5521 NM_181676 9.55 
Plate 9 E05 M-009259-00 PPP5C 5536 NM_006247 6.61 
Plate 5 H12 M-009935-01 PPP6C 5537 NM_002721 17.97 
Plate 4 B05 M-019491-00 PRC1 9055 NM_003981 96.22 
Plate 10 D07 M-019491-00 PRC1 9055 NM_003981 97.14 
Plate 9 E06 M-017949-00 PRG2 5553 NM_002728 35.46 
Plate 9 E07 M-023495-01 PRICKLE2 166336 NM_198859 6.31 
Plate 9 E08 M-007675-00 PRKAB1 5564 NM_006253 8.74 
Plate 7 F03 M-005362-01 PRKWNK1 65125 NM_018979 10.13 
Plate 9 E09 M-006017-02 PRTN3 5657 NM_002777 9.69 
Plate 6 A06 M-005709-00 PTAFR 5724 NM_000952 4.44 
Plate 1 A07 M-008999-02 PTE2B 122970 NM_152331 9.64 
Plate 6 A07 M-005712-00 PTGER2 5732 NM_000956 5.60 
Plate 6 A08 M-004557-01 PTGS2 5743 NM_000963 6.69 
Plate 10 D11 M-008584-00 PTPDC1 138639 NM_152422 8.31 
Plate 6 A12 M-019214-00 RAB22A 57403 NM_020673 13.62 
Plate 6 B03 M-008828-01 RAB24 53917 NM_130781 6.40 
Plate 6 B04 M-008933-02 RAB37 326624 NM_175738 16.77 
Plate 6 B05 M-008539-01 RAB4A 5867 NM_004578 10.75 
Plate 6 B06 M-010388-00 RAB7 7879 NM_004637 13.68 
Plate 6 B07 M-003905-00 RAB8A 4218 NM_005370 5.36 
Plate 6 B09 M-007262-01 RABGGTB 5876 NM_004582 9.43 
Plate 6 B11 M-007741-01 RAC2 5880 NM_002872 6.98 
Plate 9 E10 M-008650-00 RACGAP1 29127 NM_013277 97.72 
Plate 6 B10 M-008650-00 RACGAP1 29127 NM_013277 99.69 
    M-008650-00 RACGAP1 29127 NM_013277 99.69 
Plate 2 H03 M-020543-00 RAMP 51514 NM_016448 7.56 
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Plate 6 B12 M-007676-01 RAPGEF3 10411 NM_006105 15.17 
Plate 9 E11 M-031911-00 RASL11A 387496 NM_206827 11.24 
Plate 6 C03 M-017623-02 RBBP9 10741 NM_006606 8.70 
Plate 6 C04 M-009065-00 RBM10 8241 NM_005676 12.89 
Plate 6 D04 M-009065-00 RBM10 8241 NM_005676 14.29 
Plate 2 H10 M-016635-00 RCD-8 23644 NM_014329 21.93 
Plate 9 F04 M-017962-01 RCN3 57333 NM_020650 5.69 
Plate 9 F05 M-010008-02 RDH10 157506 NM_172037 3.32 
Plate 6 C05 M-003629-00 RDH11 51109 NM_016026 12.05 
Plate 7 E10 M-014614-00 REC14 80349 NM_025234 8.47 
Plate 6 C07 M-013796-00 RGMA 56963 NM_020211 3.95 
Plate 9 F06 M-009419-00 RGS11 8786 NM_003834 4.61 
Plate 9 F07 M-006027-00 RHBDL1 9028 NM_003961 7.27 
Plate 6 C08 M-008340-01 RHOT2 89941 NM_138769 11.25 
      RISC NTC     6.56 
Plate 9 F09 M-021381-01 RNASE4 6038 NM_194431 4.64 
Plate 9 F10 M-006980-00 RNF141 50862 NM_016422 10.87 
Plate 6 C09 M-024565-01 RNF215 200312 NM_001017981 9.72 
Plate 5 C07 M-021562-03 RP13-
15M17.2 199953 
NM_001010866 
6.65 
Plate 6 C10 M-003753-03 RP6-
213H19.1 51765 
NM_001042452 
18.98 
Plate 6 A09 M-015749-01 RPA1 6117 NM_002945 23.10 
Plate 9 F11 M-004663-02 RPS6KA2 6196 NM_001006932 13.16 
Plate 2 C11 M-005294-00 RSN 6249 NM_002956 10.53 
Plate 6 D03 M-019212-01 RSU1 6251 NM_152724 7.31 
Plate 6 D05 M-006293-01 RYR2 6262 NM_001035 17.39 
Plate 6 D06 M-011766-01 S100A10 6281 NM_002966 4.96 
Plate 6 D09 M-012191-00 S100A2 6273 NM_005978 6.75 
Plate 6 D10 M-013463-03 S100A6 6277 NM_014624 6.81 
Plate 6 D12 M-017283-01 SART1 9092 NM_005146 14.78 
Plate 8 F03 M-013644-01 SART2 29940 NM_001080976 6.42 
Plate 1 C12 M-011772-01 SCA2 6311 NM_002973 5.06 
Plate 6 E04 M-012290-00 SCGB1D1 10648 NM_006552 20.40 
Plate 6 E05 M-003705-01 SCGB2A2 4250 NM_002411 9.45 
Plate 6 E06 M-006296-02 SCN11A 11280 NM_014139 5.51 
Plate 9 G03 M-020909-00 SCN1B 6324 NM_001037 12.66 
Plate 9 G04 M-006500-03 SCN5A 6331 NM_001099405 10.66 
Plate 6 E07 M-005373-01 SCYL1 57410 NM_001048218 6.33 
Plate 6 E08 M-018964-01 SDK1 221935 NM_001079653 7.64 
Plate 6 E09 M-017396-00 SDK2 54549 NM_019064 61.22 
Plate 9 G05 M-009582-00 SEC23A 10484 NM_006364 11.46 
Plate 6 E10 M-009592-01 SEC23B 10483 NM_032986 7.26 
Plate 6 E11 M-014166-00 SEC31L1 22872 NM_014933 2.87 
Plate 3 A12 M-013312-01 SEC3L1 55763 NM_178237 11.33 
Plate 3 B03 M-019010-01 SEC6L1 11336 NM_007277 4.15 
Plate 6 E12 M-007289-02 SEMA4B 10509 NM_198925 13.74 
Plate 9 G06 M-012062-01 SEPP1 6414 NM_005410 5.99 
Plate 9 G07 M-007724-01 SH2D4A 63898 NM_022071 9.48 
Plate 6 F04 M-015810-02 SH3GLB2 56904 NM_020145 8.19 
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      SI NTC     7.71 
Plate 9 G08 M-015154-00 SIGLEC11 114132 NM_052884 5.44 
Plate 1 H08 M-012521-01 SIP 27101 NM_001007214 3.32 
Plate 9 G09 M-017524-00 SIPA1 6494 NM_006747 9.09 
Plate 6 A04 M-015817-02 SKB1 10419 NM_006109 8.72 
Plate 8 D09 M-017179-00 SKD3 81570 NM_030813 5.96 
Plate 6 F07 M-019583-01 SLAMF1 6504 NM_003037 4.58 
Plate 9 G10 M-007446-01 SLC22A12 116085 NM_144585 5.97 
Plate 9 G11 M-007486-03 SLC25A5 292 NM_001152 5.44 
Plate 6 F08 M-007529-01 SLC30A8 169026 NM_173851 4.73 
Plate 9 G12 M-010705-01 SLC35D2 11046 NM_007001 6.75 
Plate 9 H03 M-007557-01 SLC37A4 2542 NM_001467 9.69 
Plate 9 H04 M-007590-02 SLC5A2 6524 NM_003041 4.90 
Plate 6 F09 M-007591-01 SLC5A3 6526 NM_006933 6.71 
Plate 6 F10 M-007435-00 SLCO4A1 28231 NM_016354 20.74 
Plate 6 F11 M-003850-02 SLK 9748 NM_014720 9.20 
Plate 9 H05 M-006836-01 SMC2L1 10592 NM_006444 3.96 
Plate 6 F12 M-017440-00 SMTN 6525 NM_006932 8.71 
Plate 6 G03 M-021129-01 SMU1 55234 NM_018225 33.55 
Plate 6 F05 M-017521-01 SN 6614 NM_023068 12.06 
Plate 6 G04 M-010056-01 SNFT 55509 NM_018664 46.69 
Plate 6 G05 M-016821-00 SNRPG 6637 NM_003096 50.89 
Plate 6 G06 M-011520-00 SNX4 8723 NM_003794 3.93 
Plate 6 G08 M-012983-01 SON 6651 NM_032195 49.22 
Plate 9 H06 M-016807-00 SPAG4L 140732 NM_080675 13.29 
Plate 9 H07 M-031850-01 SPATC1 375686 NM_198572 6.56 
Plate 6 G07 M-020897-02 SPCS2 9789 NM_014752 3.44 
Plate 9 H08 M-012558-01 SPP1 6696 NM_000582 5.53 
Plate 6 G09 M-015457-00 SPRY4 81848 NM_030964 19.94 
Plate 9 H09 M-017767-01 SRP14 6727 NM_003134 8.68 
Plate 10 A11 M-006563-02 SSA1 6737 NM_003141 6.46 
Plate 6 G11 M-003712-02 ST14 6768 NM_021978 7.98 
Plate 9 H10 M-008402-01 ST6GAL2 84620 NM_032528 2.08 
Plate 6 G12 M-011894-01 STAU 6780 NM_017454 25.49 
Plate 6 H03 M-005383-02 STK33 65975 NM_030906 22.36 
Plate 6 H04 M-004875-02 STK39 27347 NM_013233 11.52 
Plate 6 H05 M-019572-02 STRN 6801 NM_003162 20.47 
Plate 6 H06 M-009602-02 STS 412 NM_000351 6.64 
Plate 6 H07 M-012655-02 SYP 6855 NM_003179 11.61 
Plate 9 H11 M-019166-01 SYT8 90019 NM_138567 7.37 
Plate 6 H09 M-005736-01 TAAR1 134864 NM_138327 37.38 
Plate 6 H10 M-005739-01 TAS1R2 80834 NM_152232 24.72 
Plate 9 H12 M-014409-00 TBC1D17 79735 NM_024682 9.01 
Plate 6 H11 M-012152-00 TBL1X 6907 NM_005647 10.83 
Plate 6 H12 M-003780-02 TDG 6996 NM_003211 3.75 
Plate 7 A03 M-008506-00 TDO2 6999 NM_005651 3.88 
Plate 7 A06 M-019966-01 TFIP11 24144 NM_012143 6.37 
Plate 7 A07 M-003929-02 TGFBR1 7046 NM_004612 7.58 
Plate 7 A08 M-017078-00 THEG 51298 NM_016585 20.96 
Plate 7 A04 M-019488-01 TIMELESS 8914 NM_003920 4.58 
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Plate 10 A04 M-013948-03 TIPARP 25976 NM_015508 13.64 
Plate 1 A03 M-009932-02 TJP2 9414 NM_201629 4.08 
Plate 7 A09 M-009932-02 TJP2 9414 NM_201629 6.69 
Plate 7 A10 M-008086-01 TLR1 7096 NM_003263 15.97 
Plate 10 A05 M-005120-03 TLR2 7097 NM_003264 7.34 
Plate 10 A09 M-021501-00 TLT4 285852 NM_198153 18.11 
Plate 7 B03 M-009919-00 TNFAIP3 7128 NM_006290 7.35 
Plate 10 A07 M-014328-00 TNIP2 79155 NM_024309 8.31 
Plate 7 B04 M-004740-01 TNKS 8658 NM_003747 5.88 
Plate 10 A08 M-015315-00 TNP2 7142 NM_005425 20.30 
Plate 7 B05 M-011308-01 TNPO1 3842 NM_153188 7.42 
Plate 7 B06 M-015878-01 TOMM22 56993 NM_020243 6.38 
Plate 7 B09 M-014203-00 TOR1B 27348 NM_014506 5.73 
Plate 7 B10 M-007093-01 TRIM63 84676 NM_032588 13.35 
Plate 10 A12 M-006109-01 TRPA1 8989 NM_007332 5.96 
Plate 10 B03 M-006509-01 TRPC3 7222 NM_003305 4.53 
Plate 7 B12 M-006518-03 TRPV1 7442 NM_018727 9.73 
Plate 7 C03 M-013879-00 TRUB2 26995 NM_015679 2.43 
Plate 7 C04 M-009055-01 TSP50 29122 NM_013270 2.80 
Plate 10 B04 M-028592-01 TSPYL1 7259 NM_003309 26.44 
Plate 1 G06 M-014389-02 TTMP 79669 NM_024616 2.39 
Plate 7 C06 M-010685-02 TTYH2 94015 NM_052869 5.10 
Plate 10 B05 M-025280-01 TTYH3 80727 NM_025250 15.84 
Plate 7 C07 M-008779-01 TUBA1 7277 NM_006000 35.24 
Plate 7 C08 M-008265-01 TUBB2 10383 NM_006088 17.28 
Plate 7 C09 M-006791-01 TXNDC3 51314 NM_016616 10.56 
Plate 7 C10 M-008361-00 TXNL4 10907 NM_006701 6.73 
Plate 10 B06 M-004348-01 UBE2M 9040 NM_003969 9.15 
Plate 7 C11 M-013566-00 UBQLN2 29978 NM_013444 3.87 
Plate 10 B11 M-004062-01 UCK1 83549 NM_031432 6.60 
Plate 10 B12 M-011418-02 UCN 7349 NM_003353 6.11 
Plate 7 C12 M-007638-01 UCP3 7352 NM_022803 8.43 
Plate 7 D04 M-018039-00 UNC93A 54346 NM_018974 7.08 
Plate 7 D05 M-027236-01 UNQ3033 284415 NM_198481 5.87 
Plate 8 B08 M-032544-00 UNQ3112 399967 NM_212555 10.14 
Plate 7 A05 M-027221-01 UNQ9391 203074 NM_198464 5.61 
Plate 10 C03 M-006061-02 USP1 7398 NM_001017416 5.52 
Plate 7 D09 M-006077-01 USP29 57663 NM_020903 8.50 
Plate 7 D10 M-021294-03 USP30 84749 NM_032663 4.58 
Plate 10 C04 M-021192-00 USP52 9924 NM_014871 18.50 
Plate 10 C06 M-012326-02 UTS2 10911 NM_006786 12.43 
Plate 10 C07 M-012497-00 VAMP1 6843 NM_014231 7.87 
Plate 7 D12 M-021382-01 VAPA 9218 NM_194434 6.60 
Plate 7 E03 M-009288-01 VCL 7414 NM_003373 4.98 
Plate 7 E04 M-013581-01 VCX 26609 NM_013452 9.47 
Plate 7 E05 M-010894-00 VPS35 55737 NM_018206 3.35 
Plate 7 E06 M-004683-02 VRK1 7443 NM_003384 4.76 
Plate 7 E07 M-004684-02 VRK2 7444 NM_006296 8.10 
Plate 7 E08 M-016716-01 VTI1A 143187 NM_145206 8.78 
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Plate 5 D05 M-013551-01 WBSCR20C 260294 NM_001039487 14.43 
Plate 7 E09 M-013375-00 WDR5B 54554 NM_019069 9.43 
Plate 7 E12 M-010564-02 WFDC2 10406 NM_006103 7.91 
Plate 7 F04 M-005031-02 WNK4 65266 NM_032387 7.19 
Plate 10 C10 M-008659-03 WNT4 54361 NM_030761 5.93 
Plate 2 H09 M-008044-01 XEDAR 60401 NM_021783 6.96 
Plate 7 F08 M-003030-02 XPO1 7514 NM_003400 11.86 
Plate 7 F11 M-021226-01 ZBED4 9889 NM_014838 10.84 
Plate 10 C11 M-014903-00 ZC3HDC8 84524 NM_032494 9.32 
Plate 7 H04 M-021470-01 ZFP29 54993 NM_001007072 7.35 
Plate 7 G03 M-017752-01 ZFP42 132625 NM_174900 7.40 
Plate 7 G04 M-017676-01 ZHX2 22882 NM_014943 3.28 
Plate 7 G06 M-021350-00 ZNF189 7743 NM_003452 8.86 
Plate 5 A08 M-006578-02 ZNF42 7593 NM_003422 12.13 
Plate 7 G07 M-025188-01 ZNF479 90827 NM_033273 8.04 
Plate 7 H05 M-014327-00 ZNF495 79149 NM_024303 3.87 
Plate 10 D04 M-018086-00 ZNF511 118472 NM_145806 5.97 
Plate 7 G08 M-016106-00 ZNF549 256051 NM_153263 2.13 
Plate 10 D05 M-015888-00 ZNF561 93134 NM_152289 3.69 
Plate 7 G09 M-017929-00 ZNF575 284346 NM_174945 5.61 
Plate 7 G10 M-016640-01 ZNF579 163033 NM_152600 11.27 
Plate 7 H03 M-019562-01 ZNF85 7639 NM_003429 4.52 
 
 
Genes that are known to be part of the spliceosome assembly and pre-mRNA 
splicing pathway and whose depletion leads to mitotic defects were identified 
through the MitoCheck database (See section 5.1) and chromosome spread 
analysis was carried out in HeLa cells depleted of these genes using the 
SMARTpool siRNAs as listed below. Positive and negative controls used in the 
chromosome spread analysis are shaded in grey.    
No. Well Pool Catalog Number 
Gene 
Symbol 
GENE 
ID 
Gene 
Accession 
1 A01 M-019085-00 SNRPD3 6634 NM_004175 
2 A02 M-019575-01 SNRPF 6636 NM_003095 
3 A03 M-018672-01 SFRS1 6426 NM_006924 
4 A04 M-012380-01 U2AF2 11338 NM_001012478 
5 A05 M-012325-01 U2AF1 7307 NM_001025203 
6 A06 M-020061-02 SF3B1 23451 NM_001005526 
7 A07 M-016051-01 SF3A1 10291 NM_001005409 
8 A08 M-012252-02 PRPF8 10594 NM_006445 
9 A09 M-014161-00 SNRNP200 23020 NM_014014 
10 A10 M-019851-00 EFTUD2 9343 NM_004247 
11 A11 M-012821-01 PRPF6 24148 NM_012469 
12 A12 M-019900-01 NHP2L1 4809 NM_001003796 
13 B01 M-017283-01 SART1 9092 NM_005146 
14 B02 M-013447-01 SART3 9733 NM_014706 
15 B03 M-020071-01 MFAP1 4236 NM_005926 
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16 B04 M-011237-00 CDC5L 988 NM_001253 
17 B05 M-019593-01 PLRG1 5356 NM_002669 
18 B06 M-004668-02 PRPF19 27339 NM_014502 
19 B07 M-012708-00 BCAS2 10286 NM_005872 
20 B08 M-017535-00 CTNNBL1 56259 NM_030877 
21 B09 M-012446-00 SNW1 22938 NM_012245 
22 B10 M-018665-00 BUD31 8896 NM_003910 
23 B11 M-004914-01 XAB2 56949 NM_020196 
24 B12 M-017191-01 SLU7 10569 NM_006425 
25 C01 M-013213-00 CDC40 51362 NM_015891 
26 C02 M-021129-01 SMU1 55234 NM_018225 
27 C03 M-012190-01 IK 3550 NM_006083 
28 C04 M-015475-01 SGOL1 151648 NM_001012413 
29 C05 M-003271-01 MAD2L1 4085 NM_002358 
30 C06 M-006832-01 RAD21 5885 NM_006265 
31 C07 M-006833-00 SMC1A 8243 NM_006306 
32 C08 M-017813-00 LSM2 57819 NM_021177 
33 C09 M-017025-00 LSM4 25804 NM_012321 
34 C10 M-011327-00 MAGOH 4116 NM_002370 
35 C11 M-011965-00 RBM39 9584 NM_004902 
36 C12 M-022214-01 AQR 9716 NM_014691 
37 D01 M-014879-01 THOC3 84321 NM_032361 
 
